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Multiple Sclerosis (MS) is an immune-mediated inflammatory neurodegenerative disease, 
affecting both white and gray matter, leading to physical and cognitive dysfunction. Exacerbation 
of symptoms, caused by intensification of neuroinflammation, is characteristic of the relapsing-
remitting type of MS while neurodegeneration is more typical of progressive stages. Because of 
the complexity of the disease, biomarkers are being sought to track progression and observe the 
benefits of treatments that aim to repair or protect the central nervous system. In my doctoral work, 
I used Transcranial Magnetic Stimulation (TMS), a tool that measures corticospinal excitability 
(CSE), to investigate biomarkers of MS progression, and to understand whether superior fitness 
and exercise training would positively impact these biomarkers. 
In my first study, I demonstrated that people with MS have alarmingly low 
cardiorespiratory fitness which was associated with increasing intracortical inhibition, a biomarker 
of diminished neuroplasticity. Such inhibition was also associated with fatigue, one of the most 
troubling symptoms experienced by people with MS. In the second study, I investigated the 
patterns of how MS affected each brain hemisphere and revealed that early in the disease, people 
with MS seem to have paradoxically higher excitability in the hemisphere corresponding to the 
weaker hand. This suggested that the central nervous system may be in a state of hyperexcitability 
which I could detect using TMS. In the next two studies, I investigated the acute and long-term 
(12 weeks) effects of exercise on CSE among people with progressive MS. An acute bout of 
exercise was accompanied by increased excitation and reduction in inhibition but mainly in the 
hemisphere corresponding to the stronger hand. Those who were fitter had more robust benefits. 
After 12 weeks (3x/week) of walking exercise training, CSE enhanced bilaterally. Importantly, all 
CSE enhancements were short term and returned to baseline 3 months after cessation of the 
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exercise training. The results of my doctoral work support the use of TMS to investigate CSE and 
provide biomarkers of central nervous system integrity in MS. More importantly, these results 
demonstrated that sedentarism can negatively affect the MS brain, and that performing exercise 
can potentiate cortical mechanisms related to enhanced neuroplasticity. 
Abstract word count: 350/350. 
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 Multiple sclerosis (MS) is a complex progressive brain disease that leads to body 
dysfunctions. Diagnosing, predicting, and understanding the effectiveness of treatments is 
challenging in MS, due to the high intra- and inter-individual variability of MS-related processes. 
Because of that, clinical tools that evaluate biological markers (i.e. biomarkers) in MS are being 
sought. In my doctoral work, I used transcranial magnetic stimulation (TMS), a tool that measures 
excitation and inhibition of the central nervous system, to investigate biomarkers in MS and to 
understand the impact of physical fitness and exercise training on the MS brain. 
 In my first study, I showed that the alarmingly low levels of fitness in people with MS was 
associated with increased levels of central nervous system inhibition, which in turn was associated 
with higher levels of fatigue, the most troubling symptom experienced by people with MS. Such 
inhibition is known to blunt capacity of the brain to undergo changes (i.e. neuroplasticity), and 
these findings suggest that improving fitness can boost brain mechanisms, improve neuroplasticity, 
and mitigate MS symptoms. In my second study, I investigated the patterns of how MS affected 
each brain hemisphere and I revealed an unbalance of excitability between brain hemispheres. My 
next two studies investigated the effects of exercise in people with MS who lost their walking 
ability due to progressive MS. A single session of exercise was able to increase excitation and 
reduce inhibition in the more intact brain hemisphere. Those who were fitter had more robust 
benefits. In the longer-term, 12 weeks of exercise training that aimed at restoration of walking 
ability, increased both hemisphere’s excitation. Importantly, all enhancements were short term and 
returned to baseline 3 months after cessation of the exercise training. The results of my doctoral 
work support the use of TMS to provide central nervous system biomarkers in MS. More 
importantly, these results demonstrated that sedentarism can negatively impact the MS brain, and 
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that performing exercise can potentially boost brain mechanisms related to enhanced 
neuroplasticity. 




To all of those who made this doctoral thesis possible, I express my deepest gratitude. I 
would like to thank first, my supervisor Dr. Michelle Ploughman, who saw potential in me, 
provided me with the opportunity, guided, and continuously supported me throughout my doctoral 
studies. I acknowledge Dr. Ploughman to all my academic achievements during my doctoral 
studies, which were far beyond what I could ever have expected, and for that, I am forever grateful. 
I would like to thank my committee members Dr. Craig Moore and Dr. Kevin Power for their 
instruction and supervision. I wish to extend my special thanks to the MS society of Canada for 
funding me in numerous scientific conferences and training. I am also very grateful to all the 
members of the Recovery and Performance Laboratory for their hard work and to my study 
participants for contributing their valuable time and effort. 
I would like to thank several others that have played a decisive role in my academic 
journey. Those people, somehow, contributed to the completion of my doctoral studies. I would 
like to thank my co-workers, mentors, and friends Elizabeth Wallack, for believing in my potential, 
for all altruistic guidance, and constructive criticism, and Liam Kelly, for the enthusiastic 
mentorship and all the intellectual-philosophical, academic- and life-related conversations. My 
doctoral studies would not have been as insightful, smooth, and pleasant, without their everyday 
support and companionship. I would also like to thank my former supervisors Dr. Jean Christophe-
Houzel and Dr. Mariana Acquarone, who were always exceptionally supportive and who have 
helped me to face numerous challenges during my undergraduate studies at the Federal University 
of Rio de Janeiro, Brazil. Their assistance was of the most utmost importance so I could have 
achieved my overarching academic goals, which included the start of my doctoral studies. Muito 
obrigado por tudo. Voces foram essenciais. I should also acknowledge the former coordinator of 
vii 
 
the english as a second language program at the Memorial University, Prof. Janet Benger, for 
caring and for providing me the right opportunities that were crucial so I could have started my 
doctoral studies later. I acknowledge my girlfriend Caroline Guria Chagas, who showed her care, 
supported me and, no matter what, stayed by my side in this journey. Thanks also to my friends, 
parents, and family in Brazil for all the love and support.  
viii 
 
Table of Contents 
ABSTRACT .................................................................................................................................... ii 
General Summary .......................................................................................................................... iv 
Acknowledgements ........................................................................................................................ vi 
List of Tables ................................................................................................................................ xv 
List of Figures .............................................................................................................................. xvi 
List of Abbreviations ................................................................................................................. xviii 
Chapter 1: INTRODUCTION ..................................................................................................... 1 
1.1 Multiple Sclerosis (MS) ........................................................................................................ 1 
1.2 Importance of a Biomarker. .................................................................................................. 1 
1.3 Transcranial Magnetic Stimulation (TMS) – A Tool that Investigates Corticospinal 
Excitability and Provide Biomarkers of Neuroplasticity in Health and Disease. ....................... 3 
1.4 TMS and its Biomarkers of Exercise Training-Induced Brain Health and Enhanced 
Neuroplasticity. ........................................................................................................................... 7 
1.5 Rationale and Objective of the Studies. .............................................................................. 10 
1.6 Specific objectives of the studies ........................................................................................ 12 
Co-Authorship Statement.............................................................................................................. 15 
Chapter 2: Prolonged cortical silent period is related to poor fitness and fatigue, but not 
tumor necrosis factor, in Multiple Sclerosis. ............................................................................ 17 
ABSTRACT .............................................................................................................................. 18 
ix 
 
2.1 Introduction ......................................................................................................................... 20 
2.2. Materials and Methods ....................................................................................................... 22 
2.2.1 Participants. .................................................................................................................. 22 
2.2.1 TNF. .............................................................................................................................. 24 
2.2.2 Transcranial Magnetic Stimulation. ............................................................................. 24 
2.2.3 Subjective Fatigue ........................................................................................................ 25 
2.2.4 Cardiorespiratory Fitness .............................................................................................. 26 
2.3 Statistical Analysis .............................................................................................................. 26 
2.4. Results ................................................................................................................................ 28 
2.4.1 Transcranial Magnetic Stimulation. ............................................................................. 28 
2.4.2 Levels of cardiorespiratory fitness were not associated with physical disability. ........ 29 
2.4.3 No association between cytokine levels and fitness, fatigue or TMS measures. ......... 31 
2.4.4 Low cardiorespiratory fitness predicted greater brain inhibition. ................................ 31 
2.4.5 Higher brain inhibition predicted greater fatigue. ........................................................ 34 
2.5 Discussion ........................................................................................................................... 36 
2.5.1 Levels of cardiorespiratory fitness and physical disability in MS ................................ 36 
2.5.2 Cardiorespiratory fitness as a target to foster plasticity ............................................... 37 
2.5.3 Fatigue and CSP ........................................................................................................... 39 
2.5.4 No link between cardiorespiratory fitness and motor thresholds or nerve conduction 
speed. ..................................................................................................................................... 39 
x 
 
2.5.5 Cytokines, fitness, and fatigue ...................................................................................... 40 
6. Limitations ............................................................................................................................ 41 
7. Conclusion ............................................................................................................................. 42 
8. Disclosures ............................................................................................................................ 43 
Chapter 3: Asymmetry of Brain Excitability: A New Biomarker that Predicts Objective 
and Subjective Symptoms in Multiple Sclerosis ...................................................................... 44 
ABSTRACT .............................................................................................................................. 45 
3.1 Introduction ......................................................................................................................... 46 
3.2 Materials and Methods ........................................................................................................ 48 
3.2.1 Participants ................................................................................................................... 48 
3.2.2 Walking performance ................................................................................................... 49 
3.2.3 Upper extremity function .............................................................................................. 49 
3.2.4 Subjective Symptoms and Impact of MS ..................................................................... 49 
3.2.5 Cognitive Processing Speed ......................................................................................... 49 
3.2.6 Transcranial Magnetic Stimulation .............................................................................. 50 
3.3 Statistical Analyses ............................................................................................................. 51 
3.4 Results ................................................................................................................................. 53 
3.4.1 Participants ................................................................................................................... 53 
3.4.2 AMT revealed brain asymmetry ................................................................................... 56 
3.4.3 AMT asymmetry ratio predicted clinical measures ...................................................... 59 
xi 
 
3.4.4 Having higher excitability on the weaker side was associated with lower disability and 
faster cognitive processing speed .......................................................................................... 61 
3.4.5 Having higher excitability on the weaker side was associated with less severe 
subjective MS symptoms ....................................................................................................... 63 
3.5 Discussion ........................................................................................................................... 65 
3.5.1 Typical CSE asymmetry is disrupted in MS ................................................................ 67 
3.5.2 Is hyperexcitability compensatory, or an indicator of MS progression, or both? ........ 68 
3.5.3 CSE asymmetry and its treatments – What can we learn from evidence in stroke? .... 70 
3.6 Limitations .......................................................................................................................... 72 
3.7 Conclusion ........................................................................................................................... 72 
Chapter 4: Exercise-Induced Brain Excitability Changes in Progressive Multiple Sclerosis: 
A Pilot Study ................................................................................................................................ 74 
ABSTRACT .............................................................................................................................. 75 
4.1 Introduction ......................................................................................................................... 76 
4.2 Methods ............................................................................................................................... 77 
4.2.1 Participants ................................................................................................................... 77 
4.2.2 Experimental design ..................................................................................................... 80 
4.2.3 Outcome Measures ....................................................................................................... 82 
4.3 Statistical Analysis .............................................................................................................. 88 
4.3.1 Participants’ characteristics and its associations with baseline CSE and AE-induced 
CSE changes .......................................................................................................................... 88 
xii 
 
4.3.2 Effects of AE on CSE ................................................................................................... 89 
4.4 Results ................................................................................................................................. 90 
4.4.1 Participants’ characteristics .......................................................................................... 90 
4.4.2 AE session .................................................................................................................... 90 
4.4.3 Physical fitness, not workload performed, was associated with greater AE-induced 
CSE changes .......................................................................................................................... 91 
4.4.4 Exercise-induced CSE changes were limited to the stronger hand .............................. 94 
4.4.5 Effects of AE on CSE asymmetry ................................................................................ 96 
4.5 DISCUSSION ................................................................................................................... 101 
4.5.1 The effects of AE on intracortical inhibition .............................................................. 101 
4.5.2 The effects of AE on intracortical excitation .............................................................. 103 
4.5.3 Effects of AE on CSE in progressive MS – the role of fitness ................................... 104 
4.5.4 Effects of AE on reducing CSE asymmetry ............................................................... 105 
4.5.5 Limitations .................................................................................................................. 106 
4.6 Conclusion ......................................................................................................................... 106 
Chapter 5: Walking Training Enhances Corticospinal Excitability in Progressive Multiple 
Sclerosis – A Pilot Study ........................................................................................................... 108 
ABSTRACT ............................................................................................................................ 109 
5.1 Introduction ....................................................................................................................... 111 
5.2 Materials and Methods ...................................................................................................... 113 
xiii 
 
5.2.1 Experimental design ................................................................................................... 113 
5.2.2 Participants ................................................................................................................. 113 
5.2.3 Exercise intervention .................................................................................................. 116 
5.2.4 Outcome measures ...................................................................................................... 116 
5.2.5 Statistical Analysis ..................................................................................................... 120 
5.3 Results ............................................................................................................................... 121 
5.3.1 Exercise training increased corticospinal excitability in both hemispheres ............... 121 
5.3.2 Exercise training reduced intracortical inhibition in the hemisphere corresponding to 
the stronger hand ................................................................................................................. 128 
5.3.3 Changes in body composition, fitness, and exercise performance ............................. 130 
5.3.4 Overall corticospinal excitation increased post intervention in the stronger hand and 
was associated with reductions in fatigue ............................................................................ 132 
5.4 Discussion ......................................................................................................................... 137 
5.4.1 Physical exercise training to enhance corticospinal excitation in progressive MS .... 137 
5.4.2 Physical exercise training to reduce intracortical inhibition in progressive MS ........ 139 
5.4.3 Corticospinal excitability and fatigue in MS .............................................................. 142 
5.4.4 Limitations .................................................................................................................. 143 
5.5 Conclusion ......................................................................................................................... 144 
Chapter 6: Discussion ............................................................................................................... 146 
6.1 Thesis Overview ................................................................................................................ 147 
xiv 
 
6.2 Summary of findings ......................................................................................................... 147 
6.2.1 Findings from Chapter 2 ............................................................................................. 147 
6.2.2 Findings from Chapter 3 ............................................................................................. 148 
6.2.3 Findings from Chapter 4 ............................................................................................. 150 
6.2.4 Findings from Chapter 5 ............................................................................................. 151 
6.2 Overall Discussion ............................................................................................................ 153 
6.2.1 Using TMS to Provide Biomarkers in MS ................................................................. 153 
6.2.2 Single Pulse TMS to investigate Multiple Mechanisms of CSE ................................ 155 
6.2.3 Is There a Potential Link between Inflammation and CSE? ...................................... 159 
6.3 Summary and Conclusions ................................................................................................ 159 
REFERENCES ........................................................................................................................... 160 
Appendices .................................................................................................................................. 177 
Appendix 1: Ethics Approval (Chapter 2 and 3). .................................................................... 177 





List of Tables 
Table 1. 1 Commonly used TMS Single Pulse Derived variables .................................................. 9 
Table 2. 1 Participants characteristics ........................................................................................... 23 
Table 2. 2  Predictors of Corticospinal Excitability ...................................................................... 35 
Table 3. 1 Participants and Pearson’s correlations with interhemispheric ratio using AMT and 
RMT. ............................................................................................................................................. 55 
Table 3. 2 Predictive value of brain asymmetry on subjective and objective MS measures ........ 60 
Table 4. 1 Participants’ Demographics ......................................................................................... 79 
Table 4. 2 Participants’ Physical Fitness Profile and Aerobic Exercise Session .......................... 87 
Table 4. 3 Predictors of Corticospinal Excitability Change Post Aerobic Exercise. .................... 92 
Table 4. 4 Between and Within hands’ CSE differences – Sensitivity Analysis .......................... 99 
Table 5. 1 Participants’ Demographics, Body Composition, and Fitness .................................. 115 





List of Figures 
Figure 1. 1 Basic Neurophysiological Principles of a Transcranial Magnetic Stimulation (TMS)-
induced motor evoked potential (MEP) .......................................................................................... 5 
Figure 2. 1 Cardiorespiratory fitness and severity of MS-related disability ................................. 30 
Figure 2. 2 Associations between cardiorespiratory fitness and cortical silent period (CSP), and 
CSP with fatigue ........................................................................................................................... 32 
Figure 2. 3 MS patients with poorer cardiorespiratory fitness had greater brain inhibition ......... 33 
Figure 3. 1 Calculating the active motor threshold (AMT) asymmetry ratio based on hand 
impairment revealed two groups of MS patients .......................................................................... 58 
Figure 3. 2 Relationships between brain asymmetry and objective measures of MS symptoms . 62 
Figure 3. 3 Figure 3.3 Relationship between brain asymmetry and subjective symptoms ........... 64 
Figure 3. 4 Active motor threshold (AMT) asymmetry ratio (AMTweak side/AMTstronger side) 
revealed (a)symmetry patterns in MS patients associated with disease severity .......................... 66 
Figure 4. 1 Schematic overview of the experimental design ........................................................ 81 
Figure 4. 2 Physical fitness was associated with CSE changes (% changes) from acute aerobic 
exercise (AE) ................................................................................................................................ 93 
Figure 4. 3 Effects of aerobic exercise on excitatory and inhibitory recruitment curves (REC) .. 95 
Figure 4. 4 Effects of aerobic exercise on reducing asymmetry of excitatory recruitment curve 
(eREC) parameters ........................................................................................................................ 97 
Figure 5. 1 Effects of 10-week treadmill walking exercise training on active and resting motor 
thresholds .................................................................................................................................... 123 
Figure 5. 2 Effects of 10-week treadmill walking exercise training on corticospinal gain. ....... 125 
xvii 
 
Figure 5. 3 Effects of 10-week treadmill walking exercise training on motor evoked potential 
(MEP) amplitudes ....................................................................................................................... 127 
Figure 5. 4 Effects of 10-week treadmill walking exercise training on cortical silent period (CSP) 
time ............................................................................................................................................. 129 
Figure 5. 5 Effects of 10-week treadmill walking exercise training on body composition and 
physical fitness ............................................................................................................................ 131 
Figure 5. 6 Ten weeks of treadmill walking exercise training induced increased overall 






List of Abbreviations 
AAD   Ambulatory Assistive Devices 
AE   Aerobic Exercise 
AMPA   Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AMT   Active Motor Threshold 
AUC   Area Under the Curve 
CSE   Corticospinal Excitability 
CSP   Cortical Silent Period 
DD   Disease Duration 
DEXA   Dual-energy X-ray Absorptiometry 
DMD   Disease Modifying Drugs 
D-wave  Direct Wave 
EDSS   Expanded Disability Status Scale 
EMG   Electromyography 
eREC   Excitatory Recruitment Curve 
FDI   First Dorsal Interosseous Muscle 
HR   Heart Rate 
HRmax   Maximal Heart Rate 
xix 
 
I-wave   Indirect Wave 
iREC   Inhibitory Recruitment Curve 
GABAA  Gamma Aminobutyric Acid Receptor B 
GABAB  Gamma Aminobutyric Acid Receptor A 
MEP   Motor Evoked Potential 
MoCA   Montreal Cognitive Assessment 
MSIS   Multiple Sclerosis Impact Scale 
MSO   Maximal Stimulator Output 
MS   Multiple Sclerosis 
 MVC   Maximal Voluntary Contraction 
NMDA  N-Methyl- d-aspartate 
LM   Lean Mass 
PAR-Q  Physical Activity Readiness Questionnaire 
RMT   Resting Motor Threshold 
TBW   Total Body Weight 
TMS   Transcranial Magnetic Stimulation 
TNF   Tumor Necrosis Factor 
RRMS   Relapsing Remitting Multiple Sclerosis 
xx 
 
REC   Recruitment Curve 
RER   Respiratory Coefficient Ratio 
SDMT   Symbol Digit Modality Test 
SPMS   Secondary Progressive MS 
VAS   Visual Analog Scale 
VCO2   Volume of Dioxide Oxygen 
VO2   Volume of Oxygen 
VO2max  Maximal Volume of Oxygen Consumption (intake). 
 9HPT   Nine-hole Peg Test
1 
 
Chapter 1: INTRODUCTION 
1.1 Multiple Sclerosis (MS) 
MS is a progressive neurodegenerative disease that is characterized by chronic immune-
mediated processes that assault both white and gray matter of the central nervous system1-4. Sudden 
intensifications of inflammation that induce demyelination and neuronal death are called MS 
relapses – events typical of the relapsing remitting type of MS (RRMS)2. Spontaneous recovery 
from relapses (i.e. remitting phase) is typically only partial, thus leading to disability progression 
over time1. Approximately eighty percent of people with RRMS will accumulate brain lesions and 
develop secondary progressive MS (SPMS) – a phase in which there are no relapses or remissions 
but rather a steady progression of the disease2, 3. Studies suggest that teen to fifteen percent of 
people diagnosed with MS experience steady progression of symptoms with no remissions or 
relapses3, 5. These people are diagnosed with primary progressive MS (PPMS)5.  
Although these three forms of MS (RRMS, SPMS and PPMS) have been part of the lexicon 
of MS for decades, new understanding of disease activity, lesion formation and gray matter atrophy 
has led to reconsideration of these labels4, 6. Recent recommendations suggest that MS should be 
further categorized as active or inactive based on relapses and disease activity seen on central 
nervous system imaging. These new perspectives on MS clinical phenotypes indicates that the MS 
spectrum is more complex than previously thought and not fully understood. However in all cases, 
people with MS develop a variety of autonomic (e.g. thermoregulatory dysfunction)7, physical 
(e.g. fatigue, weakness), and cognitive (e.g. memory and learning impairments) dysfunctions8-11 
which negatively influence all dimensions of quality of life8, 10-13. 
1.2 Importance of a Biomarker. 
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The neurodegenerative processes underlying MS relapses and progression can be 
asymptomatic, with symptoms only clinically diagnosed when brain damage has already happened 
(i.e. relapse) or is extensive (i.e. progression)2-4. Because of the time delay, subsequent treatment 
strategies may be less effective due to the reduced capacity of the damaged brain to undergo 
changes (i.e. neuroplasticity)14-16. Therefore, identifying biomarkers that signal changes in central 
nervous system integrity which also measure the neurophysiological changes that precede MS 
attacks, neuronal death, and structural change (identified by structural central nervous system 
imaging) is highly warranted and a hot topic in the literature17-19. For example, serum levels of 
neurofilament light chain, a marker of neuroaxonal destruction (e.g. demyelination), appears years 
before MS diagnosis17. Development of these sensitive biomarkers could also help delineate when 
people transition between inflammatory (RRMS) and neurodegenerative phases (SPMS) of MS 
(i.e. prognosis). Identifying biomarkers that predict and characterize this pathophysiological 
transition is essential for introducing preferred and more effective treatments during each phase. 
Biomarkers would also help understand the effectiveness of treatment interventions, including 
rehabilitative therapies, and may help identify new drug targets. 
Bielekova and Martin19 provided the following definition to describe a biomarker of 
disease; “A biomarker is a characteristic that is objectively measured and evaluated as an 
indicator of normal biological processes, pathogenic processes or pharmacological responses to 
a therapeutic intervention”. They described several categories of biomarkers. One type are those 
that change as a disease changes and correlate with disease severity between individuals and within 
an individual over time. The second type detects the effects of a treatment that correspond to that 
treatment’s proposed mechanism(s) of action. Some biomarkers can be collected and assayed from 
biological fluid such as blood or cerebrospinal fluid while others could involve sophisticated 
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imaging techniques such as positron emission tomography or magnetic resonance imaging19. One 
potential method to gather biomarkers of central nervous system (dys)function is to use 
Transcranial Magnetic Stimulation (TMS)20. 
1.3 Transcranial Magnetic Stimulation (TMS) – A Tool that Investigates Corticospinal 
Excitability and Provide Biomarkers of Neuroplasticity in Health and Disease. 
The most important underlying mechanism responsible for promoting neuroplasticity is 
long-term potentiation (LTP)16, 21-23. LTP involves complexes interactions between pre- and post-
synaptic inhibitory and excitatory connections mediated by a variety of neurotransmitters and their 
receptors activity. Among these cellular structures, importance has been given to excitatory 
ionotropic receptors of glutamate, N-methyl-D-aspartate (NMDAR)21 and α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPAR)24, as their upregulation increase brain excitability 
and strengthens neuronal connections to facilitate LTP. LTP also largely relies on the activity of 
ionotropic and metabotropic receptors of the inhibitory neurotransmitter gamma-aminobutyric 
acid (GABA), GABAA and GABAB, respectively. Increased amount of GABAergic-mediated 
intracortical inhibition undermines neuroplasticity, whereas its downregulation potentiates it16, 25, 
26. The process antagonist to LTP is called long-term depression (LTD)22, where the efficacy of 
neuronal connections is reduced and linked to reduced glutamatergic-mediated excitation and 
increased GABAergic-mediated inhibition26. It is important to note that, mechanistically, although 
neuroplasticity involves any brain change regardless the undergoing process (e.g. LTP or LTD)22, 
26, in the context of clinical research and rehabilitation, the term “neuroplasticity” is generally used 
to refer to positive changes that result from LTP processes. Therefore, throughout this thesis, 
“neuroplasticity” is being referred as the positive LTP-related processes. 
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In the human brain, the degree of neuronal excitation mediated by glutamatergic 
neurotransmission and voltage-gated sodium channels activity, and the degree of neuronal 
inhibition mediated by GABAergic neurotransmission can be measured by investigation of 
corticospinal excitability (CSE) using TMS20 (figure 1.1). By stimulating the brain’s primary 
motor area using a brief magnetic pulse (figure 1.1A), TMS can elicit neuronal activation and 
produce action potentials that travels through the corticospinal tract to generate a muscle twitch 
(figure 1.1B and C). This TMS-induced muscle twitch is referred to as motor evoked potential 




(A) The electrical current that is produced by the stimulator travels via an insulated wire and 
reaches the stimulator coil (e.g. figure of eight coil). The direction of flow of the electrical current 
within the coil (black arrows) is able to generate a perpendicular magnetic field (blue dotted lines), 
that (B) passes through the scalp painlessly and activates motor neurons in the primary motor area. 
(C) TMS elicits direct and/or indirect descending volleys (D- and I-waves, respectively) that travel 
from the brain to the spinal cord to elicit a MEP in the contralateral muscle under investigation 
(e.g. first dorsal interosseous, FDI). (D) TMS-induced MEPs are recorded via electromyography. 
(E) Offline analysis of corticospinal excitation (MEP peak-to-peak amplitude) and intracortical 
inhibition (cortical silent period (CSP) time; MEP onset to return of EMG background activity), 
and nerve conduction speed (MEP latency; time from TMS stimulus to MEP onset) from a TMS-
elicited MEP recorded by EMG of the FDI with participant performing tonic voluntary contraction 
(e.g. pinch grip). Original figure © Arthur R. Chaves. 
  
Figure 1. 1 Basic Neurophysiological Principles of a Transcranial Magnetic Stimulation 
(TMS)-induced motor evoked potential (MEP) 
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The most common TMS variable investigating CSE are the motor thresholds. Motor 
thresholds are evaluated as the least TMS intensity required to elicit a MEP, either in complete 
muscle relaxation or slight tonic contraction (resting and active motor threshold, respectively)20. 
Motor thresholds reflect the strength and size of the muscle representation in the primary motor 
area, availability of excitatory neurotransmitters (e.g. glutamate), its receptors (e.g. NMDAR and 
AMPAR), and sodium channels in cortical neurons20. A more detailed TMS protocol to investigate 
neuronal availability and strength of excitatory neurotransmission are the recruitment curves, in 
which a incremental increasing range of TMS stimulus intensities are employed to examine 
corresponding increases in MEP amplitudes that result from faster temporo-spatial summation of 
cortico-motoneuronal synapses20. GABAergic-mediated intracortical inhibition is typically 
measured using TMS as the length of the cortical silent period (CSP; Figure 1.1C), a period of 
interruption of muscle contraction tone post contralateral cortical stimulation, where short and 
long-lasting CSPs are mediated by GABAA and GABAB-receptor activity, respectively
20. 
Therefore, given the impact that neurological damage and neurodegeneration has on glutamatergic 
and GABAergic neuroplasticity-like mechanisms27, 28, it makes sense to investigate corticospinal 
excitability using TMS to better understand whether the lesion-disrupted brain has the potential to 
undergo recovery through neuroplasticity27, 28. 
Highly excitable and disinhibited brains require less intense TMS stimuli to evoke MEPs 
(i.e. lower motor thresholds), demonstrate higher MEP amplitudes (e.g. higher recruitment curves), 
and shortened CSP length. On the contrary, increased motor thresholds, poor TMS stimulus-to-
MEP amplitude accordance (i.e. poor recruitment curve), and excessive intracortical inhibition 
mediated by both GABAA- and GABAB-receptor activity are all biomarkers of pathologically 
reduced CSE29, brain damage (e.g. stroke)30, and diminished neuroplastic potential16, 31. Therefore, 
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in the context of clinical research and neuro-rehabilitation, the use of TMS helps to: 1) provide 
better understanding neuro-pathophysiological events, 2) identify whether these events can be used 
biomarkers that help to predict disease severity, progression, and recovery, and 3) investigate 
whether rehabilitation therapies are truly acting on the central nervous system to improve 
neuroplasticity and recovery. Table 1.1 summarizes the most typical protocol (collection and 
analysis), the proposed neurophysiological mechanisms and neurotransmission involved, as well 
as the potential clinical relevance (health and disease) of the abovementioned single pulse TMS 
variables (motor thresholds, MEP amplitude, CSP, MEP latency). 
1.4 TMS and its Biomarkers of Exercise Training-Induced Brain Health and Enhanced 
Neuroplasticity. 
 A robust body of TMS research in healthy individuals has demonstrated that long-term 
physical exercise and superior fitness improves biomarkers of CSE32-37. Fit individuals have lower 
motor thresholds35, higher MEP amplitudes35, 37, decreased CSP32, 33, and demonstrate higher 
neuroplastic potential when tested for neuroplasticity-induced protocols such as CSE-induced 
changes following acute physical exercise38 and paired-associative stimulation39. Studies have 
shown that upregulation and the chronicity of exercise-induced release of neurotrophins such as 
brain-derived neurotrophic factor, insulin grow factor-1, vascular endothelial grow factors and, 
nerve grow factor, are factors that associate with such superior brain health seen in fitter 
individuals36, 40. Neurotrophins play an essential role in supporting optimal neuronal function and 
health, proliferation of neurons and glial cells (i.e. neurogenesis and gliogenesis, respectively) and 
formation of new cerebral blood vessels (i.e. angiogenesis). For all those reasons, physical exercise 
is believed to be a potential rehabilitation therapy for counteracting the maladaptive effects of 
brain lesions. Despite such evidence, several studies demonstrate that people with MS are 
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sedentary and do not exercise41-45. This is concerning since low fitness is known to aggravate MS46, 
47.  Yet, the effects of physical inactivity and low fitness on the MS brain, however, has not been 
described in depth. Investigating the relationship between TMS variables and fitness in the MS 
brain could provide some insight into the importance of long-term exercising on neuroplasticity-
like mechanisms in MS. 
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Table 1. 1 Commonly used TMS Single Pulse Derived variables 
 



















The minimal MSO% to 
elicit 5/10 MEPs with ≥ 




Assesses integrity of the 
corticospinal tract; eliciting 
MEPs via indirect activation of 





Following brain damage 
(e.g. progressive MS, 
stroke) the corticospinal 
tract becomes less 
excitable and motor 








The minimal MSO% to 
elicit 5/10 MEPs with ≥ 
200µV, in the 
contralateral contracted 
muscle (e.g. 10% MVC). 
MSO% (0-100) 
Assesses integrity of the 
corticospinal tract; eliciting 
MEPs via direct activation of 






delivered and MEPs are 





Assesses ability of the 
corticospinal tract to permit 
increases in MEP amplitudes 










Following brain damage 
(e.g. progressive MS, 
stroke) MEP amplitudes 
are typically reduced and 
more difficult to facilitate 













delivered and MEPs are 
collected in the 
contralateral contracted 
muscle (e.g. 10% MVC). 
Time from the 
MEP onset or 
offset until the 
return of the 
EMG activity 
[Time (ms)] 
Assesses levels of spinal (initial 
~50ms of CSP) and cortical 
inhibition (later and predominant 
component of CSP). 
GABAA- GABAB-
receptor activity. 
CSP is prolonged 
especially in people 









TMS stimulations are 
delivered and MEPs are 
collected in the 
contralateral muscle. 
Time from TMS 
stimulus to the 
MEP onset [Time 
(ms)]. 
Assesses the efficiency of 
neuronal signal propagation 
(conduction time from cortex to 
muscle) through the 
corticospinal tract. 
- 
Brain damage impairs the 
overall transmission of 
the nerve impulse and 





Note: GABAA, γ-aminobutyric acid ionotropic receptor (role on short lasting inhibition); GABAB, γ-aminobutyric acid metabotropic receptor (role on long-lasting 
inhibition); MEP, motor evoked potential; MSO%, maximal stimulator output percentage (TMS stimulation intensity); NMDA, N-methyl-D-aspartate receptor; AMPA, 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; TMS, transcranial magnetic stimulation. 
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The key questions I address in this thesis are: 
1. To what extent do variables derived using TMS correlate with fitness and fatigue in people 
with MS?41 
2. Are there differences in corticospinal excitability between the hemispheres and if so, how 
does degree of asymmetry or laterality relate to disease severity?48 
3. When people with MS engage in a session of exercise, can we measure changes in 
corticospinal excitability using TMS? Are these exercise-induced changes in CSE related 
to symptom severity and/or baseline fitness?49 
4. Among people with MS with substantial walking disability, does a longer term exercise 
program produced sustained changes in CSE suggestive of neuroplasticity?50 
This thesis is written in manuscript style with each chapter addressing the overarching 
questions listed above. All the chapters have been published in peer reviewed journals with the 
publication information and authorship statements appearing before the respective chapter. For the 
purposes of thesis cohesiveness, the formatting and referencing is made uniform throughout in the 
superscript Vancouver style with the references appearing at the end of the thesis (after Chapter 6, 
Discussion). Because the chapters are stand-alone manuscripts, there is some overlap, but not 
duplication, of content particularly in the Introduction and Methods sections. 
1.5 Rationale and Objective of the Studies. 
 The ultimate goal of my doctoral work was to elucidate the effects of exercise training and 
fitness on biomarkers of CSE in MS as well as the association between exercise-induced CSE 
changes and MS symptoms. Although evidence demonstrating the impact of low levels of fitness 
on exacerbating MS symptoms exist, evidence on the impact of low fitness on the brain and 
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neuroplastic capacity in people with MS is lacking43. Yet, the current TMS literature in MS is 
marked by discrepancies across studies51-53, and therefore, it is challenging to predict and 
hypothesize the direction in which TMS biomarkers would change in response to improved fitness 
and exercise training. This variability could in part be due to the different TMS methodologies 
employed and MS population included as well as their levels of disability, and small sample sizes 
included51. Therefore, the first stage of my doctoral work was to investigate cross-sectionally the 
associations between physical fitness and neuroplastic-associated TMS variables in a cohort of 
people with MS who were consecutively recruited from an MS clinic. In this study41, I considered 
in my design and analysis some factors that could explain this literature’s variability; these 
included performing regressions while controlling for MS demographics such as disease duration, 
disability levels, MS types, and the use of disease modifying drugs, and assessing CSE bilaterally. 
The findings of this cross-sectional work would be essential in order to understand the 
relationships between CSE, fitness, and MS symptoms to finally hypothesize the direction in which 
the TMS variables would change in response to exercise in MS. The next stage of my doctoral 
work involved an interesting finding from this first work; a CSE symmetry (i.e. no difference 
between hemispheres) that is often reported by other authors as well. Because differences between 
hemispheres (e.g. dominant vs non-dominant) should exist based on healthy literature, I deemed 
that such grouped CSE symmetry in MS could be meaningful and worth of further investigation. 
Thus, in my second study48, I challenged this often overlooked finding of CSE symmetry, and I 
investigated the possible implications of such atypical feature during disease progression and MS 
symptoms. Because people with MS often demonstrate and/or complain about unilateral deficits 
such misrepresented CSE symmetry in MS suggested a particular pathophysiological feature of 
MS. The findings from these two studies paved the way in order to better design the TMS protocols 
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and hypothesize findings in my following studies. My next studies investigated the effects of 
exercise training in the CSE of highly disabled people with MS. First, I aimed to investigate the 
effects of acute exercise, and whether people with progressive MS were able to promote  bilateral 
exercise-induced CSE changes after the very first exercise session of  a 3-month period walking 
exercise training49 that was proposed to recover their walking ability54. In this study I also tested 
whether the acute exercise-induced CSE changes would be fitness dependent49. The next step was 
to test whether the in longer term this 3-month walking rehabilitative exercise training would 
promote CSE changes in these people with progressive MS, and whether the hypothesized 
enhancement in CSE would be correlated to symptom mitigation (e.g. reduces in fatigue) or fitness 
gains50. 
1.6 Specific objectives of the studies 
The four stages of my thesis are described separately in Chapters 2, 3, 4, 5, and 6 (Chapter 
1 is the thesis Introduction and Chapter 6 is the thesis (Discussion). 
Chapter 2: The primary aim of the first study was to investigate in people with MS the 
relationships between cardiorespiratory fitness, assessed as maximal volume of oxygen uptake 
(VO2max), and bilateral CSE assessed using TMS motor thresholds (resting and active motor 
threshold), MEP amplitudes and TMS recruitment curves, nerve conduction speed (MEP latency), 
and intracortical inhibition (CSP). The secondary aim of this first work was to investigate whether 
the fitness-associated CSE variables would predict MS-related fatigue when controlling for MS 
demographics [disability level (expanded disability status scale, EDSS), age, disease duration, MS 




Chapter 3: The aim of this study was to elucidate the existence of CSE (a)symmetry in MS 
and whether CSE (a)symmetry would predict disease progression and symptoms in MS.  First, I 
explored the relationships between CSE excitability asymmetry, assessed as a ratio between 
weaker and stronger sides’ AMT, and objective and subjective measures of MS symptom severity. 
Objective measures included, overall MS severity (EDSS), upper extremity dexterity (nine-hole 
peg test) and walking speed, as well as measures of cognition measured using the Montreal 
Cognitive Assessment and the Symbol Digit Modality Test. Subjective measures included fatigue, 
pain, and heat sensitivity measured using visual analog scales, and the patients’ perceptions of the 
physical and psychological impact of MS in daily life measured using the MS Impact Scale. 
Finally, I tested whether and to what degree CSE (a)symmetry predicted the severity of objective 
and subjective symptoms when controlling for MS demographics (MS type, disease duration, use 
of disease-modifying drugs, and handedness), factors thought to modulate CSE in MS or have 
implications in brain (a)symmetry. This study has been published in the Behavioural Brain 
Research journal48. 
Chapter 4: Based on my findings demonstrating possible superior neuroplasticity in fitter 
MS patients that showed lower intracortical inhibition (shorter CSP)41, my next study investigated 
whether acute exercise-induced CSE changes related to neuroplasticity were still retained in highly 
disabled people with progressive MS, and, secondly, whether exercise-induced CSE changes were 
associated with levels of fitness. Fitness levels were assessed as cardiorespiratory fitness (VO2max) 
and amount of lean mass and body fat percentage (Dual-energy X-ray absorptiometry). Exercise-
induced neuroplasticity was assessed with TMS and included: 1) resting and active motor 
thresholds, 2) MEP amplitudes and recruitment curve (slope, R2, and area under the curve), 3) 
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Short- and long-lasting CSP, and 4) MEP latency. This study has been published in the Journal of 
Neurologic Physical Therapy49. 
Chapter 5: The primary aim of this study was to investigate the effects of a treadmill 
walking aerobic exercise training program (3 months, 3x/week) on the CSE of people with 
progressive MS with severe MS-related walking disabilities. As a secondary aim, based on my 
previous findings demonstrating the link between cardiorespiratory fitness, fatigue, and CSE (CSP 
time) (Chapter 241), I expected that potential improvements in physical fitness (cardiorespiratory 
fitness, body fat) and/or mitigation of MS-related fatigue after this longer-term aerobic exercise 
training would accompany enhancements of CSE. This study has been published in the Frontiers 
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Chapter 2: Prolonged cortical silent period is related to poor fitness and 
fatigue, but not tumor necrosis factor, in Multiple Sclerosis. 
Chaves AR, Kelly LP, Moore CS, Stefanelli M, Ploughman M. Prolonged cortical silent period is 
related to poor fitness and fatigue, but not tumor necrosis factor, in Multiple Sclerosis. Clin 
Neurophysiol. 2019;130(4):474-483. doi:10.1016/j.clinph.2018.12.015 
As the first author of this, please note that I retain the right to include it in my doctoral 
thesis. Permission is not required, as I have cited the journal ‘Clinical Neurophysiology’ as the 






Objective: Poor fitness among people with multiple sclerosis (MS) aggravates disease 
symptoms. Whether low fitness levels accompany brain functioning changes is unknown. 
Methods: MS patients (n=82) completed a graded maximal exercise test, blood was drawn, and 
transcranial magnetic stimulation determined resting and active motor thresholds, motor evoked 
potential latency, and cortical silent period (CSP). 
Results: Sixty-two percent of participants had fitness levels ranked below 10th percentile. Fitness 
was not associated with disability measured using the Expanded Disability Status Scale (EDSS). 
Regression analyses revealed that, cardiorespiratory fitness, when controlling for disease 
demographics, contributed 23.7% (p < 0.001) to the model explaining variance in CSP. 
Regression analysis using cardiorespiratory fitness and CSP as predictors showed that CSP alone 
explained 19.9% of variance in subjective fatigue (p = 0.002). Tumor necrosis factor was not 
associated with any variable. 
Conclusion: Low fitness was associated with longer CSP in MS. Longer CSP was, in turn, 
related to greater MS fatigue. 
Significance: MS patients had extremely low levels of cardiorespiratory fitness. Poor fitness 
predicted longer CSP, a marker of greater intracortical inhibition, which was linked to MS 
fatigue. Future research should examine whether aerobic training could shorten CSP and 
potentially lessen inhibition of cortical networks. 
Keywords: Multiple Sclerosis; cardiorespiratory fitness; fatigue; tumor necrosis factor; 




• MS patients have extremely low levels of fitness regardless of levels of disability. 
• Poor cardiorespiratory fitness in MS associated with increased GABAergic intracortical 
inhibition. 






Multiple Sclerosis (MS) is a neuroimmune-inflammatory disease of the central nervous 
system and the most common cause of neurological disability among young adults worldwide55. 
In the relapsing remitting form of MS, unpredictable demyelination causes sudden loss of sensory, 
physical, and/or cognitive function, which may completely or partially recover as spontaneous 
remyelination occurs2. In the progressive form of MS, functions progressively worsen with little 
remyelination2. Disease-modifying therapies help reduce relapses, but presently, there is no cure 
for MS56. 
The healthy brain adapts in response to stimuli and to do so, requires the ability to undergo 
synaptic plasticity, an element of neuroplasticity57. Neuroplasticity may be useful following 
recovery from relapse and in resistance to MS progression14. A robust body of research has 
confirmed that physical exercise promotes neuroplasticity58-60, so, it is not surprising that exercise 
improves functional performance and strength61-64, fatigue62, 64, and cognition65 among people with 
MS. Unfortunately, several groups have reported that a large proportion of people with MS have 
low levels of fitness and are sedentary45, 66-70, and thus do not obtain the beneficial effects of 
exercise. Recent research in physical activity, rehabilitation and self-management, suggests that 
increasing levels of physical activity is of low priority for both clinicians and MS patients44. In 
fact, despite lack of convincing evidence, some MS patients are advised to rest and conserve 
energy to reduce fatigue; discouraging exercise because it could aggravate MS symptoms71. In 
fact, exercise is likely an essential component of MS management47, 70, since higher fitness is 
associated with better cognitive function and preserved brain white and grey matter structure on 
magnetic resonance imaging72. Exercise also reduces cardiovascular risk factors which have been 
shown to accelerate MS progression73. Nonetheless, researchers suggest that more evidence is 
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required to determine whether or not fitness modulates brain function in MS47. Current magnetic 
resonance imaging methods have failed to show enduring brain activation changes despite 
improvements in motor performance in MS patients after participating in physical exercise training 
74. Understanding the benefits of fitness on brain activation could help reveal important targets for 
rehabilitation and physical exercise interventions47, 75.  
Fatigue is the most frequent and disabling symptom76 interfering with physical and 
cognitive activities of daily living among people with MS77, and it has been proposed to be related 
to neuronal-connectivity disruption78. Fatigue may also be related to poor cardiorespiratory fitness 
or to high levels of circulating cytokines, and such, exercise prescription has been suggested in 
order to counteract inflammation in order to improve fatigue47, 79-82. Tumor necrosis factor (TNF) 
is a circulating cytokine and its dysregulation has been implicated in inflammatory-mediated 
diseases including MS83. For example, Deckx and group reported that a combined aerobic and 
resistance exercise program reduced TNF and other markers of inflammation in patients with 
MS84. Whether fitness, fatigue, brain function and levels of circulating TNF are linked is not 
known. 
Transcranial magnetic stimulation (TMS) is a non-invasive tool that measures brain 
function by quantifying the excitability of the corticospinal tract20, 85. Using TMS, corticospinal 
excitability (CSE) is determined by measuring motor neuron excitability and nerve conduction 
speed; resting and active motor thresholds (RMT and AMT, respectively), and motor evoked 
potential (MEP) latency20. Also, TMS assesses levels of brain inhibition, by measuring the length 
of the cortical silent period (CSP), an interruption of background muscle activity after a TMS 
pulse20. CSP is thought to be mediated by g-aminobutyric acid (GABA) inhibitory 
neurotransmission20 believed to be involved in neuroplasticity by modulating long-term 
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potentiation (LTP)25, 86. MS patients have several CSE abnormalities in comparison to the general 
population, including higher motor thresholds87, delayed MEP latencies87, and longer CSP88, 
which supports the usefulness of TMS as a biomarker of brain functioning in MS. 
As our primary objective, we investigated whether cardiorespiratory fitness, when 
controlling for MS severity, disease duration, and age, predicted RMT, AMT, MEP latency, and 
CSP. As our secondary aim, we investigated whether the TMS variables associated with 
cardiorespiratory fitness were related to TNF or subjective fatigue. We hypothesized that having 
lower levels of cardiorespiratory fitness would negatively impact brain excitability, and that, 
fitness-related TMS variables would be associated with greater fatigue and higher levels of TNF. 
2.2. Materials and Methods 
2.2.1 Participants.  
Eighty-two MS patients (58 females, 24 males) aged 47.81 ± 10.1 years (mean±SD), 
consecutively recruited from an MS clinic, participated in the study. All participants’ descriptive 
data are reported in table 2.1. Participants met the following inclusion criteria: 1) able to walk 
indoors independently with or without aid; 2) able to provide consent; 3) 18 years old or older, 
and; 4) no relapses in the previous 3 months. Demographic data were collected, including age 
(years), sex, MS type (relapsing remitting, secondary progressive, or primary progressive), disease 
duration ((DD) years), and type of medications and MS disability level was quantified by a 
neurologist using Expanded Disability Status Scale (EDSS; 0.5 unit increment; 0 = normal 
neurological exam, 10 = death due to MS). Participants were screened for exercise safety using 
the PAR-Q89 and for TMS safety using a standardized form90. All participants consented to 
participate in the study, and all procedures were approved by the local health research ethics board 
(Memorial University of Newfoundland; reference number: 2015.103). 
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Table 2.1 Participants characteristics 
Female (n) 58 
Male (n) 24 
Age (years) 47.40 ± 10.2 
MS Type 75 RRMS, 6 SPMS, 1 PPMS† 
Disease Duration (years) 13.10 ± 8.0 
MS Severity (EDSS 0-10) 2.04 ± 1.7 
Levels of Fatigue (0-100mm) 41.31 ± 32.5 
Fitness Profile  
VO2max (mL•min-1kg-1) 25.34 ± 7.0 
HRmax (bpm) 164 ± 17 
% of Predicted HRmax 93.46 ± 8.8 
RER at VO2max (VCO2/VO2) 1.07 ± 0.1 
TMS Variables  
RMT (MSO% 0-100) 41 ± 11 
AMT (MSO% 0-100) 36 ± 10 
MEP Latency (ms / ms/heightcm) 24.45 ± 2.6 / 0.14 ± 0.01 
CSP (ms)† 149.90 ± 37.2 
Note: Data presented as mean±SD. AMT, active motor threshold; CSP, cortical silent period; EDSS, 
Expanded Disability Status Scale; HRmax, maximal heart rate; MEP, motor evoked potential; MS, Multiple 
Sclerosis; MSIS, Multiple Sclerosis Impact Scale; MSO%, maximal stimulator output percentage; RER, 
respiratory exchange ratio; RMT, resting motor threshold; RRMS, relapsing remitting MS; TMS, 
transcranial magnetic stimulation; SPMS, secondary progressive MS; PPMS, primary progressive MS; 
VO2, volume of oxygen; VCO2, volume of dioxide oxygen; VO2max, maximal volume of oxygen intake 
(cardiorespiratory fitness); † CSP was collected in a subsample of 49 MS patients. † PPMS patient (female, 
52, EDSS 6) was removed from all analyses. 




Peripheral venous blood (5mL) was drawn from all study participants in plasma collection 
tubes. Blood was spun at 1200 rpm for 10 minutes and plasma was aliquoted and stored in liquid 
nitrogen for long-term storage. The concentration of TNF within the plasma was quantified using 
a human BD OptEIATM TNF Enzyme-Linked Immunosorbent Assay kit (BD BioSciences) and 
performed according to manufacturer’s instructions. 
2.2.2 Transcranial Magnetic Stimulation 
Motor evoked potentials (MEP) were elicited from both brain hemispheres using 
monophasic magnetic posterior-anterior pulses from a BiStim 2002 stimulator (Magstim Co. 
Whitland, UK) connected to a double 70mm figure-of-eight coil (Magstim, Co.). To measure 
electromyography (EMG) activity and collect the MEPs, foam surface electrodes (Kendall 200 
Coviden, Mansfield, MA) were placed on the belly of the first dorsal interosseous (FDI) muscle, 
and the ground and the reference electrodes were placed on the styloid process and the 
interphalangeal joint of the index finger, respectively. Both dominant and non-dominant sides were 
assessed. Dominance determination was self-reported. A neuronavigation device (Brainsight, 
Rogue Research Inc, Montreal, QC, Canada) guided coil position and collected the MEPs with its 
built-in EMG system. This system uses a 2500V/V amplification and collects with a sampling rate 
of 3kHz and a gain of 600V/V with a bandwidth of 16-550Hz. The Montreal Neurological Institute 
brain template was rendered into the BrainSight software and used as a 3-D stereotaxic template91, 
92. 
With the participant seated, the TMS coil was maintained tangentially to the scalp with the 
handle pointing backward and laterally at an angle of 45° from the midline perpendicular to the 
central sulcus. First, TMS suprathreshold stimulations were fired at different locations over the 
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primary motor area and the site with the highest averaged FDI response (MEP peak-to-peak 
amplitude) was taken as the hotspot. Motor thresholds were determined as the minimum amount 
of intensity of the TMS necessary to elicit 5 out of 10 MEPs with a peak-to-peak amplitude of 
≥50µV during muscle relaxation and ≥200µV during 10% of FDI’s maximal voluntary 
contraction, known as RMT and AMT, respectively20. To measure CSP, 6 pulses at 155% of AMT 
were delivered with participants’ performing a pinch grip at 10% of the maximal contraction 
measured20. A pinch dynamometer (B&L engineering, Santa Ana, CA) was used to measure the 
maximal pinch grip, collected before the TMS assessment, and to provide feedback on the level of 
muscle contraction during the TMS assessment. 
AMT and RMT were recorded as the maximal stimulator output (0-100%). The time in 
milliseconds between the MEP onset until the EMG activity returned to ±2SD of the mean EMG 
background activity was taken as the CSP20. MEP latency was calculated from the valid MEPs 
recorded during the RMT assessment as the time in milliseconds from the TMS stimulus to the 
MEP onset. MEP onset was determined as the time-point where the MEP exceeded ±2SD from 
the EMG background activity20. Because MEP latency is influenced by height and limb length93-
96, the normalized MEP latency (ms/heightcm) was used for analysis. MEPs with preceding EMG 
background activity ±2SD from the mean were disregarded. Each MEP was visually inspected. 
MEPs were analyzed with Signal software v6.04 (Cambridge Electronic Design, Cambridge, UK). 
2.2.3 Subjective Fatigue  
Prior to any physical or neurophysiological assessment, participants indicated on a 100mm 
line their present level of MS-related fatigue, from worst (100mm – severely fatigued) to best 
(0mm – Not fatigued at all). 
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2.2.4 Cardiorespiratory Fitness  
Levels of cardiorespiratory fitness were determined by the maximal capacity of volume of 
oxygen uptake (VO2max) during a graded exercise test using a total body recumbent stepper 
(NuStep, Ann, Arbor, MI)97. Throughout the test, an indirect calorimetry system (Moxus, AEI 
Technologies, Pittsburgh, PA) was used to collect volume of oxygen uptake (VO2), volume of 
carbon dioxide production (VCO2), and heart rate (HR) (H10, Polar Electro Inc., NY, USA). In 
brief, participants were required to maintain a speed of 80 strides per minute while the load (1-10; 
beginning at level 3) was increased by one unit every 2 minutes. If exhaustion was not reached 
after completed load level 10 (maximal load), the strides per minute were increased by 10 every 2 
min. The criteria for terminating the test were: (i) volitional exhaustion, (ii) no increase in VO2 or 
HR despite increases in workload, (iii) inability to maintain workload, or; (iv) signs of excessive 
fatigue. Achievement of VO2max was assessed based on attainment of at least two of the following 
criteria: (i) a plateau in VO2 (<80 mL.min
−1) despite increasing workload; (ii) respiratory exchange 
ratio (VCO2/VO2) ≥ 1.1; and/or (iii) HRmax ±10 bpm of predicted maximum HR, calculated as 
206.9 − (0.67 × age) or 164 − (0.7 × age) if prescribed beta-blockers98. The breath-by-breath 
collected data was smoothed using a moving average of 10 data points. From the smoothed data, 
the absolute VO2max was identified as the highest VO2 uptake from participants’ and further divided 
by their weight, to obtain participants’ relative VO2max (VO2max = mL.min
-1kg-1). 
2.3 Statistical Analysis 
TMS variables (RMT, AMT, MEP latency, and CSP) differences were investigated 
between the dominant and non-dominant sides using paired t-tests. Differences in TMS variables 
between patients prescribed disease-modifying drugs versus those that were not were tested with 
Independent t-tests. Parametric or non-parametric t-tests were performed depending on the 
27 
 
normality of the data assessed with Shapiro-Wilk, kurtosis and skewness tests 99. For non-
parametric independent and paired t-tests, statistics were reported using Mann-Whitney U (Z-
value) and Wilcoxon Signed-Ranks Test (Z-value), respectively, whereas for parametric 
independent and paired t-tests, t statistic with degrees of freedom (e.g. t(dof)) was reported. In the 
case of differences or no differences between dominant and non-dominant sides, the TMS values 
were analyzed separately or collapsed, respectively. 
To explore the relationship between levels of cardiorespiratory fitness and levels of 
physical disability, Pearson’s correlation were performed with the absolute relative VO2max and 
EDSS, as well as between EDSS and participants’ VO2max when normalized for age and sex 
98. 
Pearson’s correlations were also performed to explore the relationship between TNF and VO2max, 
fatigue, and TMS measures. 
Hierarchical linear regression analyses were performed to examine the degree to which 
cardiorespiratory fitness predicted the TMS variables when controlling for MS patients’ 
demographics. In the first block, MS type, disease duration, EDSS, disease-modifying drugs, and 
age, were included. In the second block, VO2max was added and its contribution (ΔR
2) to the final 
model was calculated. Separate hierarchical regressions were performed for each TMS variable 
(RMT, AMT, MEP latency, and CSP). 
In order to better understand the relationship between the TMS variables that were 
associated with cardiorespiratory fitness and fatigue, stepwise linear regression analyses were 
performed with VO2max and TMS variables predicting level of fatigue. 
Acceptable collinearity between the predictors was identified using tolerance levels (> 0.1) 
and the variance inflation factor (< 5.0)100. Outliers were identified with residuals plots (±3SD) 
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and Cook’s distance (> 4/sample size), and removed from the regression analyses to avoid the 
influence of this data point on the results101. Due to the presence of random missing data, pairwise 
case exclusion was selected during the regressions102. 
Significance was set at an alpha level of <0.05. Data are reported as Mean±SD. All data 
were analyzed on SPSS v.24 (IBM Corporation, Armonk, New York). Graphs were created with 
GraphPad Software v.6 (La Jolla, California, USA). 
2.4. Results 
2.4.1 Transcranial Magnetic Stimulation 
All participants had recordable MEPs in at least one of the FDIs. RMT could not be 
measured in 11 dominant and 8 non-dominant sides, and AMT could not be measured in 7 
dominant, and 5 non-dominant sides, because: (i) TMS overheated; (ii) maximal levels of the 
stimulator output did not elicit MEPs, or; (iii) during RMT assessment, higher levels of EMG 
background activity preceding MEPs (i.e. participants unable to rest). 
There were no differences between dominant and non-dominant sides for RMT (Z=-0.1.33, 
p=0.183) or MEP latency (Z=-0.68, p=0.496). AMT was higher in the non-dominant in comparison 
to the dominant side (t(70)=-2.10, p=0.039). CSP was collected in a subsample of 49 MS patients, 
and for the same abovementioned reasons (i.e. i and ii), CSP could not be collected in 3 dominant 
side, and 8 non-dominant sides. There was no difference between dominant and non-dominant 
sides for CSP (t(37)=-1.52, p=0.138). All TMS variables, with exception of AMT, were averaged 
between hemispheres for further analyses (see table 2.1 for descriptive TMS values). Forty-seven 
patients were being treated with disease-modifying drugs including teriflunomide (2), interferon 
β-1a (4), glatiramer-acetate (6), fingolimod (5), dimethyl fumarate (29), and natalizumab (1). 
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There were no differences between treated and untreated MS patients for any TMS variable (Z < 
-0.754, p > 0.451; t < -0.634, p > 0.528), with exception of MEP latency, in which patients 
prescribed disease-modifying drugs had faster nerve conduction speed (untreated vs treated: 0.15 
± 0.01 vs 0.14 ± 0.02ms/heightcm; Z=-2.20, p=0.028). 
2.4.2 Levels of cardiorespiratory fitness were not associated with physical disability 
Fitness data is provided in table 2.1. Levels of cardiorespiratory fitness among participants 
ranged from very poor (n=31; ) to excellent (n=1)98 and were irrespective of their levels of physical 
disability measured using EDSS. Figure 2.1 shows the levels of physical disability and 
cardiorespiratory fitness normalized by age and sex as recommended by the American College 
Sports of Medicine98 (r=-0.055, p=0.645). There was a relationship between the non-normalized 
levels of cardiorespiratory fitness (mL.min-1Kg-1) and EDSS (r=-0.233, p=0.049). It was notable 
that 91% of participants had values below the 50th percentile, and 63% had values below the 10th 
percentile of normative values. Also, eighteen participants across all levels of disability (EDSS 0-
6) scored below the very poor cut off. We could not obtain VO2max values from 9 MS patients due 
to participants’ inability to wear a mask during the test. Seventeen participants did not meet the 
pre-determined criteria for achieving a VO2max (e.g. reached a respiratory exchange ratio of  ≤ 1.1 






Figure 2. 1 Cardiorespiratory fitness and severity of MS-related disability 
73 MS patients were ranked against the percentiles of normative values for cardiorespiratory 
fitness with reference to age and sex as 1-15% (very poor), 20-35% (poor), 40-55% (fair), 60-
75% (good), and 90-99% (superior) levels of fitness98. EDSS, Expanded Disability Status Scale; 




2.4.3 No association between cytokine levels and fitness, fatigue or TMS measures  
From the total sample, 72 participants (89%) were tested for TNF (mean±SD: 7.38 ± 
11.4pg/mL). TNF did not correlate with any physical (fitness and fatigue) or neurophysiological 
(AMT, RMT, CSP, and latency) measure (p>0.05). 
2.4.4 Low cardiorespiratory fitness predicted greater brain inhibition 
The results of the hierarchical regressions are summarized in table 2.2. In the first block, 
MS demographics explained significant variance in RMT (F(5, 61)=2.45, p=0.044), and MEP 
latency (F(5,60)=2.77, p=0.026), but not CSP or AMT (both sides). The addition of cardiorespiratory 
fitness in the second block contributed significantly (p=0.008), adding 13.8% to the final model 
explaining variance in CSP (R2=0.263, F(5,41)=2.43, p=0.042), whereby higher levels of fitness 
predicted less brain inhibition (shorter CSP). Figure 2.2A shows the association between CSP and 
VO2max (r=-0.424, p<0.003). Cardiorespiratory fitness did not contribute to variance in RMT, 
AMT, or MEP latency. Figure 2.3 shows representative data from three MS subjects, their levels 
of cardiorespiratory fitness and CSP. 
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(A) Low cardiorespiratory fitness predicted greater brain inhibition; (B) Greater inhibition 
predicted greater fatigue: MS patients with longer CSP reported greater levels of fatigue on a visual 
analog scale (0-100mm). 
  
Figure 2. 2 Associations between cardiorespiratory fitness and cortical silent period (CSP), 
and CSP with fatigue 
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Representative MEP outputs showing cortical silent period. (A) 33-year-old female, RRMS, EDSS 
2.0; (B) 23-year-old female, RRMS, EDSS 1.0, and; (C) female 40-year-old, RRMS, EDSS 2.0. 
Ranked fitness was normalized by age and sex according to American College Sports of Medicine 
(Ferguson, 2014). The vertical dotted lines indicate the CSP time in milliseconds, (time-point 
where the MEP leaves ±2SD from the EMG background activity until the EMG activity returned 
to ±2SD of the mean EMG background activity). 
Figure 2. 3 MS patients with poorer cardiorespiratory fitness had greater brain inhibition 
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2.4.5 Higher brain inhibition predicted greater fatigue 
CSP predicted 11.6% of the variance in fatigue (F(1,46)=6.04, p=0.018) while VO2max was 
excluded from the model. In other words, increased GABAergic-related brain inhibition (longer 
CSP) predicted worsened fatigue in MS. Figure 2.2B shows the associations between CSP and 




Table 2. 2  Predictors of Corticospinal Excitability































+0.005 0.33 0.567 0.162 2.21 0.066 
AMT 0.167 2.85 0.032* +0.054 3.85 0.055 0.220 3.17 0.014* 
MEP Latency 0.186 3.49 0.012* +0.008 0.62 0.434 0.195 2.90 0.021* 
CSP 0.093 0.93 0.460 +0.237 12.41 <0.001† 0.331 3.46 0.012* 
Note: AMT, active motor threshold; CSP, cortical silent period; DD, disease duration; EDSS, Expanded Disability Status Scale; MEP, motor evoked 
potential; MS, Multiple Sclerosis; RMT, resting motor threshold; VO2max, maximal volume of oxygen intake (mL•min-1kg-1). Sig, p-value; * model 
significantly predicted the outcome variable (p<0.05); ΔR2, R2 change (amount of contribution of VO2max to the final model); † VO2max significantly 




 We undertook this study to examine the link between cardiorespiratory fitness, brain 
excitability, circulating TNF and subjective symptoms of fatigue in MS. In this clinic sample, we 
demonstrated that MS patients indeed had very low levels of cardiorespiratory fitness suggesting 
that participation in any exercise was very unlikely. Using TMS, we demonstrated that, when 
controlling for MS disease demographics, cardiorespiratory fitness predicted levels of brain 
inhibition, more specifically, MS patients with poor levels of cardiorespiratory fitness had greater 
brain inhibition. Moreover, having greater brain inhibition predicted worsened fatigue. Cytokine 
levels (TNF) were not associated with any other measure collected in this study. 
2.5.1 Levels of cardiorespiratory fitness and physical disability in MS 
In a meta-analysis involving 40 studies and a total of 1,137 MS patients, Langeskov-
Christensen et al. (2015) reported weak to moderate (r = -0.250-0.580) associations between poor 
levels of fitness and higher levels of disability. We also noted a similar association; however, in 
comparison to that reported by Langeskov-Christensen et al. (2015), our association of unadjusted 
fitness scores with disability was weaker (r = -0.233), and barely significant (p = 0.049). When 
values were converted to percentile ranks98, as previously proposed42, there was no significant 
relationship. This difference in results may be equipment-related, since previous authors employed 
bicycle ergometer during fitness testing103-106, which restricts the workload to the legs. Since 
degree of disability correlates with the severity of lower limb impairment107, it is likely that 
participants with greater leg weakness would not be able to fully achieve their maximal values on 
a leg ergometer. Ponichtera-Mulcare et al. (1995) confirmed that MS patients were only able to 
achieve their predicted maximal fitness values when using both upper and lower body, but not 
when using only the arms or the legs108. In our study, we employed a recumbent stepper which 
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permitted the workload to be distributed between the upper and lower body. It is also important to 
note that, our participants were recruited consecutively from an MS clinic and therefore they likely 
represent a typical clinic cohort. Other studies examining fitness levels among MS patients 
typically report baseline characteristics of people volunteering for exercise trials42, which could 
inflate fitness values due to recruitment bias. 
Over 60% of our participants had cardiorespiratory fitness levels below the cut off for high 
risk of all-cause mortality (< 27 mL.min-1 kg-1)42, and 28% had insufficient cardiorespiratory 
fitness to comfortably carry-out activities of daily living (< 20 mL.min-1 kg-1)109. Considering that 
MS patients require more energy to perform activities of daily living (e.g. walking) due to physical 
impairments110, poor fitness will likely impact independence111. Also, in an event of a relapse 
whereby physical function decreases considerably, the cardiorespiratory fitness reserve would not 
be sufficient to maintain and to optimally re-gain function during recovery. It is reasonable to 
consider therefore, that that exercise therapies should be implemented at the time of first MS 
symptoms43. Improving fitness during this “window of opportunity” may postpone diagnosis of 
clinical definite MS, preserve neurological reserve (i.e. brain volume and functionality), and 
reduce manifestation and progression of disability43. It was notable that all (100%) of our 
asymptomatic MS patients (EDSS 0) had poor fitness that was below the 50%, and alarmingly, 
65% of them were below the 1% of normative value98. Clearly, there is a need for both health care 
professionals and people with MS to increase focus on fitness. 
2.5.2 Cardiorespiratory fitness as a target to foster plasticity 
We demonstrated that, when controlling for MS demographics, higher levels of 
cardiorespiratory fitness predicted shorter CSP in MS, a measure of the strength of GABAergic-
mediated brain inhibition20. The long-lasting intracortical inhibition seen in the CSP is from both 
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spinal and cortical origins20 whereby longer CSP represents increased inhibition20. CSP is 
mediated by both ionotropic GABAA and the metabotropic GABAB receptors
20, 25 as well as by 
glutamatergic activity112, 113. Increased activity of both GABAA and GABAB suppresses neuronal 
depolarization and undermines LTP formation25, 86. Accordingly, in healthy individuals, less 
GABAergic inhibition measured as shorter CSP predicts enhanced LTP response31 assessed with 
paired-associative stimulation114. Although in MS, reduced GABAergic activity (less inhibition) 
has been associated with greater disability115, it is unknown whether this phenomenon contributes 
to MS progression. Lengthening of CSP has been reported in MS patients with motor disfunction88, 
and in MS patients post-relapse, with longer CSP associated with larger brain lesions and poorer 
upper extremity function88, 116. Longer CSPs are indicative of exaggerated intracortical inhibition, 
greater disability, and poor motor function in other clinical populations such as Huntington’s117 
and stroke30, 118. 
Exercise may be a stimulant to foster LTP. Cirillo et al. (2009) showed that individuals 
involved in regular structured exercise (e.g. running, cycling) had superior LTP following paired-
associative stimulation in comparison to their sedentary peers39.  In healthy individuals, Sale et al. 
(2007) showed that CSP, but not other TMS measures, predicted LTP, more specifically, with 
shorter CSP predicting enhanced LTP31, which points the importance of having less GABAergic 
activity (short CSP) at baseline for neuroplasticity to occur. We suggest that poor fitness in MS 
patients may impact brain inhibition levels and hinder neuroplasticity. Longitudinal studies 
investigating physical, cognitive, and fitness changes over time should consider the investigation 
of CSP and its implication during learning, function, and neuroplasticity in MS. Our results support 
that improving cardiorespiratory fitness could enhance neuroplasticity mechanisms by decreasing 
brain inhibition and shortening CSP. 
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2.5.3 Fatigue and CSP 
 We showed that CSP, but not fitness or TNF, predicted fatigue, which suggests that 
improving fitness could mitigate fatigue by decreasing GABAergic-mediated brain inhibition 
(shortening CSP). In MS, previous studies support that physical disability and fatigue can be 
lessened by as little as 10 weeks of structured exercise training119. Using diffusor tensor imaging, 
Russo et al. (2017) demonstrated disruption of thalamo-frontal connections in MS patients with 
higher levels of subjective fatigue78. Interestingly, using TMS, these authors also demonstrated 
that fatigued MS patients had reduced brain facilitation78, concluding that reduced corticospinal 
output due microstructural damage in cortico-subcortical white matter tracts may explain 
subjective and central fatigue in MS patients120. Our findings align with Russo et al. (2017), since 
we demonstrated that greater brain inhibition predicted subjective fatigue in MS. Therefore, 
improving fitness may act through reduction in brain inhibition to reduce some of the central 
fatigue experienced by people with MS. 
2.5.4 No link between cardiorespiratory fitness and motor thresholds or nerve conduction 
speed 
In MS, prolonged MEP latency is a biomarker of degree of demyelination and disease 
progression 87, 116, 121 that is associated with decrements in motor function121, 122. The role of motor 
thresholds, RMT and AMT, in MS, however, remains ambiguous. For example, although lower 
CSE assessed by higher motor thresholds has been shown in MS patients recovering from relapses 
123 and in highly disabled MS patients124, there is an enormous variability among study results. For 
instance, when compared to healthy individuals, some authors report higher motor thresholds in 
MS87, 121 while others report no differences116, 122. Nonetheless, we confirmed that MS 
demographics (age, disease duration, EDSS, and type of MS) predicted 16.7% of variability in 
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RMT, and 18.7% of variability in MEP latency, suggesting that these biomarkers of damage and 
repair are being negatively affected by MS. It was interesting to note that the use of disease-
modifying drugs was related to faster conduction speed (MEP latency). This could be due to the 
neuroprotective effects of the prescribed drugs or the fact that drugs are prescribed earlier in the 
disease. Ayache et al. (2015) have previously demonstrated that disease-modifying drugs preserve 
CSE among MS patients125. 
In comparison to athletes, non-athletes have lowered CSE, as measured by decreased MEP 
amplitude responses38, 39, higher motor thresholds35, 126, and lengthened MEP latencies35. We 
expected therefore, that higher levels of cardiorespiratory fitness would be associated with lower 
motor thresholds and faster MEP latencies in our cohort of MS patients. However, we did not 
detect these associations; possibly due to the fact that our participants were severely deconditioned. 
Similarly, no differences in motor thresholds were detected between physically active and 
sedentary healthy subjects38, 39, such as that between athletes and non-athletes, suggesting that 
long-term intense structured exercise training may be necessary in order to modulate brain 
mechanisms that enhance CSE. For example, in an animal model of MS, Naghibzadeh et al. (2018) 
showed that a long-term aerobic exercise regimens of both moderate intensity continuous type or 
high intensity interval training protected against demyelination and loss of motor function, and 
increased neurotrophic factors, with greater responses after the high intensity interval type of 
training127. Future research should examine whether long-term exercise, especially using higher-
intensity type of training, could improve motor thresholds and MEP latency in MS. 
2.5.5 Cytokines, fitness, and fatigue 
Long-term strength or aerobic-type of training reduces cytokine levels in MS patients80, 81, 
84. We therefore hypothesized that MS patients with higher levels of fitness would have lower 
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levels of TNF, a pro-inflammatory cytokine that is thought to be related to MS disease activity and 
demyelination47, 83. However, we did not detect such association. This could be, again, due to the 
fact that our MS patients had very poor levels of fitness, and therefore, any anti-inflammatory 
effect from improved fitness may not become apparent in this cohort. Nonetheless, Dalgas et al 
(2012), reported in a review investigating exercise and disease progression that the effects of 
exercise on TNF levels is equivocal with some studies reporting increase, decrease or no change 
of this cytokine after chronic or acute exercise47. We also hypothesized that levels of TNF would 
correlate with fatigue, however, no association was found. Similarly, Malekzadeh, A. et al (2015) 
measured several anti- and pro-inflammatory cytokines, including TNF. With the exception of 
interleukin-6, there was no association between anti- or pro-inflammatory cytokines and fatigue128. 
Because, neuroinflammation in MS increases glutamatergic activity2, 129-132, and increased 
glutamatergic activity is known to prolong the CSP112, 113, 133, we expected that higher levels of 
cardiorespiratory fitness would exert anti-inflammatory effects, and an association between TNF 
and CSE would exist. However, circulating levels of TNF did not correlate to any TMS measure. 
Whether levels of cytokines within the CNS (rather than the systemic circulation) are associated 
with fitness, fatigue or CSE is an area for future research.   
6. Limitations 
 Although this study is the first to describe the relationship between fitness and CSE in MS, 
there are some limitations. First of all, we can not determine causality from this cross-sectional 
study. Longitudinal and interventional studies which measure fitness levels, CSE changes, and 
symptoms are necessary. The sample was one of convenience including consecutive patients 
recruited from an MS clinic, therefore generalizability cannot be assured. Furthermore, we 
attempted to recruit patients with a wide disability range, but those with EDSS > 4 were 
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underrepresented. Although we showed that fitness predicted short CSP, the functionality of 
having short CSP in MS needs to be elucidated. For example, studies investigating fitness and CSP 
change, in response to paired-associative stimulation and learning are needed to determine the role 
of fitness and CSP on neuroplasticity. Also, prolonged CSP only accounted for 11.6% of the 
variance in fatigue suggesting that other factors besides brain inhibition might explain fatigue. 
Moreover, levels of fatigue were measured subjectively, and although it correlates with 
fatigability, measuring fatigue objectively could have better helped decipher the mechanisms 
underlying fatigue and its relationship to CSP. We used a visual analogue scale to measure the 
experience of fatigue at the time of testing as opposed to validated questionnaires such as the 
modified Fatigue Impact Scale134. The relationship between CSE and impact of fatigue has yet to 
be elucidated. Also, MEPs could not be collected bilaterally from some participants because the 
TMS overheated or the stimulator output was not enough to elicit a MEP. Especially because of 
the latter, data from MS patients with greater unilateral CST damage could have been missed. 
Lastly, we attempted to use TNF as a biomarker of neuroinflammation, and possibly demonstrate 
that this biomarker would be decreased in MS patients with higher levels of fitness, decreased 
fatigue, or increased CSE. The susceptibility of this cytokine to daytime variations 135, 136, and 
gender-related differences137, 138, may explain these lack of associations between TNF and other 
values, especially in a cross-sectional design. Future research should take into consideration 
gender and time of the day when analysing TNF. 
7. Conclusion 
 MS patients had extremely low levels of cardiorespiratory fitness; 60% were in the high 
risk category of all-cause mortality (< 27 mL.min-1 kg-1) 42, and 28% had cardiorespiratory fitness 
too low to comfortably carry-out activities of daily living (< 20 mL.min-1 kg-1)109, which may also 
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worsen MS symptoms43, 47. Evidence in healthy populations supports that long-term training and 
higher fitness improves LTP, lowers motor thresholds and quickens nerve conduction speed 
(shorter MEP latency)35, 38, 39, 139. However, we did not detect an association between 
cardiorespiratory fitness and RMT, AMT, or MEP latency in this cohort of MS patients, which 
could be a result of their extremely low levels of cardiorespiratory fitness. Importantly, CSP, a 
measure of GABAergic-mediated brain inhibition, was a more sensitive biomarker, with poor 
cardiorespiratory fitness predicting greater brain inhibition (prolonged CSP). Prolonged CSP is 
indicative of neurological impairment88 and diminished neuroplastic capacity31. Moreover, greater 
brain inhibition, but not lower cardiorespiratory fitness, predicted fatigue, which may suggest that 
this mechanism of brain inhibition may explain some of the central fatigue experienced by MS 
patients. Levels of the pro-inflammatory cytokine TNF was not associated with any physical 
(fitness and fatigue) or TMS measure. Our findings support that poor cardiorespiratory fitness in 
MS patients may negatively impact brain mechanisms that are important for neuroplasticity to 
occur. Therapists should encourage physical exercise strategies such as aerobic exercise in order 
to improve cardiorespiratory fitness in MS patients. Assessing the effects of long-term exercise on 
brain excitability in MS is worthy of future research.  
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Objectives: Investigate whether asymmetrical corticospinal excitability exists in Multiple 
Sclerosis (MS) and its association with MS symptoms.  
Methods: Bilateral resting and active motor thresholds (RMT, AMT) were gathered using 
transcranial magnetic stimulation among 82 MS patients. Corticospinal excitability (CSE) 
asymmetry was expressed as the ratio between weaker and stronger sides’ RMT and AMT. 
Stronger and weaker side was determined by pinch and grip strength. We examined whether 
CSE asymmetry predicted symptoms.  
Results: AMT asymmetry ratio revealed atypical CSE asymmetry whereby the hemisphere 
associated with the weaker hand was more excitable in early MS. After controlling for MS 
disease demographics, shifting of CSE asymmetry towards greater excitability in the stronger 
side significantly predicted more severe symptoms including Expanded Disease Severity Scale, 
nine-hole peg test, cognitive processing speed, walking speed, heat sensitivity, fatigue, and 
subjective impact of MS.  
Conclusion: CSE asymmetry significantly predicted the severity of MS-related physical and 
objective cognitive symptoms. The phenomenon may be related to neuroinflammation-mediated 
hyperexcitability. Shifting of asymmetry toward less excitability on the weaker side may suggest 
the onset of a more neurodegenerative phase of the disease.  
Significance: Shifting of hemispheric excitability, detected using a CSE asymmetry ratio, may 






Multiple Sclerosis (MS), the most common cause of neurological disability among young 
adults worldwide, is an unpredictable inflammatory neuroimmune-mediated disease that 
demyelinates and degenerates the brain and spinal cord2, 55. MS lesions create structural and 
functional brain damage that affects essential sensorimotor and cognitive functions2, 3, 140. 
Magnetic resonance imaging (MRI) studies have helped elucidate the relationships between the 
integrity of the corticospinal tract (CST) and MS symptoms including severity 141, pain 142, walking 
function141, and upper extremity impairment143. However, MRI primarily detects structural change 
rather than dysfunction in neuronal networks, and only weakly predicts the severity of MS 
symptoms144, 145. Due to its relatively safe profile and ease of use, transcranial magnetic stimulation 
(TMS) has proved to be a suitable, non-invasive tool, to assess the functionality of the CST and to 
better understand the lesion-disrupted brain146-149. Yet, as with MRI, TMS variables have been 
reported to be weak biomarkers in MS52, 53.  
Measures of nerve conduction speed such as motor evoked potential (MEP) latency and 
central motor conduction time are among the most consistent TMS measures that correlate with 
MS symptoms and progression53, 87, 150. However, concerns have been raised regarding the 
variability that exists between studies investigating corticospinal excitability (CSE) using more 
sophisticated TMS protocols that probe intracortical excitatory and inhibitory mechanisms in 
MS52, 53. For example, studies investigating cortical silent period, have reported increased151, 
decreased152, or no differences153 in this GABAergic-mediated type of brain inhibition between 
MS and controls. In a recent review, Ayache, S. (2017) summarized the findings of TMS paired-
pulse studies in MS and argued that more reliable TMS biomarkers are greatly needed52. 
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Due to lesions in the frontal lobes, corona radiata, and CST, MS patients experience 
asymmetrical loss of upper154 and lower extremity strength155-160; this asymmetry is characteristic 
of disease progression142, 154-161. In the field of stroke, asymmetrical sensorimotor deficits 
correspond to an imbalance of CSE and TMS has helped demonstrate how excessive inhibition of 
the ipsilesional hemisphere by the contralesional hemisphere potentially limits recovery27, 162. 
Novel rehabilitative therapies involving brain stimulation techniques aim to increase CSE in the 
ipsilesional hemisphere or suppress CSE in the contralesional hemisphere27. Despite the fact that 
MS lesions are asymmetrically dispersed in the brain, TMS studies in MS tend to investigate 
variables derived from testing one hemisphere116, 122, 163 or collapse data from both hemispheres 
during analyses87, 164, 165. It is reasonable to think that disregarding bilateral measures may actually 
impede our understanding of whether an asymmetry of brain excitability exists and its role in MS. 
We hypothesized that, like in stroke, brain excitability asymmetry occurs in MS and is 
associated with upper extremity and walking impairment. The TMS variable motor threshold (MT) 
quantifies the ability of the CST to transmit a TMS pulse and elicit a MEP in the target muscle20, 
166. Increased levels of glutamate and/or larger motor cortex representation lower MT values 
indicating a higher CSE20, 27, 166. In MS, structural brain damage and neurochemical imbalance 
may increase MTs87. In this study, we measured MTs from each brain hemisphere of MS patients 
and calculated brain excitability asymmetry; a ratio between the hemispheres’ MTs. Greater 
symmetry between hemispheres’ MTs indicates recovery from stroke167, 168. Enhanced learning 
after an acute session of aerobic exercise in stroke survivors has been associated with more 
symmetrical intracortical inhibition between hemispheres169. 
To test the validity of this biomarker, we explored the relationships between brain 
excitability asymmetry and objective and subjective measures of MS symptom severity. Objective 
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measures included, overall MS severity (Expanded Disability Status Scale; EDSS), upper 
extremity dexterity (nine-hole peg test; 9HPT) and walking speed, as well as measures of cognition 
measured using the Montreal Cognitive Assessment (MoCA) and the Symbol Digit Modality Test 
(SDMT). The SDMT is considered the gold standard test to assess cognitive processing speed in 
MS170 and strongly correlates with brain atrophy and injury on MRI140. Subjective measures 
included fatigue, pain, and heat sensitivity measured using visual analog scales, and the patients’ 
perceptions of the physical and psychological impact of MS in daily life measured using the MS 
Impact Scale (MSIS-29)171, 172. These are symptoms that have been related to disease severity, 
brain lesions, and excitability abnormalities in MS7, 78, 173. Finally, we tested whether and to what 
degree the new brain excitability asymmetry ratio predicted the severity of objective and subjective 
symptoms when controlling for MS demographics (MS type, disease duration, use of disease-
modifying drugs and handedness) that are thought to modulate CSE in MS87, 125 or have 
implications in brain asymmetry174. 
3.2 Materials and Methods 
3.2.1 Participants 
Following approval by the local health research ethics board (HREB 2015.103), 
participants were recruited from a MS registry associated with a MS clinic. Inclusion criteria were: 
1) able to walk at least indoors with or without aid; 2) diagnosed with MS by a MS neurologist 
using MacDonald criteria 175; 3) ≥ 18 years old; 4) able to participate in TMS assessment as per 
standardized TMS screening form90, and; 5) ≥ 3 months relapse-free. Demographic data were 
recorded, including age, sex, MS type and disease duration (years). Levels of cognition were 
determined using the MoCA (normal > 26, mild cognitive impairment = 18-26, and moderate-
severe < 18)176. The MS neurologist provided the EDSS score177. 
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3.2.2 Walking performance 
Participants walked at a self-selected pace across an instrumented walkway (Protokinetics 
Inc., Havertown, PA, USA) to determine walking speed (cm/s). Walking speed was normalized by 
height (cm/s/heightcm)
178. 
3.2.3 Upper extremity function 
First, in order to determine the strongest hand, grip and pinch strength were measured using 
a dynamometer (Lafayette Instruments, Lafayette, IN, and B&L Engineering, Santa Ana, CA, 
respectively). The dominant hand grip strength was measured prior to the non-dominant hand, and 
after a 2 minute-interval, the process was repeated. Pinch strength was measured using the same 
sequence. The average score from the 2 trials was reported. Since the weaker side of the body is 
thought to be the side that is most affected154, 157, 159, the hand with the lowest value of grip and 
pinch strength together (grip + pinch) was designated as the weaker (most affected) side. The 
bilateral measures (MTs and 9HPT) were divided based on this criterion (e.g. 9HPTWeaker (w), 
9HPTStronger (s)). During the 9HPT, participants placed and removed 9 pegs into 9 holes in a wooden 
board (7mm diameter, 32 mm length) as quickly as possible179. The time to complete the task 
(seconds) was recorded twice for each hand with the average score reported. 
3.2.4 Subjective Symptoms and Impact of MS 
Participants indicated their present level of fatigue, pain, and heat sensitivity using visual 
analog scales, from high (100mm) to low (0mm). The MSIS-29 was used to measure subjective 
physical and psychological impact of MS171. 
3.2.5 Cognitive Processing Speed 
 Cognitive processing speed was determined using the SDMT140. In brief, in a page 
containing rows of abstract symbols in random order, participants matched numeric values 
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provided in the page header with the symbols. The number of correct answers recorded in 90 
seconds was taken as the score, with higher scores indicating faster cognitive processing speed. 
3.2.6 Transcranial Magnetic Stimulation 
Motor evoked potentials (MEP) were elicited from each brain hemisphere by single 
monophasic magnetic posterior-anterior pulses that were delivered using a 70mm figure-of-eight 
coil connected to a BiStim 2002 (Magstim Co. Whitland, UK). To measure electromyography 
(EMG) activity and the MEPs, the skin was prepared 180 and foam surface electrodes (Kendall 200 
Covidien, Mansfield, MA) applied over the belly of the first dorsal interosseous (FDI) muscle.  
The ground and the reference electrodes were positioned on the styloid process and the 
interphalangeal joint of the index finger, respectively. A neuronavigation device (Brainsight, 
Rogue Research Inc, Montreal, QC, Canada) helped guide the coil and record the MEPs with its 
built-in EMG system. This system uses a 2500V/V amplification and has an analog to digital 
converter of 12-bits. It records with a sampling rate of 3kHz, has 4.5mVpp of input range, a gain 
of 600V/V, and has a passband bandwidth of 16-550Hz. The Montreal Neurological Institute brain 
template was rendered into the Brainsight and used as a 3-D stereotaxic template91, 92. 
With the participant seated, the coil was maintained tangentially to the scalp with the 
handle pointing backward and laterally at an angle of 45° from the midline perpendicular to the 
central sulcus. First, suprathreshold stimulations were performed at different sites over the primary 
motor area and the site with the highest averaged FDI response (MEP peak-to-peak amplitude) 
was taken as the hotspot. Secondly, MTs were determined as the minimum amount of intensity of 
the maximal stimulator output percentage (MSO%) necessary to elicit 5 out of 10 MEPs with a 
peak-to-peak amplitude of ≥ 50µV during muscle relaxation and ≥ 200µV during 10-15% of FDI’s 
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maximal voluntary contraction, known as resting motor threshold (RMT) and active motor 
threshold (AMT), respectively20, 166. MTs values were reported as MSO%.  
The asymmetry ratio was calculated by dividing the MTs of the weak side by the MTs of 
the stronger side (e.g. AMTW/AMTS). Values < 1.0 indicated that the weaker side of the body had 
higher CSE and values > 1.0 indicated that the weaker side had lower CSE in comparison to the 
stronger side. 
3.3 Statistical Analyses 
The existence of brain excitability (a)symmetry between weaker and stronger sides’ MTs 
was investigated with one sample t-test to test the null hypothesis (H0) that MS patients did not 
have brain asymmetry (MTW/MTS= 1.0) versus the alternative hypothesis (Ha) that MS patients 
did have brain asymmetry (MTW/MTS ≠ 1.0). Mean difference and 95% confidence intervals (CI) 
were reported. 
Side-to-side differences were investigated between MTs (AMTW vs AMTS and RMTW vs 
RMTS) and upper extremity function (9HPTW vs 9HPTS). Independent t-tests were performed to 
investigate whether MS patients using disease-modifying drugs had different RMTW, RMTS, 
AMTW, and AMTS, brain excitability asymmetry ratios (RMTW/RMTS and AMTW/AMTS) or 
performed differently in any of the objective physical or cognitive (9HPTW and 9HPTS, walking 
speed, and MoCA) or subjective symptoms (fatigue, pain, and heat sensitivity, MSISPhysical and 
MSISPsychological). Parametric or non-parametric t-tests were performed depending on normality of 
the data tested with Shapiro-Wilk (p < 0.05), skewness, and kurtosis tests99. For non-parametric 
independent, and paired t-tests, statistics were reported using Mann-Whitney U (Z-value) and 
Wilcoxon Signed-Ranks Test (Z-value), respectively, whereas for parametric independent and 
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paired t-tests, t-statistic with degrees of freedom (e.g. t(dof)) were reported. A total of 3 paired and 
15 independent t-tests were performed. To correct for multiple comparisons, levels of significance 
were adjusted with Bonferroni’s correction (α = 0.05/n of dependent variables) with α = 0.017 and 
α = 0.003 for paired t-test and independent t-test, respectively. 
To investigate the potential clinical relevance of CSE asymmetries in MS, Independent t-
tests were performed between MS patients with higher CSE in the weaker side (asymmetry ratio 
< 1.0) versus MS patients with higher CSE in the stronger side (asymmetry ratio > 1.0) for the 
objective (EDSS, MoCA, SDMT, walking speed, 9HPTW, and 9HPTS) and subjective (pain, 
fatigue, heat sensitivity, MSISPhysical and MSISPsychological) clinical variables measured. To correct 
for multiple comparisons, significance level was adjusted with Bonferroni Holm’s181. 
Pearson’s correlation coefficients were calculated with the asymmetry ratios 
(AMTW/AMTS and RMTW/RMTS) as the independent variables, and objective (age, disease 
duration, EDSS, MoCA, SDMT, walking speed, 9HPTW, and 9HPTS) and subjective (fatigue, pain, 
and heat sensitivity, MSISPhysical and MSISPsychological) measures as the dependent variables. 
Significance level during correlations was adjusted with Bonferroni Holm’s181. 
Using hierarchical linear regression analyses, we examined the degree to which the 
asymmetry ratio variable predicted the objective and subjective outcomes when controlling for 
MS type, disease duration, use of disease modifying drugs, and handedness. In the first step of the 
analysis, demographics (MS type, disease duration, use of disease modifying drugs, and 
handedness) were entered into the first block as independent variables to determine the amount of 
variance explained by these variables on the outcome (dependent) variables (EDSS, walking 
speed, MoCA, SDMT, 9HPTW, 9HPTS, subjective fatigue, pain, and heat sensitivity, and 
MSISPhysical and MSISPsychological). Brain excitability asymmetry ratio was added in the next block 
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as independent variable and amount of variance explained by this predictor variable in the models 
was calculated. Acceptable collinearity between the predictors was identified using tolerance 
levels (> 0.1) and the variance inflation factor (< 5.0)100. Outliers were identified with residuals 
plots (±3SD) and Cook’s distance (> 4/sample size)101, and removed from the regression analyses 
to avoid the influence of this data point on the results. Such a conservative method of identifying 
and removing outliers is essential to ensure validity of the brain asymmetry as a biomarker. Due 
to the presence of random missing data, pairwise case exclusion was selected during the 
regressions102. 
Data are reported as Mean±SD. All data were analyzed on SPSS (IBM Corporation, 




Eighty-two MS patients (58 females) participated in the study. Among participants, 
seventy-four were diagnosed with relapsing-remitting MS (RRMS), six had secondary-progressive 
(SPMS), one had primary-progressive MS (PPMS), and one participant’s MS type was unknown. 
Levels of MS disability ranged from EDSS 0 (no symptoms) to 6 (walks with aid). MoCA scores 
revealed that forty-six participants had no cognitive impairment, thirty-six had mild impairment, 
and one participant had moderate-severe cognitive impairment176. The mean SDMT score 
indicated that participants had slower cognitive processing speed in comparison to normative 
values from the general population (47 vs ~52)182. Descriptive data are reported in Table 3.1. 
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Forty-seven patients were prescribed disease-modifying medications, including 
teriflunomide (n = 2), interferon β-1a (n = 4), glatiramer-acetate (n = 6), fingolimod (n = 5), 
dimethyl fumarate (n = 29), and natalizumab (n = 1). There were no differences in any subjective 
or objective physical or cognitive scores, RMT and AMT in either side (weak or strong), nor 
differences in brain asymmetry ratios (RMT or AMT) between patients taking or not taking 
medications (Z < -1.58, p > 0.113, and t < -1.50, p > 0.139, for non-parametric and parametric 




Table 3. 1 Participants and Pearson’s correlations with interhemispheric ratio using AMT and RMT. 
 
Variables (mean±SD) (n=82) 
Variables vs Interhemispheric Ratio (r) 
AMTW/AMTS (n=71) 
(mean±SD: 1.08 ± 0.3) 
RMTW/RMTS (n=67) 
(mean±SD: 1.07 ± 0.3) 
Age (years) 47.51 ± 10.2 -0.088 -0.102 
Disease duration (years) 13.06 ± 7.9 0.106 -0.015 
Disease severity (EDSS 0-10) 2.08 ± 1.7 0.384** 0.261 
Cognition (MoCA 0-30) 26.27 ± 2.8 -0.144 -0.051 
Cognitive Processing Speed (SDMT 0-110) 47.44 ± 11.9 -0.346* -0.041 
Physical Impact of MS (MSIS 20-100) 38.41 ± 15.7 0.326* 0.020 
Psychological Impact of MS (MSIS 9-45) 18.95 ± 7.9 0.034 -0.079 
Fatigue (0-100mm) 41.32 ± 32.3 0.320* 0.052 
Pain (0-100mm) 19.40 ± 26.1 0.136 0.043 
Heat Sensitivity (0-100mm) 27.43 ± 32.5 0.342** 0.203 
9HPT strong hand (seconds) 22.18 ± 4.4# 0.553** 0.121 
9HPT weak hand (seconds) 24.51 ± 8.6 0.475** -0.024 
Walking Speed (cm/s/heightcm) 0.61 ± 0.1 -0.271* -0.083 
Note: EDSS, Expanded Disability Status Scale; MoCA, Montreal Cognitive Assessment; MSIS, MS Impact Scale; 9HPT, nine-hole peg test; AMTW, active 
motor threshold from weaker side; RMTW, resting motor threshold from weaker side, AMTs, AMT from stronger side; RMTS, RMT from stronger side; 
SDMT, Symbol Digit Modality Test; **Significant correlations with Bonferroni-Holm’s correction (p<0.001); *Significant correlations without Bonferroni-
Holm’s correction (p<0.05); # 9HPT performance differed between weaker and stronger side (p=0.005). All participants (n=82) had recordable motor evoked 
potentials in at least one side of the body. Asymmetry ratios were only calculated for the MS patients with bilateral AMT (n=71) and RMT (n=67). Four 
participants were not assessed for MSIS and SDMT; one participant was not assessed for fatigue, pain, or heat sensitivity due to visual impairment, one 
participant was not assessed for 9HPT in either hand, and for one participant, EDSS level and disease duration was unknown. 
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3.4.2 AMT revealed brain asymmetry 
When testing the hypothesis that MTs were symmetrical (H0: MTW/MTS = 1.0 vs Ha: 
MTW/MTS ≠ 1.0), one sample t-test rejected the null hypothesis for AMTW/AMTS (t(70 )= 2.75, p = 
0.008; Mean difference = 0.08, 95% CI 0.02-0.14) but did not reject for RMTW/RMTS (t(64) = 1.74, 
p = 0.086; Mean difference = 0.04, 95% CI = -0.01-0.08). Therefore, MS patients demonstrated 
brain excitability asymmetry by measuring AMT, but not RMT. 
The non-dominant hand was weaker in 70.3% of participants. As expected, the weaker 
hand was slower to complete the 9HPT in comparison to the stronger hand (Z = -2.80, p = 0.005). 
Participants in this study had a relatively slow walking speed (0.61 cm/s/heightcm) in comparison 
to previously reported values from the general population of the same age and sex (~0.82 
cm/s/heightcm)
178. 
RMT and AMT could not be measured from one side of the body in 16 and 11 participants, 
respectively, due to: (i) participant’s inability to rest during RMT assessment noted by high EMG 
background activity, or (ii) MSO at maximum value of 100% without eliciting MEPs (no 
response). The MEP amplitudes collected during the RMT and AMT experiments did not differ 
between stronger and weaker sides; RMT (stronger: 149.89 ± 90.3µV; weaker: 158.36 ± 105.5µV; 
Z = -1.35, p = 0.178) or AMT (stronger: 341.12 ± 118.22µV; weaker: 344.11 ± 111.5µV, Z=-1.02, 
p = 0.307). There were no significant differences between RMTW (43 ± 13) and RMTS (40 ± 10) 
MSO% (Z = -0.68, p = 0.495) nor differences between AMTW (37 ± 12) and AMTS (34 ± 7) 
MSO% (Z = -1.81, p = 0.07, corrected α = 0.017; Figure 3.1C), which is counterintuitive, since 
one would expect that the stronger and faster hand would have lower MTs in comparison to the 
weaker side. When calculating CSE asymmetry based on hand impairment, two groups of MS 
patients were noted: 1) MS patients with higher CSE in the weaker side (AMT asymmetry ratio < 
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1.0) (Figure 3.1A), and 2) MS patients with higher CSE in the stronger side (AMT asymmetry 
ratio > 1.0) (Figure 3.1B). However, when analyzing all MS participants together, CSE symmetry 
is observed (Figure 3.1C). MS patients with higher excitability in the weaker side were less 
physically disabled, having lower EDSS (t(68) = 3.58, p = 0.001), faster walking speed (t(68) = 2.74, 
p = 0.008), superior performance during 9HPT in both stronger (t(68) = -3.52, p = 0.002) and weaker 
(t(68) = -2.98, p = 0.007) hands, and had superior cognition, performing better in the SDMT (t(65) = 
2.49, p = 0.015) (Figure 3.1D). MS patients with the weaker side more excitable also reported less 
MS-related symptoms of fatigue (t(68) = -2.62, p = 0.011), heat sensitivity (t(68) = -4.67, p < 0.001), 
and less impact of MS in activities of daily living (MSISPhysical) (t(65) = -2.62, p = 0.011) (Figure 




(A) MS patients with higher excitability (lower AMT) in the weaker side, and (B) MS patients with higher excitability in the stronger 
side. (C) When performing a paired t-test between weaker and stronger sides with all MS patients together, this asymmetry is diluted 
and no difference between hemispheres’ AMT is noted (corrected α < 0.017). (D) Independent t-tests between groups revealed that MS 
patients with higher excitability in the weaker side were less disabled and had less severe MS symptoms. Expanded Disability Severity 
Score (EDSS; corrected α < 0.007), faster walking speed (cm/s/heightcm; corrected α < 0.017), needed less time (seconds) to conclude 
the nine-hole peg test (9HPT) in both weaker (corrected α < 0.013), and stronger (corrected α < 0.008) hands, superior processing speed 
measured using the symbol digit modality test (SDMT; corrected α < 0.05), as well as reported less MS symptoms of fatigue (corrected 
α < 0.025) and heat sensitivity (corrected α < 0.006) measured using visual analog scales (0-100mm), and reported less physical impact 
of MS measured using the Multiple Sclerosis Impact Scale (MSIS; corrected α < 0.010). *Difference is statistically significant at the 
Bonferroni Holm’s corrected level of significance. 
  




3.4.3 AMT asymmetry ratio predicted clinical measures 
The regression analyses are summarized in Table 3.2. The addition of the AMT brain 
asymmetry ratio contributed significantly to the models predicting EDSS, subjective physical 
impact of MS, fatigue, heat sensitivity, upper extremity function in both hands, and processing 
speed, with a substantial degree of variance being predicted by AMT asymmetry ratio; from 5% 
(EDSS) to 31% (9HPTS).
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Table 3.2 Predictive value of brain asymmetry on subjective and objective MS measures. 
















































7.11 <0.001 0.36 
MoCA 0.06 0.98 0.427 +0.02 0.80 0.557 0.06 
SDMT 0.20 3.76 0.008 +0.06† 4.25 0.002 0.26 
MSISPhysical 0.18 3.42 0.013 +0.07† 4.12 0.003 0.26 
MSISPsychological 0.17 3.14 0.020 +<0.01 2.47 0.042 0.17 
Heat Sensitivity 0.17 3.30 0.016 +0.07† 4.09 0.003 0.25 
Fatigue 0.09 1.22 0.196 +0.09** 2.73 0.027 0.18 
Pain 0.07 0.97 0.311 +0.01 1.14 0.346 0.08 
9HPTS 0.13 2.30 0.068 +0.31* 9.57 < 0.001 0.43 
9HPTW 0.34 8.51 < 0.001 +0.14* 11.88 < 0.001 0.48 
Walking Speed 0.25 5.06 0.001 +0.02 4.43 0.002 0.27 
Note: DD, disease duration; DMD, disease modifying drugs; EDSS, Expanded Disability Status Scale; MoCA, Montreal Cognitive Assessment; MSIS, MS 
Impact Scale; 9HPTW, nine-hole peg test weak hand; 9HPTS, strong hand; AMT asymmetry ratio (AMTW/AMTS); Heat sensitivity, pain, and fatigue were 
measured with visual analog scales (0-100mm); MS type: Relapsing remitting MS or Secondary Progressive MS; ΔR2, R2 change (amount of contribution of 
AMT asymmetry ratio to the final model). † significant contribution to the model (p<0.001); *significant contribution to the model (p<0.01); **significant 
contribution to the model (p<0.05). Outliers identified with Cook’s distance >4/sample size and removed from the regressions (n): EDSS (7), MoCA (5), 
SDMT (5), MSISPhysical (5), MSISPsychological (2), heat sensitivity (4), fatigue (3), pain (4), 9HPTS (8), 9HPTW (7), walking speed (6). 
Table 3. 2 Predictive value of brain asymmetry on subjective and objective MS measures
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3.4.4 Having higher excitability on the weaker side was associated with lower disability and 
faster cognitive processing speed 
Interestingly, correlation analysis revealed that having higher CSE in the weaker side 
(AMTW/AMTS < 1.0) was associated with lower disability measured using EDSS (p < 0.001) 
(Figure 3.2A) and superior performance during 9HPT in both weaker (p < 0.001) and stronger (p 
< 0.001) hands (Figure 3.2B and C). Having higher CSE in the weaker side was also associated 
with superior processing speed measured using the SDMT (p = 0.007) (Figure 3.2D) and with 





(A) MS patients with the weaker side more excitable than the stronger side were less disabled 
(lower Expanded Disability Status Scale, EDSS) (corrected α  < 0.005), had superior hand 
dexterity in both (B) stronger (corrected α < 0.003) and (C) weaker hands (corrected α < 0.004), 
measured as shorter time in seconds to conclude the nine-hole peg test (9HPT), (D) walked faster 
(walking speed, cm/seconds/heigthcm) (uncorrected α < 0.05), and (E) had superior cognitive 
processing speed, measured with the symbol digit modality test (uncorrected α < 0.05).  
Figure 3. 2 Relationships between brain asymmetry and objective measures of MS symptoms 
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3.4.5 Having higher excitability on the weaker side was associated with less severe subjective 
MS symptoms 
Having higher CSE in the weaker side was associated with fewer subjective symptoms of 
heat sensitivity (p = 0.004) (Figure 3.3A) and with less subjective physical impact (MSISPhysical; p 
= 0.007) (Figure 3.3C) and fatigue (p = 0.007) (Figure 3.3B) but only when considering the non-
corrected p-value (α = 0.05). No other correlations were present for brain excitability asymmetry 
ratio using AMT. Brain asymmetry ratio using RMT did not relate to any variable. All correlations 




(A) MS patients with the weaker side more excitable reported less heat sensitivity (corrected α < 
0.005) and (B) fatigue measured using visual analog scale (0-100mm) (uncorrected α < 0.05), and 
(C) reported less impact of MS on physical activities of daily living, measured using the Multiple 
Sclerosis Impact Scale (MSIS) (uncorrected α < 0.05). 
  




Biomarkers help to signify the degree of underlying neurological injury and the potential 
for recovery 149, 183. In other fields, such as stroke, TMS biomarkers are recommended in clinical 
trials in order to track motor recovery18. MS is a heterogeneous disease and is therefore well-
positioned to benefit from biomarkers that could help predict treatment choices and outcomes. 
Data supports that, in stroke, a laterality index, calculated by examining the integrity of the CST 
bilaterally, predicts treatment gains167, 169, 184, 185. In this study we show, for the first time, that an 
asymmetry of brain excitability, particularly an atypical higher excitability in the weaker side, 
predicted lower disability, better upper extremity function, reduced fatigue and physical burden of 
MS, less heat sensitivity, and superior cognitive processing speed, when controlling for MS type, 
disease duration, use of disease modifying drugs, and handedness. All these symptoms worsened 
in MS patients when the CSE shifted towards symmetry or towards higher CSE in the stronger 
side. Furthermore, the AMT asymmetry ratio revealed asymmetry in brain excitability despite no 
differences between MTs when using conventional paired t-test analysis between hemispheres 
(Figure 3.1C). We propose that higher CSE in the weaker side could be explained by cortical 
hyperexcitability due to neuroinflammation, affecting predominantly one hemisphere in early MS. 
Loss of this unilateral neuroinflammation-mediated hyperexcitability may indicate a shift from 
inflammatory to neurodegenerative phases and signify MS progression (see Figures 3.1D and 
Figure 3.4). The AMT asymmetry ratio may serve as a useful biomarker of disease severity in MS 
that may help clinicians map MS-related changes, identify responders to interventions and monitor 





Figure 3. 4 Active motor threshold (AMT) asymmetry ratio (AMTweak side/AMTstronger side) 
revealed (a)symmetry patterns in MS patients associated with disease severity 
(A) Asymmetry towards higher corticospinal excitability (CSE) (lower AMT) in the weaker side 
(AMT asymmetry ratio < 1.0), was associated with early MS stages (EDSS 0-1, and better physical 
function). (B) MS patients slightly more progressed in the disease (EDSS 1.5-3) had a more 
symmetrical CSE (asymmetry ratio ~1.0). (C) CSE asymmetry with the stronger side having 





3.5.1 Typical CSE asymmetry is disrupted in MS 
As a result of strengthening of neuronal connections through long-term potentiation from 
preferred use and extensive daily practice57, 186 MTs are typically lower in the dominant hand 
among healthy individuals 174. Following stroke, the affected side exhibits higher MTs (lower 
CSE)27, 162, associated with poorer motor recovery27. Likewise, it would be expected that MTs 
would be higher on the weakest (assumed to be the most affected) side in MS. Indeed, in 
comparison to healthy individuals, MTs are higher (lower CSE) in severely disabled MS 
patients124, a stage in which the CST is considerably damaged141, 187. CSE is also lowered during 
MS relapse123, possibly because of acute axonal loss and brain edema which weakens neuronal 
excitation2. In early or remitting MS, however, studies comparing MTs between healthy 
individuals and MS patients bilaterally87, 125, 164, 165, 188 or unilaterally (right, left, or dominant 
side)116, 121, 122, 153, 163, 189-192 have reported disparate results as some showed higher MTs and others 
no differences between controls and MS patients. One potential explanation is that, since unilateral 
deficits in MS are common142, 154-159, 161, assessing one side arbitrarily may create variability among 
results. TMS studies investigating MTs in the affected side of MS patients are scarce, lacking 
rationale for assessing the affected side125, 151, 163, 193 or they omit reporting of how the affected side 
was determined125, 151, 193. When converting the data to a brain excitability asymmetry ratio, we 
reveal atypical and unexpected CSE asymmetry in which MS patients with milder disability (lower 
EDSS), who were likely earlier in the disease, exhibited lower CSE (higher MTs) in the stronger 
and faster hand and higher CSE (lower MTs) in the weaker and slower hand (Figures 1D and 4). 
This suggests that the balance of CSE between the hemispheres was uniquely altered in mild and 
early MS. Detecting such a shift would have been impossible using conventional paired t-test 
analysis of MTs since participants with high levels of excitability and low levels of excitability 
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would be combined, essentially diluting the effect (see Figure 3.1C). In MS, especially in early 
and relapsing-remitting type, upregulation of chemokines130 and cytokines132 may mobilize 
immune cells into the brain and promote excessive release of glutamate leading to excessive 
excitation2, 194. Therefore, we suggest that the more affected side in MS, although damaged, may 
present with hyperexcitability due to neuroinflammation in the early stages. 
TMS may help fill the biomarker gap but it has been notoriously variable146-148, 195. Besides 
disease-related factors147, 148, CSE is also influenced by hormonal differences196, age197, physical 
fitness35, 198, cortical thickness199, wakefulness and amount of sleep200, 201, stimulants (e.g. caffeine) 
202 and medications203, and even levels of education198. With such numerous confounding variables 
in addition to MS heterogeneity, it is not surprising then that TMS has been reported as only weakly 
associated with clinical correlates of MS52, 53. Our findings reveal a new and potentially important 
TMS variable that should be subjected to scrutiny in a randomized controlled trial of disease-
modifying drugs or rehabilitative interventions. 
3.5.2 Is hyperexcitability compensatory, or an indicator of MS progression, or both? 
In MS, TMS studies using paired-pulse paradigms reported associations between increased 
intracortical facilitation130-132 or suppressed intracortical inhibition123 and higher levels of 
neuroinflammatory markers that are associated with hyperexcitability; mediated by increased 
glutamatergic and decreased GABAergic activity. Mori et al. (2014) proposed that 
hyperexcitability in MS, identified as increased intracortical facilitation assessed with TMS, may 
compensate for axonal loss and promote long-term potentiation131. However, other studies have 
failed to replicate the same results52, 122 or show long-term potentiation associated with 
hyperexcitability in MS130. Additionally, although compensatory, hyperexcitability may 
demyelinate and destroy neurons through excitotoxicity 2, 129. We showed that MS patients with 
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less disability, likely in early stages of the disease, had higher CSE in the brain hemisphere 
responsible for the weaker side of the body (Figure 3.1A). This suggests that, in early MS, 
hyperexcitability affecting one brain hemisphere could be compensatory, however, paradoxically, 
it may also lead to further neurodegeneration due to excitotoxicity2, 3, 129. This finding is in 
accordance with studies investigating other neurodegenerative diseases such as Alzheimer’s204, 205, 
Huntington’s206, and Amyotrophic Lateral Sclerosis207, whereby hyperexcitability-associated with 
excessive glutamate release in early stages is responsible for further neurodegeneration due to 
excitotoxicity. We propose that a similar pattern of disease progression, from hyperexcitability 
(early stages) to less excitability (late stages), could occur in MS. However, hyperexcitability in 
MS may affect predominantly one side as demonstrated by the lower AMT asymmetry ratios 
(AMTW/AMTS < 1.0) in early, and higher AMT asymmetry ratios (AMTW/AMTS > 1.0) in later 
stages. 
The AMT asymmetry ratio was highly associated with and was a strong predictor of hand 
function when controlling for MS type, disease duration, use of disease modifying drugs, and 
handedness. This relationship could be explained by the fact that the MEPs were measured in a 
hand muscle (FDI) that had an essential role in the upper extremity test employed (9HPT). The 
AMT brain asymmetry ratio also predicted subjective symptoms of fatigue, and physical impact 
of MS, but not pain or psychological impact. In fact, as far as we know, there have been no studies 
in MS associating TMS variables with pain scores or cognitive variables. This could be because 
pain relies on sensory systems208 which may not be adequately probed using TMS. 
Interestingly, the AMT asymmetry ratio also predicted subjective levels of heat sensitivity. 
MS patients experience heat sensitivity related to autonomic and endocrine dysfunction7. The 
degree of thermoregulatory dysfunction worsens as the disease progresses since demyelinated 
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axons increase heat-induced blockage of action potentials7. Our results confirmed that heat 
sensitivity and fatigue is worse among those with higher disability (and lower CSE on the weaker 
side; Figure 3.1). White et al. (2013) showed increased MTs (lowered CSE) and lowered nerve 
conduction speed in MS patients, but not in healthy controls, after 45-60 minutes of passive heat 
exposure 153. Grover, G. et al. (2017) showed decreased motor drive to the weaker leg of MS 
patients after 30 minutes of moderate aerobic exercise in ambient (warmer) temperatures 209. Also, 
cold therapy lessened the severity of physical symptoms and suppressed fatigue among MS 
patients reporting a high degree of heat sensitivity210. The AMT asymmetry ratio may be a useful 
tool to understand the effects of heat and cold on the motor system in order to build better 
rehabilitative treatments for MS. 
3.5.3 CSE asymmetry and its treatments – What can we learn from evidence in stroke? 
Following stroke, decreased excitation caused by neuronal loss in the affected hemisphere 
167, 168 or excessive activation in the contralateral hemisphere27 causes CSE asymmetry. The 
recovery process after stroke is marked by reduced CSE asymmetry167. In fact, Di Pino, G. et al. 
(2014) proposed that recovery post-stroke depends on brain structural reserve and the excitability 
relationships between hemispheres (bimodal balance-recovery model), whereby in large lesions, 
higher CSE of the unaffected hemisphere may be beneficial and compensatory (vicariation model), 
whereas, in smaller lesions, higher excitation of the non-affected brain may weaken motor 
recovery (interhemispheric competition model)27. These models were proposed based on TMS 
protocols, interhemispheric inhibition and interhemispheric facilitation, that investigate the ability 
of one hemisphere to inhibit or facilitate the other through callosal connections20, 27. We have 
shown that, like in stroke167, 168, participants with greater MS-related disability demonstrated brain 
excitability asymmetry due to lower CSE (higher MTs) in the weaker side. In fact, in MS, callosal 
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dysfunction becomes apparent even at the earliest stages of MS211. Previous TMS research 
reported increased interhemispheric inhibition (longer ipsilateral silent period) in MS patients that 
correlated with the degree of physical disability87, 212. Future research examining the relationships 
between affected and less affected hemispheres is needed in order to understand interhemispheric 
competition in MS. More importantly, elucidating the nature of this relationship, whether is 
harmful or beneficial, could guide new treatment strategies for MS.  
In stroke, brain stimulation methods such as repetitive transcranial magnetic stimulation 
(rTMS) and transcranial direct current stimulation (tDCS) have been used to either increase CSE 
in the ipsilesional213 or decrease CSE in the contralesional hemisphere214 to reduce 
interhemispheric inhibition and CSE asymmetry to improve capacity for motor recovery. Also, 
improved motor acquisition and learning of the affected hand following a bout of aerobic exercise 
has been related to suppressed CSE asymmetry169. Therefore, especially in late MS, as in stroke, 
increasing CSE in the affected hemisphere may be beneficial. However, due to the distinct nature 
of MS (both neuroinflammatory and degenerative), comparing our findings to the CSE 
interhemispheric relationship reported in stroke is challenging, and whether any of the models of 
recovery proposed by Di Pino, G. et al. (2014), and its treatments (e.g. brain stimulation methods) 
is applicable for MS is unknown and requires further investigation. If brain excitability asymmetry 
in MS exists because of excessive inflammation-induced excitation, further activation may be 
contraindicated because of the potential for further death of neurons from glutamate-mediated 
excitotoxicity2. In the few trials examining rTMS and transcranial direct current stimulation to 
increase CSE in MS, researchers treated the affected side and the results were inconclusive215, 216.  
Interestingly, Mori et al. (2014), using an inhibitory type of rTMS protocol to reduce CSE, showed 
decreased CSE post-rTMS in healthy controls but not in recently diagnosed MS patients 131. Using 
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a similar method, Zeller and group (2012)121 demonstrated that following inhibitory rTMS, CSE 
diminished and hand strength decreased in healthy controls but not in MS patients with low to 
moderate levels of disability. Taken together, these findings suggest that CSE is altered in early 
MS, and although pathological, hyperexcitation may function to lessen physical disability. 
Whether hyperexcitability is a reasonable and safe target for restorative interventions is worthy of 
further research. 
3.6 Limitations 
The limitations of this study include the fact that we used a convenience sample of 
consecutive MS patients attending a MS clinic who consented to the study, which may not 
represent all patients. Furthermore, we attempted to recruit patients with a wide disability range, 
but those with EDSS > 4 were underrepresented. Hand dominance can be an issue since 70.3% of 
participants showed weakness in the non-dominant hand, however, handedness was one of the 
variables we controlled for in the regression analyses. Future studies should be attentive to 
investigating the sample with respect to side of hand impairment. Also, as this was a cross-
sectional study, longitudinal data is required in order to confirm whether MS progression is 
accompanied by shifting CSE (loss of hyperexcitability) in the brain hemisphere responsible for 
the weaker side of the body. Based on our findings, TMS protocols investigating direct 
interhemispheric stimulation such as interhemispheric inhibition/facilitation and ipsilateral silent 
period are warranted to further elucidate the issues of hemispheric communication in MS. 
3.7 Conclusion 
Neurophysiological changes occurring in early and in pre-symptomatic MS may work as 
biomarkers to predict MS progression and to understand the benefits of drugs or rehabilitation 
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interventions. To date, TMS variables are only weakly associated with clinical symptoms52, 53. 
Using a ratio between weaker and stronger sides, we showed strong relationships between 
asymmetry of brain excitability measured using AMT and MS symptom severity and disability. 
Specifically, MS patients were less physically and cognitively disabled if presenting with a CSE 
asymmetry with the weaker side more excitable than the stronger side. This atypical CSE 
asymmetry could be a result of hyperexcitability induced by greater inflammation in early MS 2 
affecting predominantly the weaker side. In contrast, neurodegeneration and cessation of 
inflammatory events2 may explain the shift of CSE asymmetry later in the disease. Longitudinal 
studies are necessary in order to confirm whether the degree of unilateral hyperexcitation in the 
weaker side, may in fact predict degree of disease progression, in other words, whether a CSE 
asymmetry with weaker side presenting with higher excitability would signal faster MS 
progression due to excitoxicity-mediated degeneration. More studies are also necessary to 
understand the effects of drug therapies and rehabilitation interventions on CSE asymmetry. 
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Background and Purpose: Even a single bout of aerobic exercise (AE) enhances corticospinal 
excitability (CSE); a biomarker of neuroplasticity. Because neurodegeneration limits capacity for 
neuroplasticity, it is not clear whether AE would induce CSE changes in people with progressive 
Multiple Sclerosis (MS). 
Methods: People with progressive MS (n = 10) requiring ambulatory assistive devices completed 
a graded maximal exercise test. Dual Energy X-Ray Absorptiometry was used to quantify body 
fat and lean mass. Before and following one 40-minute AE session using body-weight supported 
(<10% support) treadmill at moderate intensity, CSE was measured using transcranial magnetic 
stimulation (TMS). Variables included resting and active motor thresholds, motor evoked 
potentials (MEP) amplitudes, recruitment curves, and length of the cortical silent period (CSP). 
Results: AE reduced inhibition (shorter CSP) and increased excitation (increased MEP amplitude) 
only in the hemisphere corresponding to the stronger hand. Controlling for age, higher fitness and 
lower body fat significantly predicted exercise-induced reduction in resting motor threshold (ΔR2 
= +0.458, p = 0.046) and CSP (ΔR2 = +0.568, p = 0.030), respectively. 
Discussion and Conclusions: Despite high levels of disability, capacity for exercise-induced 
neuroplasticity was retained among people with progressive MS. The hemisphere contralateral to 
the weaker hand was resistant to exercise-induced CSE changes suggesting less neuroplastic 
potential. Lower fitness and higher body fat was associated with diminished exercise-induced CSE 
benefits suggesting that therapists should consider interventions aimed at improving fitness and 





Multiple Sclerosis (MS) is a neuro-inflammatory mediated disease that affects both white 
and gray matter leading to physical, sensory, and cognitive impairments.1 In progressive MS, 
chronic brain lesions and neurodegeneration are thought to limit capacity for neuroplasticity and 
research suggests that gradual loss of plasticity explains disability progression.1 Exercise is one of 
several lifestyle interventions (e.g. abstaining from smoking, absence of cardiovascular co-
morbidities) purported to provide neuroprotection in MS43, 47, 65, 106 possibly by affecting the brain 
directly.41 In healthy people and people with stroke, a single bout of aerobic exercise (AE) is 
known to enhance cerebral blood flow, elevate serum levels of neurotrophic factors such as brain-
derived neurotrophic factor,107, 217 and upregulate neuroprotective hormones and 
neurotransmitters; processes that promote neuroplasticity.36, 40, 218-220 For this reason, there is an 
emerging field of research examining whether acute AE can ‘prime’ the brain to synergistically 
enhance the benefits of other rehabilitation therapies among clinical populations, such as stroke.169, 
217, 221-223 Using transcranial magnetic stimulation (TMS), a non-invasive tool that assess 
mechanisms of corticospinal excitability (CSE)20, several studies in healthy individuals have 
proposed that the main factors responsible for enhancing neuroplasticity-associated with improved 
brain function post AE are the transient increases in glutamatergic-mediated intracortical 
excitation and decreases in gamma-aminobutyric acid (GABA)-mediated intracortical 
inhibition.219, 221, 224, 225 Using TMS, Nepveu, et al. (2017) showed that among people with chronic 
stroke, reduced GABAergic-mediated intracortical inhibition in the affected hemisphere after a 
single AE session paired with a motor learning task was a potential mechanism that facilitated 
superior motor learning in the affected hand.169 Whether acute AE promotes similar 
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neuroplasticity-associated CSE changes among people who have substantial MS-related motor 
disability, such as in progressive MS, is not known. 
It is reasonable to think that people who have higher levels of fitness could respond 
differently to acute AE.226 TMS studies have shown that adherence to exercise in the longer term 
increases baseline levels of brain excitability, allowing fitter individuals to benefit more robustly 
from neuroplasticity-inducing interventions39 including acute AE.38 Likewise, among people with 
MS, Chaves et al. (2019) reported an association between lower levels of fitness and increased 
GABAergic-mediated intracortical inhibition measured with longer cortical silent period (CSP),41 
a TMS biomarker of diminished neuroplasticity.16, 31 Similarly longer CSP has been linked to 
greater neurological impairment in stroke,30, 118 Huntington’s,117 and in MS.88 In general, most 
people with MS do not engage in regular physical activity,41, 43, 45, 66 therefore it is important to 
understand whether lower fitness levels and sedentarism may be hindering the potential benefits 
of strategies aimed at improving brain function. The aim of this pilot study was to first, investigate 
whether a single bout of AE could induce neuroplasticity in people who had severe walking 
disability due to progressive MS, and second, to determine whether levels of fitness would be 
associated with CSE changes post AE. Based on previous research, we hypothesized that lower 
levels of fitness could be a factor limiting AE-induced changes in brain excitability. 
4.2 Methods 
4.2.1 Participants 
Ten people with progressive MS (9 females, and 1 male) aged 53.20 ± 15.6 years 
(mean±SD), recruited consecutively through referrals from a neurologist, physiotherapists, and 
through posters at a tertiary rehabilitation center, participated in the study. Participants met the 
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following inclusion criteria: 1) Confirmed diagnosis of progressive MS by a neurologist, 2) ≥ 18 
years of age, 3) free of relapses in the previous 3 months, 4) walking with bilateral (e.g. ambulatory 
assistive devices; canes or walker) support, 5) disability level quantified using the Expanded 
Disability Status Scale of ≥ 6.0 (EDSS; 0.5-unit increment; 0 = normal neurological exam, 10 = 
death due to MS), 6) able to participate in physical exercise as per PAR-Q screening form,89 and 
7) able to undergo TMS and Dual Energy X-ray Absorptiometry (DEXA) as per safety 
standardized forms.90, 227 All participants provided written consent. All procedures were approved 
by the local health research ethics board (Memorial University of Newfoundland, #2018.088). 
Participants’ descriptive data are reported in table 4.1. Demographic data were collected, including 




Table 4.1. Participants’ Demographics 
ID Gender Age (years) DD (years) 
MS Severity 
(EDSS 0-10) 
MS Type AAD 
1 Female 57 10 6.5 PPMS Walker 
2 Female 58 33 6.5 SPMS Walker 
3 Male 42 19 6.5 PPMS Walker 
4 Female 50 28 6.0 SPMS Canes 
5 Female 38 19 6.5 SPMS Canes 
6 Female 42 8 6.5 SPMS Walker 
7 Female 72 18 6.0 SPMS Canes 
8 Female 74 10 6.5 PPMS Walker 
9 Female 29 2 6.0 SPMS Canes 
10 Female 70 29 6.0 SPMS Canes 
 Mean ± SD: 53.20 ± 15.6 17.60 ± 10.2 6.3 ± 0.3 - - 
Note: Ambulatory assistive devices, AAD; DD, disease duration; EDSS, Expanded Disability Status Scale; MS, Multiple 
Sclerosis; PPMS, primary progressive MS; SPMS, secondary progressive MS. 
Table 4. 1 Participants’ Demographics
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4.2.2 Experimental design 
Participants were assessed in 3 sessions that were 7-10 days apart. In session 1, whole body 
lean mass (Kg) and fat percentage (%) were assessed using DEXA. In session 2, cardiorespiratory 
fitness (VO2max) was assessed in a graded maximal exercise test. In session 3, CSE was assessed 
with TMS, performed pre and post body-weight supported treadmill AE. Figure 1 illustrates a 
schematic overview of the experiment design.
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AMT, active motor threshold; DEXA, Dual Energy X-Ray Absorptiometry; eREC, excitatory 
recruitment curve (Motor evoked potentials amplitudes); GXT, graded maximal exercise test 
(VO2max, maximal volume of oxygen uptake); iREC, inhibitory recruitment curve (cortical silent 
period time); RMT, resting motor threshold; TMS, transcranial magnetic stimulation. 
Figure 4. 1 Schematic overview of the experimental design 
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4.2.3 Outcome Measures  
4.2.3.1 Body Composition & Cardiorespiratory Fitness 
 Levels of physical fitness were determined by quantifying cardiorespiratory fitness and 
body fat percentage, both of which are biomarkers of sedentarism and their poor levels have been 
proposed to contribute to development and progression of MS.41, 43, 47, 228, 229 Whole body Dual 
Energy X-Ray Absorptiometry (Discovery-A densitometer, Hologic Inc., Bedford, MA, USA) was 
used to assess participants’ total body weight (Kg), amount of muscle (i.e. lean) mass (Kg), and 
body fat percentage (%).230 Specialized trained technicians performed equipment calibration 
before the assessments as per manufacturer’s guidelines.227 Data analysis was performed using the 
system’s built in software (v.12.6.1:3, Hologic Inc., Bedford, MA, USA). 
Levels of cardiorespiratory fitness were determined by the maximal capacity of volume of 
oxygen uptake (VO2max) during a graded exercise test using a total body recumbent stepper 
(NuStep, Ann, Arbor, MI).97 The stepper permits subjects to use all for limbs in a seated position 
and has been shown to be acceptable for people with MS who have mobility disability.108, 231 With 
participants maintaining a speed of 80 strides per minute, the resistance level (1-10; beginning at 
level 3) was increased by one unit every 2 minutes. If exhaustion was not reached until completion 
of resistance level 10 (maximal NuStep resistance), workload was augmented by increasing the 
speed (strides per minute) by 10 every 2 minutes. During the test, an indirect calorimetry system 
(Moxus, AEI Technologies, Pittsburgh, PA) was used to measure volume of oxygen uptake (VO2), 
volume of carbon dioxide production (VCO2), and heart rate (HR) (H10, Polar Electro Inc., NY, 
USA). The criteria for terminating the test were: (i) volitional exhaustion, (ii) no increase in VO2 
or HR despite increases in workload, and (iii) inability to maintain required workload. The breath-
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by-breath collected data was smoothed using 15 seconds moving average. Proper achievement of 
VO2max was investigated based on: (i) respiratory exchange ratio (VCO2/VO2) ≥ 1.1; and/or (ii) 
HRmax ±10 bpm of predicted maximum HR calculated as 206.9 − (0.67 × age) or 164 − (0.7 × 
age) if prescribed beta-blockers.98 From the smoothed data, the highest absolute VO2 was divided 
the participants’ total body weight (Kg) to obtain participants’ relative VO2max (mL.min
-1kg-1Total 
body weight (TBW)) which was used for descriptive analysis of participants’ fitness. As well, the 
absolute VO2max was divided by the amount of muscle/fat free mass (i.e. lean mass (Kg)), to 
provide a more accurate value of cardiorespiratory fitness, especially in populations with higher 
body fat % (mL.min-1kg-1Lean mass (LM)).
232 
4.2.3.2 Transcranial magnetic stimulation (TMS). 
With the participant seated, Motor Evoked Potentials (MEP) were elicited using 
monophasic magnetic pulses from a BiStim 2002 stimulator (Magstim Co. Whitland, UK) 
connected to a double 70mm figure-of-eight coil (Magstim, Co.). Throughout the experiment, the 
TMS coil was maintained tangentially to the scalp with the handle pointing backward and laterally 
at an angle of 45° from the midline perpendicular to the central sulcus to deliver posterior-anterior 
directed pulses in the primary motor cortex area.233 To measure electromyography (EMG) activity 
and collect the MEPs, foam surface electrodes (Kendall 200 Coviden, Mansfield, MA) were placed 
on the belly of the first dorsal interosseous hand’s muscle, and the ground and the reference 
electrodes were placed on the styloid process and the interphalangeal joint of the index finger, 
respectively. A neuronavigation device (Brainsight, Rogue Research Inc, Montreal, QC, Canada) 
guided coil position and collected the MEPs with its built-in electromyography (EMG) system. 
This system uses a 2500V/V amplification and collects with a sampling rate of 3kHz and a gain of 
600V/V with a bandwidth of 16-550Hz. The Montreal Neurological Institute brain template was 
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rendered into the BrainSight software and used as a 3-D stereotaxic template.91, 92 Since MS can 
affect either (or both) brain hemispheres, indiscriminately,48 MEPs were assessed bilaterally; 
Stronger (less affected) and weaker (more affected) hands48 were determined by EMG recordings 
of the first dorsal interosseous muscle with the participant performing maximal voluntary 
contraction of the pincer grip. Three to six trials were collected (10-15 seconds apart) and the EMG 
values were recorded and averaged for each hand. A priori analysis showed no differences pre or 
post AE on EMG values across the maximal voluntary contraction trials on each hand (t < 2.37, p 
> 0.099). None of the participants reported fatigue throughout the TMS assessment, pre or post 
AE. Therefore, fatigability was likely not an issue when identifying stronger and weaker hand or 
when assessing CSE. 
TMS suprathreshold stimulations were delivered at different locations over the primary 
motor area and the site with the highest averaged MEP peak-to-peak amplitude was taken as the 
hotspot. The hotspot was assessed pre and post AE because of its susceptibility to change in 
location as a result of acute interventions (e.g. exercise)234 and its higher variability, especially in 
older adults.235 Resting and active motor thresholds (RMT and AMT, respectively) were 
determined as the minimum amount of TMS intensity (maximal stimulator output percentage, 
MSO% 0-100) necessary to elicit MEPs with a peak-to-peak amplitude of ≥ 50µV during muscle 
relaxation and ≥ 200µV during 10% of pincer grip maximal voluntary contraction, respectively, 
in at least 50% of the trials.20 Recruitment curves (REC) were assessed with the participant 
contracting 10% of the pincer grip maximal voluntary contraction and 3-6 stimulations, 3-5 
seconds apart, at each 105%, 115%, 125%, 135%, 145%, and 155% of AMT, were performed in 
randomized order. The averaged Peak-to-peak MEP amplitudes and the CSP length at each TMS 
intensity (105-155% of AMT) were recorded.20 
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The absolute MEP amplitudes were normalized by the MEP with the largest peak-to-peak 
amplitude (µV) recorded during the REC assessment prior to the exercise (i.e. % of the largest 
baseline MEP).236 For the excitatory REC, normalized MEP amplitudes were plotted against the 
TMS intensities and the slope and R squared (R2) of this linear relationship were calculated, which 
represents neuronal recruitment gain and accuracy of the structurally available descending axonal 
tracts.237 Likewise, the inhibitory REC slope and R2 were calculated by plotting the CSP length 
against the TMS intensities.238 For calculation of overall corticospinal excitation237 and 
inhibition239, the area under the curve was calculated for both excitatory and inhibitory RECs using 
the trapezoid rule ΔX x (Y1+Y2)/2, whereby X were the MSO% used (i.e. X axis values, 105-155% 
of AMT) and Y are the recorded CSP lengths (ms) or the absolute MEP amplitudes (mV).237 The 
length of the CSP was taken as the time (milliseconds) between the MEP onset, time-point where 
the MEP exceeded ±2SD from the EMG background activity, until the EMG activity returned to 
±2SD of the mean EMG background activity.20 
4.2.3.3 Intervention 
The intervention consisted in 40 minutes of AE walking on a treadmill (model T652m, 
SportsArt Fitness Co.) with a harness supporting 10% of participants’ bodyweight. This AE dosage 
(type, length, and intensity) was based on previous review investigating the optimal AE dosage to 
promote neuroplasticity in MS.107 Body weight supported treadmill training has been used largely 
to restore walking ability in populations experiencing walking impairments due to stroke,240 spinal 
cord injury,241 and progressive MS.107, 242 The level of body weight support was kept to a minimum 
(10%); sufficient to reduce risk of fall while not affecting the work performed.243 During the AE, 
intensity was monitored using heart rate (Polar H10 Heart Rate monitor). During the first 5-
minutes, the speed (starting at 80% of self-selected speed) and/or incline of the treadmill (i.e. 
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grade; starting at 1%) were progressively increased until ~60% of heart rate reserve was achieved 
(e.g. intensity target = 60% x (HRMax – HRRest) + HRRest). Speed and incline were adjusted as 
necessary in order to maintain the intensity target throughout the AE. If breaks (resting) were 
required, treadmill was halted and only resumed when participants reported that they were ready 
to continue. The total time exercising was calculated by subtracting minutes resting from 40 
minutes. A 5-minute cooldown, in which the treadmill speed and incline were gradually decreased, 
was provided for participants who completed the 35-minute protocol (total AE session time = 40 
minutes). For those who could not complete the 40-minute AE (e.g. walked for a total of 7.7-30 
minutes; see table 4.2), the session was terminated after the last walking bout. The total amount 
of workload performed during the AE session was estimated using standardized prediction 
equations.244 First, the VO2 (mL.min
-1.Kg-1) uptake during the AE was calculated using the 
equation VO2 (ml.min
-1.Kg-1) = [(Resting component (3.5mL.min-1.Kg-1) + Horizontal component 
(speed (m/min) x 0.1mL.Kg-1.meter-1) + Vertical Component (1.8mL.Kg-1.meter-1 x speed (m.min-
1) x inclineFractional Grade)];
244 changes in speed and incline throughout the AE were taken into 
consideration. The averaged VO2 (ml.min
-1.Kg-1) was transformed into metabolic equivalents, and 
the kilocalorie(Kcal)/minute was calculated using the equation Kcal/min = (Metabolic equivalents 
x 3.5 x total body weight in kg) / 200.244 Finally, the total amount of workload performed was 
expressed as Kcal/session, calculated by multiplying the Kcal/minute by the total time in minutes 
the participants exercised (i.e. total minutes walking).
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Table 4. 2 Participants’ Physical Fitness Profile and Aerobic Exercise Session 
Table 4.2 Participants’ Physical Fitness Profile and Aerobic Exercise Session  
 Body Composition (DEXA) 
Cardiorespiratory Fitness (Graded Maximal Exercise 
Test) 
AE Session: Duration: 40min, Intensity Target: 










































1 164.0 108.95 57.22 45.6 20.05 10.53 0.92 111 66.15 89.54 23.5 59.03 
2 162.0 81.54 43.26 44.8 22.61 11.99 0.80 129 77.18 92.72 9.0 15.81 
3 185.0 88.36 54.99 35.1 24.79 15.43 0.92 134 75.34 94.98 23.0 66.53 
4 167.6 51.38 29.47 39.1 41.84 24.00 1.23 158 91.59 90.00 40.0 87.64 
5 169.0 93.85 54.31 39.1 33.31 19.28 1.03 144 79.76 88.87 12.8 54.74 
6 157.0 79.30 41.62 45.0 26.87 14.10 1.01 156 87.71 85.53 30.0 73.96 
7 158.0 52.68 32.87 34.4 31.61 19.72 1.26 145 91.91 93.15 40.0 114.46 
8 162.0 84.90 # # 27.31a 13.86 1.05 148 94.62 97.27 7.7 12.68 
9 157.5 79.60 41.74 44.7 48.28 25.31 1.06 189 101.30 89.99 40.0 219.13 





















92.14 ± 4.2 26.60 ± 13.38 78.95 ± 58.3 
Note: AE, aerobic exercise; bpm, beats per minute; DEXA, dual energy x-ray absorptiometry scan; HR, heart rate; HRR, heart rate reserve (HRR = HRMax – 
HRRest); LM, lean mass; RER, respiratory equivalent ratio; VCO2, volume of carbon dioxide production; VO2, volume of oxygen uptake;  VO2max (mL.min-
1Kg-1 of lean mass (LM));  VO2max (mL.min-1Kg-1 of total body weight (TBW)); # participant 8 declined to undergo DEXA, and the aVO2max (mL.min-1Kg-1 of lean mass (LM)) was 
calculated by diving this participant’s VO2max (mL.min-1) by the LM (kg) of sample mean (43.10 Kg).  b AE Intensity target: [Intensity60% x (HRmax – HRrest) 
+ HRmax]; % of Predicted HRmax = 206.9 – (age x 0.67).c Rest time is subtracted from total exercise duration (40min) d AE total workload performed = 
3.5mL.min-1Kg-1 + (Speedm/min x 0.1) + (InclineGrade x Speedm/min x 1.8). The averaged VO2 (ml.min-1Kg-1) was transformed into metabolic equivalents, and 
the Kcal/minute was estimated using the equation Kcal/min = (Metabolic equivalents x 3.5 x total body weight in kilograms) / 200. The total amount of Kcal 
spent was calculated by multiplying the Kcal/minute by the total time in minutes participants spent exercising (Kcal/session). 
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4.3 Statistical Analysis 
4.3.1 Participants’ characteristics and its associations with baseline CSE and AE-induced 
CSE changes 
Exploratory relationships between fitness (mL.min-1Kg-1LM and body fat %) with baseline 
CSE (TMS variables RMT, AMT, excitatory and inhibitory REC values (MEP amplitudes105-155% 
AMT, CSP lengths105-155% AMT, slope, R
2, and area under the curve)), and AE-induced CSE changes 
(TMS variables % changes = post-exercise – pre-exercise / pre-exercise) were investigated in 
order to elucidate possible impact of fitness on baseline CSE and CSE responses to AE, 
respectively. Also, to examine the impact of the amount of exercise performed on CSE changes, 
relationships between the total workload performed during the AE (Kcal/session) and TMS 
variables’ % changes were investigated. Normally and non-normally distributed data were 
investigated with Pearson’s (r) or Spearman’s (rho) coefficients, respectively.245 Hierarchical 
regression analyses were performed in addition, to further test whether significant relationships (p 
< 0.05) were still present when controlling for age. We limited the inclusion of controlling 
variables to one due to the small sample size, and age was selected due to its known impact on 
both the independent (VO2max, body fat %, Kcal/session)
98 and the dependent (TMS) variables.246 
Separate regressions were performed for each independent variable (VO2max, body fat %, and 
Kcal/session) which were added in the first block, with the independent controlling variable age 
(years) added in the second block. Significant contribution (ΔR2, F(dof) = rejection region, p-value) 
of each independent variable to the final model explaining variance on the CSE responses 
(dependent variables, CSE % changes) to exercise were investigated. Acceptable collinearity 
between the predictors was identified using tolerance levels (> 0.1) and the variance inflation factor 
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(< 5.0). Outliers (±3SD, and Cook’s distance > 1.0),247 if present, were removed from the 
regressions to avoid influence of this data point in the results. 
4.3.2 Effects of AE on CSE 
A priori, we used a two-way repeated measures ANOVA (2 x 2: Time (Pre x Post), and 
Group (Stronger x Weaker hands) for RMT, AMT, MEP latencies, and REC’s area under the 
curve, and a three-way repeated measures ANOVA (2 x 2 x 6: Time (Pre x Post), Group (Stronger 
x Weaker), and Intensity (105-155%) for each normalized MEP amplitude (excitatory REC) and 
CSP lengths (inhibitory REC) collected.248 Normality was assessed using Shapiro-Wilk. Since the 
majority of the data did not pass the assumptions of distribution, pre- and post-exercise differences 
between hands (stronger Pre vs. weaker Pre, and stronger Post vs. weaker Post) as well as within 
hands’ (weaker Pre vs. weaker Post, and stronger Pre vs. stronger Post) changes from exercise 
were assessed with separate parametric or non-parametric paired t-tests. CSE (a)symmetry indexes 
(ratio = CSE weaker / CSE stronger hand) differences between pre and post AE were also 
investigated using paired t-tests 169. When performing non-parametric t-tests, Wilcoxon or Sign 
paired t-tests were used depending on the distribution of the differences between the two related 
variables being compared (i.e. symmetrical: Wilcoxon, and asymmetrical: Sign).245 Non-
parametric, and parametric paired t-tests statistics were reported as Z-score and t(Degrees of Freedom(dof)), 
respectively (e.g. t(dof) = or Z = rejection region value, p-value). Sensitivity analysis
249 were 
performed whenever outliers (±3SD) were present and both results, with and without outliers, were 
reported (see table 4). This approach was employed due to small sample size, to clarify possible 
impact of outliers in the results and avoid misleading conclusions.249  
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All comparison (t-tests) and relationship analysis’ significance were set at an alpha (α) 
level of < 0.05 and not Bonferroni adjusted  because: (i) they were exploratory, (ii) were a priori 
planned, and (iii) were planned to serve as hypothesis for future investigation.250 Data are reported 
as Mean±SD. Data were analyzed on SPSS v.24 (IBM Corporation, Armonk, New York). Graphs 
were created with GraphPad Software v.6 (La Jolla, California, USA). 
4.4 Results 
4.4.1 Participants’ characteristics 
All participants performed the graded maximal exercise test. Participants 4 and 7 met both 
pre-determined criteria for achieving VO2max whereas participants 8, 9 and 10 met at least one, and 
participants 1, 2, 3, 5, and 6 could not meet either criteria (RER ≥ 1.1 and/or HRmax within 10% of 
the predicted). Using normative percentiles values of cardiorespiratory fitness (VO2max = mL.min
-
1Kg-1TBW) normalized by age and sex,
98 participants 4, 7, and 9, were ranked as having very poor 
fitness (< 15%) and the remaining seven participants had fitness levels that were below the 1% 
(i.e. worse than very poor fitness). Using normative percentiles values of body fat % normalized 
by age and sex 98, participant 7 had poor (< 30%), 3, 4, 5, and 10 had very poor (< 5%), and 
participant 1, 2, and 6 had values below the 1% of normative values (worse than very poor). 
Participant 8 declined to undergo DEXA scan. All fitness and body composition individuals’ 
values are reported in table 4.2. 
4.4.2 AE session 
Participants 4, 7, 9, and 10 were able to fully complete the exercise session at the intended 
duration and intensity (40 minutes at 60% of HRR). The remaining six participants (number 1, 2, 
3, 5, 6, and 8) could not exercise for the intended duration (range: 7.7-30 minutes), and three of 
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them (number 1, 2, and 5) could also not maintain the intensity target while exercising (HR was 
below 40% of HRR). Participants who exercised for longer duration and at higher intensity had 
greater workload performed during exercise (Kcal/session). 2 reports the participants’ individual 
data for intensity achieved (%HRR) and time exercising (minutes) as well as the total workload 
performed by the end of the AE session (Kcal/session). 
4.4.3 Physical fitness, not workload performed, was associated with greater AE-induced CSE 
changes 
Having higher cardiorespiratory fitness (mL.min-1Kg-1LM) was associated with greater 
exercise-induced RMT reductions in the hemisphere corresponding to the stronger hand (r = -
0.745, p = 0.021) (Figure 4.2A). Furthermore, having lower body fat % was associated with 
greater increases of normalized MEP145% AMT post exercise in the weaker hand (r = -0.722, p = 
0.044; Figure 4.2B) and greater reductions of intracortical inhibition (shortened CSP105% AMT) in 
the stronger hand (r = 0.692, p = 0.039; Figure 4.2C). Total workload performed during the AE 
(Kcal/session) was not associated with any CSE change from AE. When testing these associations 
during the regression analyses controlling for age, in the stronger hand, higher cardiorespiratory 
fitness significantly contributed to the model explaining greater reductions of RMT (ΔR2 = +0.458, 
p = 0.046), and lower body fat % significantly contributed to the model explaining greater 
shortening of CSP105% AMT (ΔR
2 = +0.568, p = 0.030). In the weaker hand, older age significantly 
predicted increases of normalized MEP145% AMT (increased CSE) (R
2 = 0.697, p = 0.010), with 
lower body fat % contributing (ΔR2 = +0.162, p = 0.062) to the final model (R2 = 0.859, p = 0.007). 
Table 4.3 summarizes the regression analyses results.
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Table 4. 3 Predictors of Corticospinal Excitability Change Post Aerobic Exercise. 
  
Block 1: Controlling 
Variable – Age 
Block 2: Interesting Variable – Physical 
Fitness (VO2max, and Body Fat%) 





R2 Fstatistic Sig. 
Interesting 
Variable: 
ΔR2 Fstatistic Sig. R2 Fstatistic sig. 
Stronger 
RMT 0.105 0.82 0.395 VO2max +0.458 6.28 0.046* 0.563 3.86 0.084 
CSP105% AMT 0.003 0.02 0.885 Body Fat % +0.568 7.96 0.030* 0.572 4.00 0.079 
Weaker MEP145% AMT 0.697 13.77 0.010* Body Fat % +0.162 4.94 0.062† 0.859 15.21 0.007** 
Note: AMT, active motor threshold; CSP, cortical silent period; EDSS, Expanded Disability Status Scale; HRmax, maximal heart rate; MEP, motor evoked 
potential; MS, RMT, resting motor threshold; VO2max, maximal volume of oxygen uptake (mL.min-1kg-1Lean Mass). Sig, p-value; ΔR2, R2 change (amount 
of contribution of interesting variable to the final model); % Change = [(post – pre-exercise) / pre-exercise]; * significantly contributed to the final model 
(p<0.05); ** final model significantly predicted the outcome variable (p<0.01); † contributed to the significant final model. 
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Physical fitness measured with (A) higher cardiorespiratory fitness (mL.min-1.Kg-1Lean Mass) was 
associated with greater increases of corticospinal excitability (lowered resting motor threshold) in 
the stronger hand, and (B) Lower body fat percentage (%) was associated with greater increases 
in motor evoked potential (MEP) amplitude tested at 145% of active motor threshold (AMT) in 
the weaker hand, and (C) with greater reduction of cortical silent period tested at 105% of AMT 
in the stronger hand.




4.4.4 Exercise-induced CSE changes were limited to the stronger hand 
In the stronger hand, CSP lengths were shorter post- than pre-exercise; effect that was noted 
at 115% of AMT (t(9) = 2.71, p = 0.024) (Figure 3A). Normalized MEP amplitudes were slightly 
higher post- than pre-exercise in 5 out of 6 TMS intensities tested on the stronger hand. This effect 
was most evident at 125% of AMT (t(9) = -2.45, p = 0.037) (Figure 3C). There were no pre-post 
AE differences noted in the weaker hand for CSP lengths or normalized MEP amplitudes (Figure 




Figure 4. 3 Effects of aerobic exercise on excitatory and inhibitory recruitment curves (REC) 
In the stronger hand, (A) Cortical silent period (CSP) time (milliseconds ms)) was reduced after 
aerobic exercise in the stronger hand when tested at a transcranial magnetic stimulation intensity 
(TMS) of 115% of active motor threshold (AMT). (B) CSP changes were not noted in the weaker 
hand in any TMS intensity. (C) Motor evoked potential (MEP) amplitude tested at 125% of AMT 




4.4.5 Effects of AE on CSE asymmetry 
Before AE, AMT was higher (lower CSE) in hemisphere corresponding to the weaker hand 
in comparison to the stronger hand (t(9) = -2.56, p = 0.031). Also, excitatory neuronal recruitment 
slope and accuracy (R2) were lower in the weaker in comparison to the stronger hand (t(7) = 3.36, 
p = 0.012, and t(6) = 2.49, p = 0.047, respectively) (Figure 4). Compared to the stronger, the weaker 
hand presented with an earlier neuronal recruitment saturation (i.e. plateauing), noted by an earlier 
approach of MEP amplitudes to the largest MEP value (i.e. 100%) at lower MSO% intensities, 
indicating limited ability of the contralateral hemisphere to recruit further neurons with increased 
stimulations intensities (e.g. MEP125% AMT: t(7) = -2.70, p = 0.031). After AE, these baseline 
differences between weaker and stronger hand did not exist (p > 0.05). For the AMT, this 
difference did not exist after AE because of participants 2 and 8 whom had great asymmetry at 
baseline could not be re-assessed, likely reducing the AMT asymmetry group effect. Nonetheless, 
because participants 2 and 8 could not be assessed for REC neither pre or post AE (too high AMT 
to perform REC) in the weaker side, the reduced asymmetry between hands for REC values (slope 
and R2) was likely a true group effect (Figure 4). Although the within weaker hand’s difference 
(Pre x Post) was not significant (p > 0.05), there were observable improvement in recruitment gain 
(slope) and accuracy (R2) in the weaker hand post AE (Figure 4). There were no pre-post AE 
differences for the (a)symmetry indexes (p > 0.05).
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(A) eREC gain (slope) and (B) eREC accuracy (R2) were different between stronger and weaker 
hand pre but not post aerobic exercise. 
Figure 4. 4 Effects of aerobic exercise on reducing asymmetry of excitatory recruitment 
curve (eREC) parameters 
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RMT could not be collected in participant 2 in either hand pre or post exercise because of 
very low CSE at rest (e.g. > 100% of MSO). All participants had recordable AMT in both hands 
before exercise. Before exercise, REC could not be recorded on the weaker side of participant 2 
and 8 because participants’ AMTs reached the 100 % of the MSO and higher stimulus intensities 
based on AMT could not be applied, and because TMS overheated during the assessment, 
respectively. Prior to exercise, 155% of AMT could not be obtained in the weaker side of 
participant 5 during the REC because the required intensity surpassed the limits of the stimulator 
(i.e. AMT155% = 104 > 100% MSO). After exercise, AMT could not be measured in the weaker 
side of participants 2 and 8 because of lowered CSE (i.e. MEPs of ≥ 200µV were not detected 
during contraction), as well, procedures based on this measure (e.g. REC) could not be recorded. 
RMT and AMT amplitudes did not differ within or between stronger and weaker hands at pre or 
post exercise (t < 1.73, p > 0.123) indicating that the same relative TMS intensities between hands 




Table 4. 4 Between and Within hands’ CSE differences – Sensitivity Analysis 
 Between Hands’ Differences 
Within Hands’ 
Differences 
 Pre AE Post AE Stronger Weaker 
TMS Variable 
Stronger Weaker Sig. Stronger Weaker Sig. Pre vs. Post 
Pre vs. 
Post 
RMT (MSO%) 43 ± 12 54 ± 23 0.174 45 ± 15 53 ± 24 0.248 0.222 0.930 
AMT (MSO%) 36 ± 13 49 ± 26 0.031* 34 ± 13 37 ± 13 0.080 0.138 0.370 
MEP105% AMT 31.67 ± 22.3 44.78 ± 21.1 0.069 28.85 ± 19.2 36.49 ± 19.35 0.441 0.333 0.192 
MEP115% AMT 40. 17 ± 28.04 62.12 ± 32.19 0.195 46.17 ± 27.8 59.65 ± 25.1 0.372 0.396 0.776 
MEP125% AMT 47.09 ± 20.9 70.70 ± 25.5 0.031* 68.58 ± 30.3 62.48 ± 28.3 0.731 0.037* 0.312 
MEP135% AMT 74.52 ± 18.77 78.61 ± 20.8 0.497 66.12 ± 20.1 77.72 ± 37.7 0.567 0.279 0.934 
MEP145% AMT 79.50 ± 22.2 79.67 ± 22.5 0.985 91.18 ± 46.6 89.52 ± 33.8 0.952 0.592 0.279 
MEP155% AMT 99.79 ± 0.6 91.18 ± 8.8 0.068 115.66 ± 52.2 107.71 ± 33.9 0.674 0.575 0.310 
eREC Slope 
(Gain) 
1.49 ± 0.4 0.79 ± 0.6 0.012** 1.45 ± 1.1 1.24 ± 1.0 0.755 0.751 0.246 
eREC R2 
(Accuracy) 
0.82 ± 0.1 
0.86 ± 0.1b 
0.49 ± 0.4 
0.48 ± 0.4b 
0.058 
0.047b** 
0.76 ± 0.3 
0.87 ± 0.1d 
0.71 ± 0.3 









48.00 ± 41.7 36.12 ± 20.8 0.472 46.55 ± 31.3 36.70 ± 22.3 0.418 0.884 0.853 
CSP105% AMT 
83.73 ± 44.9 
67.20 ± 34.29b 
90.81 ± 71.2 
68.12 ± 33.2b 
0.401 
0.949b 
65.07 ± 28.2 
61.05 ± 31.2b 
88.26 ± 68.8 







102.58 ± 47.3 
86.81 ± 44.2b 
111.15 ± 68.4 
88.92 ± 29.2b 
0.401 
0.735b 
84.50 ± 40.1 
72.56 ± 38.0b 
100.99 ± 60.4 







121.75 ± 52.8 
98.92 ± 35.6b 
128.68 ± 57.7 
110.57 ± 28.6b 
0.161 
0.462b 
102.98 ± 40.0 
90.95 ± 40.1b 
125.31 ± 79.9 







134.53 ± 51.8 
116.95 ± 43.0b 
142.58 ± 64.6 
124.09 ± 40.9b 
0.308 
0.659b 
124.09 ± 54.1 
112.12 ± 61.2b 
133.03 ± 60.3 







143.79 ± 62.5 
120.72 ± 44.4b 
155.33 ± 79.7 
130.95 ± 43.2b 
0.220 
0.432b 
139.93 ± 49.0 
122.51 ± 48.1b 
151.27 ± 71.3 







159.45 ± 62.0 
146.67 ± 37.7c 
143.73 ± 41.1 
157.86 ± 18.7c 
0.487 
0.372c 
165.22 ± 65.5 
160.77 ± 58.9c 
163.82 ± 72.7 








1.36 ± 0.6 1.49 ± 0.6 0.572 1.79 ± 1.2 1.53 ± 0.7 0.598 0.402 0.817 
iREC R2 
(Accuracy) 






54.88 ± 19.4 62.57 ± 24.3 0.307 51.29 ± 19.8 59.81 ± 24.3 0.306 0.260 0.389 
Note: AE, aerobic exercise; AMT, active motor threshold; CSE, corticospinal excitability; CSP, cortical silent period; eREC, excitatory recruitment curve; 
iREC, inhibitory recruitment curve; MEP, motor evoked potential; MSO%, maximal stimulator output percentage; RMT, resting motor threshold; eREC 
Slope = Normalized MEP (% of the largest baseline MEP amplitude) by TMS intensity105-155% AMT; iREC Slope = CSP timems by TMS intensity105-155% AMT; 
** Difference is significant at α < 0.05; * Difference is significant at the unadjusted α (adjusted α for eREC and iREC (MEP amplitudes and CSP) = < 0.008); 
Outliers (±3SD) removed during analysis: a participant 6 (MEP latency: Pre and Post AE: Stronger hand: 31.20 and 32.09ms, and weaker hand: 30.26 and 
29.42ms; b participant 5 (Weaker hand’s CSP105-145% AMT time (ms) (pre and post AE): 249.76 and 245.35, 266.75 and 238.38, 255.44 and 299.54, 272.03 and 
252.41, 325.93 and 302.92; Stronger hand’s eREC R2 (pre-exercise): 0.51. c participant 10 (Weaker hand CSP155% AMT time (ms) (pre and post): 58.22ms; d 




This is the first study to investigate the effects of acute AE on neuroplasticity-like 
mechanisms measured in the upper limb among people with progressive MS. Previous research 
has proposed that CSE changes following a bout of AE when measured in the non-exercised upper 
limb are likely mediated by neuroplasticity-related mechanisms,40, 169, 219, 225, 251 rather than 
peripheral exercise-induced fatigue.252 In this preliminary pilot study, we showed that capacity for 
AE-induced improvements in brain excitability still exists in this group of people with progressive 
MS, who, because of significant central nervous system damage, require bilateral ambulatory 
assistive devices (e.g. canes, walker) in order to walk. Regardless of whether they were able to 
complete the entire 40-minute bout of exercise, changes in brain excitability were noted. These 
benefits were observed only in the hemisphere corresponding to the stronger hand suggesting that 
there may be somewhat reduced flexibility in the hemisphere corresponding to the weaker side of 
the body. Furthermore, when controlling for age, responsivity to exercise was greater in those 
participants with higher levels of cardiorespiratory fitness and lower body fat. Our results support 
that improving fitness and participation in AE is an important therapeutic target among people 
with progressive MS because AE likely has beneficial effects directly on the brain. 
4.5.1 The effects of AE on intracortical inhibition 
Intracortical inhibition occurs when the main inhibitory neurotransmitter GABA binds to 
its ionotropic GABAA or metabotropic GABAB receptor, producing a short- or long-lasting type 
of inhibition, respectively.25 In the adult brain, the balance between brain excitation and inhibition 
assures proper brain functioning.253 Excessive activity of both GABAA- and GABAB-receptor 
activity, however, is considered pathological16, 25 because it diminishes neuroplasticity-like 
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mechanisms  that are necessary for learning and memory consolidation.16, 25, 31, 254 Measured with 
longer CSP, excessive GABAergic-mediated intracortical inhibition corresponds to greater lesion 
load, poorer recovery, and worse symptom progression in diseases affecting the brain such as 
stroke, 30, 118 Huntington’s, 117 and MS. 88, 116 For this reason, treatment strategies aiming at 
reducing GABAergic-mediated intracortical inhibition are purported to improve neuroplasticity, 
protect brain functions, and prime recovery in ageing and in disease neurodegenerative 
conditions,25, 254 including MS.14 
In this sample of people with progressive MS, we noted that CSP tested at lower but not 
higher TMS intensities was reduced immediately following a single session of AE. GABAA and 
GABAB-receptor activity are sensitive to stimulus intensity, with lower TMS stimulations 
intensities producing shorter CSPs predominantly mediated by GABAA-receptors.
20, 238 Our results 
showing AE-induced shortening of CSP only when tested at lower TMS intensities suggest 
predominant involvement of GABAA-receptors. This finding align with those previously described 
in healthy populations exposed to acute AE,40, 219, 251, 255 supporting that the benefit of AE on 
reducing GABAA-mediated brain inhibition is preserved in people with progressive MS. It is 
important to note that this benefit was detected only in the hemisphere corresponding to the 
stronger hand. Compared to the weaker side at baseline, the hemisphere corresponding to the 
stronger hand had higher CSE (lower AMT) and superior excitatory neuronal recruitment gain 
(slope) and accuracy (R2). Because lower RECs parameters are indicative of corticospinal tract 
damage and predictors of poor recovery following stroke,237, 256, 257 our results suggest that a more 
intact and efficient cortical representation and excitatory network of contralateral descending 
neurons could explain the retained and higher capacity for neuroplasticity in the hemisphere 
corresponding to the stronger side. We have previously shown that lower CSE in the hemisphere 
103 
 
corresponding to weaker side among people with MS corresponds to a more advanced disease 
stage, and poorer physical and cognitive performance.48 
In comparison to GABAA, the effects of acute exercise on GABAB-mediated intracortical 
inhibition have not been as elucidated.40 In these progressive MS patients, reductions of CSP tested 
at higher TMS stimulations intensities were not noticed, indicating that acute AE likely did not 
reduce GABAB-receptor activity. In healthy volunteers, CSP investigated with higher TMS 
stimulations intensities is reduced following long-term exercise training.32, 33 Accordingly, we 
have recently reported that CSP derived from higher TMS stimulation intensities were longer in 
people with MS with lower fitness levels.41 This suggests that GABAB-mediated intracortical 
inhibition is fitness-associated in healthy and in people with MS. Because excessive activity of 
both GABAA- and GABAB-receptors diminishes neuroplasticity, rehabilitation strategies should 
not only rely on acute AE, but, more importantly, should also focus on implementing long-term 
exercise training to improve physical fitness of people with MS. 
4.5.2 The effects of AE on intracortical excitation 
Higher amplitude of the MEP is a key indicator of elevated brain excitability20 and 
improved neuroplasticity-like mechanisms.39 Increases in MEPs following exercise have been 
attributed to increased release of catecholamines, such as norepinephrine, a key mediator of 
increased sympathetic nervous system activity to prepare the brain and body during exercise (e.g. 
flight-or-fight response), and to enhance neuroplasticity.40 We report here that, only measured in 
the stronger hand, MEP amplitudes were higher post AE in 5 out of 6 intensities tested during the 
REC. Statistical significance was reached around the midpoint of the REC (i.e. 125% of AMT), 
previously shown to correspond to the “inflection point” of the REC,237 which represents the point 
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of steep recruitment of higher threshold motoneuronal pool lying deep within the corticospinal 
tract. It is interesting to note that this point in the REC is also sensitive and negatively affected by 
passive heat stress among people with MS.153 
Previous studies investigating the effects of acute AE on CSE have shown benefits among 
young (~20-30 years-old) healthy individuals with high levels of fitness (~50 mL.min-1Kg-1).40, 225, 
251, 258, 259 It is noteworthy that only a modest volume of AE (moderate intensity, 7.7-40min) 
performed by these older, disabled, and deconditioned progressive MS patients was able to induce 
similar observable CSE improvements. Our findings support that patients with MS, even those 
with more advanced disease, should be prescribed AE. 
4.5.3 Effects of AE on CSE in progressive MS – the role of fitness  
Previous research has confirmed that the effects of AE on brain excitability appear to be 
intensity-dependent with higher exercise intensities inducing greater increases of brain excitability 
associated with higher levels of neurotrophins such as brain-derived neurotrophic factor,260 
excitatory neurotransmitters (e.g. dopamine, norepinephrine), lactate,259 and increases in cerebral 
blood flow.36, 40 Based on this assertion, we expected that higher total workload could be associated 
with superior CSE gains, with participants performing 40 minutes of exercise benefiting more than 
those who performed only 7 minutes. However, this was not the case; total workload performed 
(Kcal/session) was not associated with AE-induced changes in any TMS variable tested. 
Importantly, higher fitness tested at baseline, was associated with greater CSE gains. Specifically, 
higher cardiorespiratory fitness (mL.min-1Kg-1LM) was associated with increases in CSE (measured 
with reductions of RMT) in the hemisphere corresponding to the stronger hand. Coco, M. et al., 
(2010) showed that reduction of RMT after a single session of exhaustive AE was associated with 
105 
 
increased levels of lactate.259 However, Coco, M. et al., (2010) investigated highly fit, lean, and 
young individuals; fitness profiles opposite that of our participants. Whether the fitness-dependent 
changes in CSE could be related to elevated lactate levels in people with MS is worthy of future 
research. Furthermore, we found that lower body fat % was also associated with greater CSP 
reductions (less intracortical inhibition) in the hemisphere corresponding to the stronger side and 
elevated MEP amplitudes (higher CSE) in the hemisphere corresponding to the weaker hand. 
Recent evidence has demonstrated the link between disability, poor cardiorespiratory fitness, and 
higher body fat percentage in MS patients.228 We suggest that lower cardiorespiratory fitness and 
higher body fat percentage may also diminish AE-induced neuroplasticity-like mechanisms in 
people with MS. 
4.5.4 Effects of AE on reducing CSE asymmetry 
CSE asymmetry is a hallmark of stroke, whereby the lesioned brain has a much lower 
excitability,27 with its magnitude related to lesion size, predicting worse symptoms and 
disability.167 For that reason, reducing CSE asymmetry with advanced brain stimulation techniques 
has been a desirable goal during rehabilitation interventions in stroke.27, 169 In MS, we have 
recently demonstrated that CSE asymmetry also predicts disease and symptom progression, with 
CSE asymmetry of more advanced MS stages (EDSS 3-6) comparable to the ones reported in 
stroke.48 In accordance with our previous results, we noted in this group of people with progressive 
MS, lower excitability (higher AMT) and inferior quality of excitatory neuronal activity (lower 
excitatory REC gain (slope) and accuracy (R2)) in the weaker compared to the stronger hand. It is 
noteworthy that only the TMS variables measuring excitation (AMT, excitatory REC) and not 
inhibition (CSP, inhibitory REC), were different between hemispheres. This asymmetry of 
excitation could be mediated by excitotoxicity due to excessive glutamatergic activity typical of 
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early MS stages.2, 48 After AE, we noted that differences between excitatory REC (slope and R2) 
were dissolved, with slight increase of the excitatory REC parameters in the weaker side. 
Therefore, it is possible that AE could have transiently restored excitatory glutamatergic activity 
in the hemisphere corresponding to the weaker side in this sample of people with progressive MS. 
4.5.5 Limitations 
This pilot study was designed to explore, in a preliminary way, the effects of acute AE on 
brain excitability in a group of people with progressive MS who use bilateral ambulatory assistive 
devices to walk. There are some important limitations to the study, most important of which is the 
small sample size. Because severity of MS could have a major impact on acute AE effects, we 
attempted to recruit a homogenous group of people with MS with EDSS scores between 6.0 and 
6.5. We did not complete a power analysis, so it is not surprising that some of our regression 
analyses were underpowered. Moreover, because we performed multiple comparisons (sensitivity 
analysis using t-tests), the unadjusted (i.e. Bonferroni corrected) significances found in this study 
should be interpreted with care. Despite a small sample size, our findings may serve to develop 
hypotheses and methods for future longitudinal and interventional studies investigating 
associations between fitness and neuroplasticity in progressive MS. 
4.6 Conclusion 
MS patients participating in this study were diagnosed with the progressive form of MS 
and required ambulatory assistive devices (e.g. canes, walker) to walk likely due to severely 
damaged corticospinal tract. In addition, their fitness scores indicated that they were also severely 
deconditioned and only 4 of 10 participants could complete the intended 40 minutes of body-
weight supported treadmill AE. Despite these physical challenges, neuroplasticity-related CSE 
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improvements were noted after a single bout of AE. Specifically, a bout of AE resulted in enhanced 
excitation (increased MEP amplitude) and reduced intracortical inhibition (shortened CSP) in the 
hemisphere associated with the stronger hand. The hemisphere contralateral to the weaker hand 
was resistant to exercise-induced CSE changes, had lower baseline CSE (higher AMT) and poorer 
neuronal recruitment (lower excitatory REC), likely suggesting less neuroplastic potential. 
Nonetheless, typical CSE asymmetry expected in this group of people with progressive MS was 
dissolved after AE, which could indicate some potential for neuroplasticity in the hemisphere 
corresponding to the weaker side. The benefits of AE-induced improvements in CSE was not 
related to intensity of the workload but rather baseline cardiorespiratory fitness and percentage of 
body fat; with fitter participants with less body fat receiving greater benefits. The results of this 
preliminary study support that reducing levels of sedentarism, prescription of AE, and decreasing 
body fat, may have direct benefits on the brain; improving brain plasticity in people with 
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Background: Inflammatory lesions and neurodegeneration leads to motor, cognitive and sensory 
impairments in people with multiple sclerosis (MS).  Accumulation of disability is at least partially 
due to diminished capacity for neuroplasticity within the central nervous system. Aerobic exercise 
is a potentially important intervention to enhance neuroplasticity since it causes upregulation of 
neurotrophins and enhances corticospinal excitability which can be probed using single-pulse 
Transcranial Magnetic Stimulation (TMS). Whether people with progressive MS who have 
accumulated substantial disability could benefit from walking rehabilitative training to enhance 
neuroplasticity is not known. 
Objective: We aimed to determine whether 10 weeks of task-specific walking training would 
affect corticospinal excitability over time (PRE, POST and 3-month Follow-Up) among people 
with progressive MS who required walking aids.  
Results: Eight people with progressive MS (7 females; 29-74 years-old) with an Expanded 
Disability Status Scale of 6-6.5 underwent harness-supported treadmill walking training in a 
temperature controlled room at 16°C (10 weeks; 3 times/week; 40 minutes at 40-65% heart rate 
reserve). After training, there was significantly higher corticospinal excitability in both brain 
hemispheres; reductions in TMS active motor thresholds and increases in motor evoked potential 
amplitudes and slope of the recruitment curve (REC). Decreased intracortical inhibition (shorter 
cortical silent period) after training was noted in the hemisphere corresponding to the stronger 
hand only. These effects were not sustained at follow-up. There was a significant relationship 
between increases in corticospinal excitability (REC, area under the curve) in the hemisphere 
corresponding to the stronger hand and lessening of both intensity and impact of fatigue on 
activities of daily living (Fatigue Severity Scale, and Modified Fatigue Impact Scale, respectively).  
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Conclusion: Our pilot results support that vigorous treadmill training can potentially improve 
neuroplastic potential and mitigate symptoms of the disease even among people who have 
accumulated substantial disability due to MS. 
Keywords: Transcranial Magnetic Stimulation (TMS), Neuroplasticity, Rehabilitation, Exercise, 





Multiple sclerosis (MS) is a chronic neurodegenerative disease that causes structural (i.e. brain 
lesions and atrophy) and functional (i.e. neuronal connectivity and conduction alterations) central 
nervous system dysfunction261. Most people with MS are initially diagnosed with the relapsing-
remitting form of the disease (RRMS). RRMS is considered to be the inflammatory phase of MS 
with unpredictable development of central nervous system lesions that result in physical, sensory, 
and/or cognitive symptoms (i.e. relapses)2. About 80% of people diagnosed with RRMS will 
eventually develop secondary progressive MS (SPMS), that is considered to be less inflammatory 
and more neurodegenerative2, 3. As well, approximately ten percent of people with MS present 
with primary progressive MS (PPMS), in which there is a steady disease progression from initial 
diagnosis of MS2, 3. Several lines of evidence suggest that accumulation of disability in progressive 
MS is related to diminished capacity for neuroplasticity2, 3, 262. Because most disease modifying 
drugs act by reducing neuroinflammation, these same treatments do not seem to be as effective 
during progressive stages263. Treatments that provide neuroprotection and enhancement of 
neuroplasticity to recover function and halt MS progression are highly warranted14, 52, 125, 264, 265. 
Animal and human research has shown that exercise enhances neuroplasticity by upregulating 
neurotrophins that facilitate cerebral gliogenesis, neurogenesis, synaptogenesis, and angiogenesis 
(for reviews see 60, 266). In some neurological conditions, such as Alzheimer’s disease267, stroke60, 
217 and spinal cord injury268, exercise has also been shown to promote neuroplasticity. In MS, 
studies have shown that engagement in physical exercise training improves aerobic capacity42, 43, 
physical function (e.g. walking capacity)107, and mitigates physical symptoms (e.g. reduce fatigue, 
muscle weakness)43, 269, 270. Recent studies support that a high degree of task practice (e.g. 
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constraint-induced movement therapy) can enhance neuroplasticity in people with progressive 
MS271, suggesting that there is continued capacity for plasticity even in later stages of the disease. 
In humans, rehabilitation-induced neuroplasticity is typically measured using functional brain 
imaging272, 273 and transcranial magnetic stimulation (TMS)20. TMS generates a brief magnetic 
field through an insulated coil placed on the participant’s scalp that induces neuronal activation of 
the primary motor cortex resulting in a motor evoked potential (MEP) travelling through the 
corticospinal tract20. Studies using TMS in healthy individuals have shown that exercise training 
promotes corticospinal excitability changes that are related to enhanced neuroplasticity32, 33, 38, 236. 
Typical TMS biomarkers that demonstrate exercise training-induced changes in corticospinal 
excitability include lower motor thresholds35 and higher input-to-output MEP amplitudes 
responses38; biomarkers mediated by increased glutamatergic (excitatory) neurotransmission274. 
As well, in healthy individuals, exercise training has shown to reduce cortical silent period (CSP) 
duration33, 34, an interruption of the electromyographic activity of a sustained muscle contraction 
after TMS-elicited MEP, suggestive of less activity of the inhibitory neurotransmitter gamma-
aminobutyric acid (GABA)20, 29. 
Excessive GABAergic-mediated intracortical inhibition and lower corticospinal excitability 
measured with longer CSP and higher motor thresholds and lower input-to-output MEP 
amplitudes, respectively, are biomarkers of neurological impairment (e.g. stroke and MS)30, 48, 87, 
88, 116, 118, 125 and reduced neuroplastic potential16, 31. In MS, demyelination causes delay of the onset 
latency of the TMS-elicited MEP51. Since MEP latency shortening is associated with recovery of 
physical function after stroke28 and is faster in physically active individuals35, in addition to 
excitatory and inhibitory TMS variables, MEP latency could also be altered by exercise221. 
Although evidence from cross-sectional studies suggest a possible link between greater physical 
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fitness and enhanced neuroplasticity in MS41, no study has investigated the long-term effects of 
exercise training on neuroplasticity-like mechanisms using TMS, particularly in progressive stages 
of MS. 
The primary aim of the present study was to investigate whether an rehabilitative walking training 
program induced corticospinal excitability changes related to enhanced neuroplasticity in people 
with progressive MS with severe MS-related walking disabilities. Since, excessive fatigue is 
among the most disabling symptoms in progressive MS107 and previous research has demonstrated 
the link between corticospinal excitability, fatigue41, 120, 275 and fitness levels41, 49, our secondary 
aim was to investigate whether exercise training-induced corticospinal excitability changes were 
associated with changes in physical fitness (cardiorespiratory fitness, body fat)98 and subjective 
levels of fatigue134, 276. 
5.2 Materials and Methods 
5.2.1 Experimental design 
This study was part of a feasibility and proof-of-principle interventional study aiming at restoring 
walking function among patients with MS-related walking disability54. The data on feasibility and 
restoration of walking has been reported elsewhere54. This interventional study (10-week, 3x/week 
exercise training) with TMS assessment Pre, Post, and 3-month Follow-up was approved by the 
local health ethics board prior to initiation (Health Research Ethics Board, #2019.0225, 
NCT04066972). 
5.2.2 Participants 
Ten participants were recruited via referral from neurologists and physiotherapists in the local MS 
clinic, as well as from an outpatient rehabilitation service discharge database. All participants 
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signed informed consent prior to study inclusion. Recruitment and screening details have been 
described elsewhere54. Participants; 1) were diagnosed with progressive MS (SPMS or PPMS), 2) 
reported no relapses three months prior to inclusion, 3) presented with walking impairments (e.g. 
use of bilateral or unilateral gait aids), 4) had disability level  6.0 on the Expanded Disease Status 
Scale (EDSS), 3) were capable of participating in physical exercise (as per Physical Activity 
Readiness Questionnaire (PAR-Q) screening form277), and 4) were eligible to undergo TMS278 and 
Dual Energy X-ray Absorptiometry (DEXA)279 as per screening procedures. Written informed 
consent was obtained from participants for the publication of any potentially identifiable images 
or data included in this article. 
Two participants dropped out during the intervention54, reporting not being able to commit 
to the proposed frequency of exercise sessions (3x/week). Eight participants (7 females) completed 
the intended exercise training and pre-post data was collected. One participant (number 2) could 
not be reached during follow-up assessment. Participant demographics are presented in table 5.1.
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Table 5. 1 Participants’ Demographics, Body Composition, and Fitness 













Lean mass (Kg) VO2peak (mL.min-1kg-1LM) Body Fat % 
Pre Post 3-mo Pre Post 3-mo Pre Post 3-mo 
1 PPMS 6.5 Walker 55-60 10 57.22 58.47 59.88 20.05 21.71 19.48 45.6 46.6 46.5 
2 SPMS 6.5 Walker 55-60 33 43.26 44.64 - 22.61 20.75 - 44.8 44.5 - 
3 PPMS 6.5 Walker 40-45 19 54.99 57.06 57.63 24.79 34.28 29.74 35.1 35.4 34.6 
4 SPMS 6.0 Cane 45-50 28 29.47 31.18 33.56 41.84 36.98 36.50 39.1 39.6 36.9 
5 SPMS 6.5 Cane 35-40 19 54.31 56.05 54.52 33.31 37.87 41.17 39.1 40.0 37.8 
6 SPMS 6.0 Cane 70-75 18 32.87 32.32 33.12 31.61 37.69 41.28 34.4 37.4 33.1 
7 PPMS 6.5 Walker 70-75 10 - - - 27.31# 21.69# 18.09# - - - 
8 SPMS 6.0 Cane 25-30 2 41.74 43.56 42.62 48.28 48.66 48.13 44.7 40.8 39.9 
Note: DD, disease duration; EDSS, Expanded Disability Status Scale; MS, Multiple Sclerosis; PPMS, primary progressive MS; SPMS, secondary progressive MS; 
# participant 7 declined to undergo Dual Energy X-ray Absorptiometry, and the maximal (peak) volume of oxygen uptake (VO2peak (mL.min-1Kg-1Lean Mass(LM)) was 
calculated by diving this participant’s VO2peak (mL.min-1) by the LM (kg) of total sample mean. 3-mo, 3-month follow-up. 
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5.2.3 Exercise intervention 
Participants underwent a 10-week (3x/week) of vigorous treadmill walking exercise 
training in a temperature-controlled room (16ºC)54. The treadmill was equipped with a harness to 
prevent falls and to support ≤ 10% of participants’ body weight. The dosage target of the exercise 
was 40 minutes (5 minutes warm-up and cool down) at a moderate-high intensity (40-65% heart 
rate reserve) which was adjusted throughout the training by increasing the speed and incline of the 
treadmill and/or reducing body weight support. Manual assistance to advance legs and resting 
breaks of ≤ 2 minutes were provided whenever necessary54. 
5.2.4 Outcome measures 
All outcome measures were assessed before the intervention (n = 8), after the 10-week 
period intervention (n = 8) and at 3-month follow-up after the exercise intervention had ended (n 
= 7). 
5.2.4.1 Cardiorespiratory fitness 
Levels of cardiorespiratory fitness were assessed as the peak rate of oxygen uptake (VO2peak 
expressed in mL O2.min) during a graded maximal exercise test performed on a recumbent stepper 
(NuStep, Ann Arbor, MI, USA) as described elsewhere41, 54, 217, 221, 280. Briefly, participants 
exercised at a cadence of 80 strides per minute while the equipment resistance level (1-10, 
beginning at level 3) was increased by one level every 2 minutes. If exhaustion was not reached at 
resistance level 10 (maximal NuStep resistance) the cadence was increased by 10 strides per 
minute every 2 minutes. Heart rate was continuously monitored during the test (H10, Polar Electro 
Inc., Kempele, Finland). The maximal and resting heart rate were used to calculate the proposed 
intensities of the exercise sessions (e.g. intensity target = 60% × (Heart RateMax – Heart RateRest) 
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+ Heart RateRest)). Fitness levels were calculated as the absolute VO2peak (mL O2.min) relative to 
the total lean body mass (kg) (VO2peak = mL O2.min
-1Kg-1lean mass). The latter has been shown to be 
a more accurate measure of cardiorespiratory fitness in populations with a high body fat 
percentage281. 
5.2.4.2 Body composition 
Participants’ total body weight (kg), body fat percentage (%), and lean body mass (kg) 
were assessed using whole body Dual Energy X-ray Absorptiometry (Discovery-A densitometer, 
Hologic Inc., Bedford, MA, USA). Trained technicians calibrated the system prior to each 
assessment and built-in software was used to analyze the data (v.12.6.1:3, Hologic Inc., Bedford, 
MA, USA). 
5.2.4.3 Total amount of workload performed during the exercise sessions 
Total amount of workload performed was estimated using standardized equations98. First, 
the VO2 (mL O2.min
-1.Kg-1) uptake during the exercise was calculated using the equation VO2 (mL 
O2.min
-1.Kg-1) = [(Resting component (3.5mL O2.min
-1.Kg-1) + Horizontal component (speed 
(m/min) x 0.1mL O2.Kg
-1.meter-1) + Vertical Component (1.8mL O2.Kg
-1.meter-1 x speed (m.min-
1) x inclineFractional Grade)]; adjusted for treadmill changes in speed and incline throughout the 
exercise were taken into consideration. The averaged VO2 (ml O2.min
-1.Kg-1) was transformed into 
metabolic equivalents. The kilocalorie (Kcal)/minute was calculated using the equation Kcal/min 
= (Metabolic equivalents x 3.5 x total body weight in kg) / 200. Finally, the total amount of 
workload performed was calculated by multiplying the Kcal/minute by the total time in minutes 
the participants exercised. This data was calculated from the first and the last exercise session 
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participants performed during the exercise training and from the exercise session performed during 
the follow-up visit. 
5.2.4.4 Levels of fatigue 
The intensity of fatigue perceived by the patients was assessed by the Fatigue Severity 
Scale (FSS)276, 282, whereas the impact of fatigue on activities of daily living was measured by the 
Modified Fatigue Impact Scale (MFIS)134, 283, 284 (for more details see54). 
5.2.4.4 Transcranial magnetic stimulation 
Monophasic magnetic pulses were delivered to the right and left brain hemispheres using 
a BiStim 2002 stimulator (Magstim Co. Whitland, UK). With participants seated, a coil (70mm 
figure-of-eight coil; Magstim Co. Whitland, UK) was positioned tangentially to the scalp with the 
handle pointing backwards and laterally at an 45 angle from the midline perpendicular to the 
central sulcus to deliver posterior-anterior directed pulses in the area of the primary motor 
cortex233. Electromyographic (EMG) activity and MEPs were collected by surface electrodes 
(Kendall 200 Coviden, Mansfield, MA, USA) placed on the contralateral first dorsal interosseous 
hand muscle. Assessing corticospinal excitability on a non-exercised muscle (i.e. FDI rather than 
leg muscles) was considered important in order to more accurately investigate widespread effects 
on central nervous system mechanisms involved in brain plasticity258, 285. A neuronavigation 
system (Brainsight, Rogue Research Inc, Montreal, QC, Canada) was used to ensure consistency 
of the coil position (i.e. angle and orientation) on participants’ scalp during the TMS assessment. 
The Montreal Neurological Institute brain template was rendered in the BrainSight software and 
used as a 3-D stereotaxic template92. The same system was used to collect EMG muscle activity 
and record MEPs with its built-in EMG system. The system collects at a sample rate of 3kHz and 
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uses a 2500 V/V amplification and a gain of 600 V/V with a bandwidth of 16-550 Hz. Stronger 
and weaker hands were determined during baseline assessment (Pre) by EMG recorded in the FDI 
muscle while participants performed a pinch grip maximal voluntary contraction (MVC) (mean 
EMG activity during MVC (stronger vs weaker hand (mean±SD)): 106.07 ± 79.3µV vs 51.49 ± 
45.12µV; Z = -2.34, p = 0.018). In order to be more precise when differentiating between stronger 
and weaker sides’ brain-to-muscle connectivity (potentially less and more affected sides, 
respectively), EMG signal was prioritized over force production, since EMG represents the 
electrical activity from motor units firing action potentials generated by the central nervous system. 
5.2.4.4.1 Motor thresholds and MEP latency 
Suprathreshold TMS stimulations were delivered at different locations around the hand 
primary motor area. The location with the highest average peak-to-peak MEP amplitude was 
chosen as the hotspot. The hotspot was re-assessed at Pre, Post, and Follow-up, since it can show 
variability235 and changes following interventions (e.g. exercise234). The relative frequency method 
was used to determine resting motor thresholds (RMT) and active motor thresholds (AMT)20, 286, 
and were determined as the minimum TMS intensity (maximal stimulator output percentage, 
MSO%) required to elicit peak-to-peak MEP amplitudes of  50 V at rest (RMT) and  200 V 
with participant performing 10% of pinch grip MVC (AMT) in at least 5 out of 10 trials. RMT and 
AMT are reported as MSO% (0-100). MEP latencies were determined from the valid MEPs 
collected during the RMT experiment and were calculated as the time (in milliseconds (ms)) 
between the TMS artifact and the MEP onset; the timepoint where the MEP amplitude surpassed 




5.2.4.4.2 Excitatory and Inhibitory recruitment curves 
To create recruitment curves, TMS stimulation intensities of 105%-155% of AMT 
(increments of 10%) were employed in randomized order with participants performing a pinch 
grip at 10% of MVC49. Three to six stimulations38, 193, 287 were delivered at each intensity and the 
averaged peak-to-peak MEP amplitude (µV) and CSP time (ms) were recorded. CSP was defined 
as the time between the MEP onset to the return of EMG activity ( ±2 standard deviation from 
background EMG activity)20. MEP amplitudes were normalized to the largest peak-to-peak 
amplitude236 collected during baseline assessment (i.e. first TMS session; prior to beginning of the 
exercise training). A linear relationship between the normalized MEP amplitudes against the used 
TMS intensities (105-155% of AMT) determined the excitatory recruitment gain and accuracy 
(slope and R2 of the linear relationship, respectively) of the corticospinal tract in recruiting 
neurons87, 236, both previously reported potential biomarkers of corticospinal tract integrity237. 
Similarly, the inhibitory recruitment curve slope and R2 was calculated by plotting the CSP time 
against the TMS intensities. As an estimate of overall corticospinal excitation (MEP amplitudes) 
and inhibition (CSP time), the area under the curve was calculated using the trapezoid rule ΔX x 
(Y1+Y2)/2, with X being the TMS intensity used (105-155% of AMT) and Y being the normalized 
MEP amplitudes (% of largest baseline MEP) or the recorded CSP time. 
5.2.5 Statistical Analysis 
A priori, we planned to use a one-way repeated measures analysis of variance and Friedman 
test when testing normal and non-normally distributed data, respectively. Because tests of 
normality (e.g. Shapiro Wilk) typically require samples sizes of n ≥10 to generate reliable 
results288, the more robust non-parametric alternative (i.e. Friedman test)289 was preferred245 to 
determine changes in TMS variables (RMT, AMT, and excitatory and inhibitory recruitment 
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curves (MEP amplitudes105-155% AMT, CSP time105-155% AMT, slope, R
2, and area under the curve)), 
fitness (mL.min-1Kg-1LM, body fat %), and workload performed (Kcal/session), at the different time 
points (Pre, Post, and follow-up). Analysis between time points (Pre vs Post vs Follow-up) is 
reported as χ2(degrees of freedom) = test statistic, p-value. When statistically significant (p < 0.05), 
Bonferroni corrected pairwise comparisons were performed to identify the difference across time 
points, and the adjusted p-value for multiple comparisons is reported. All data in the text is 
presented as median (Mdn). 
Relationships between changes in cardiorespiratory fitness (mL.min-1Kg-1lean mass), lean mass 
(Kg), body fat (%), levels of fatigue (FSS, MFIS), workload performed (Kcal/session) and TMS changes 
were investigated with Spearman’s coefficient (rho) at the unadjusted significance level of p < 
0.05. Change scores were calculated as % changes = post – pre / pre. 
Difference between TMS values of the stronger and weaker hand were investigated 
separately for each time point (Pre, Post, Follow-up) with Wilcoxon non-parametric paired t-tests. 
5.3 Results 
5.3.1 Exercise training increased corticospinal excitability in both hemispheres 
Friedman’s test showed a significant difference for AMT between time points (Pre, Post, 
Follow-up) in both stronger and weaker hands (χ2(2) ≥ 8.27, p ≤ 0.016). Pairwise analysis revealed 
higher corticospinal excitability (i.e. lower AMT) in participants post compared to pre intervention 
in both stronger (MSO%; Mdn (Pre vs Post) = 33 vs 27, p = 0.033) and weaker hands (MSO%; 
Mdn (Pre vs Post) = 41 vs 37, p = 0.013) which returned to baseline at follow-up (Figure 5.1A 
and B). Higher variability was found for RMT; no change, increases, and decreases of RMT were 
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noted across participants in both hemispheres (stronger and weaker hands), and no statistically 
significant changes were observed in either hemisphere (Figure 5.1C and D).
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(A and B) Increased corticospinal excitability (CSE) was noted during active motor threshold 
(AMT) assessment, in both brain hemispheres (i.e. corresponding to the weaker and stronger 
hands) as lower values of the maximal stimulator output (MSO%) were needed to elicit motor 
evoked potentials (MEPs) in the contralateral first dorsal interosseous muscle (200µV amplitude 
MEPs collected during 10% of pincer grip maximal voluntary contraction). AMT returned to 
baseline during the 3-month follow up period assessment (3-mo). (C and D) There was no 
difference in MSO% between time points (Pre, Post, 3-month follow-up) for resting motor 
threshold (RMT) (i.e. MEPs collected during resting) measured in the hemisphere corresponding 
to the weaker hand. Because the absence of MEPs is an outcome that represents too low CSE (i.e. 
100% of MSO not eliciting MEPs)27, participants in this condition are represented as open circles. 
Pre intervention, too low CSE (i.e. no MEPs) was noted in Participant 2’s stronger and weaker 
hands during RMT assessment. This participant’s weaker hand demonstrated some recovery of 
CSE post intervention as RMT’s MEPs could be elicited at 92% of MSO. Lowered CSE (no MEPs) 
at 3-month follow-up was noted in participant 8’s weaker hand as AMT and RMT could not be 
recorded. 




Corticospinal gain (excitatory recruitment curve slope) was statistically different between 
time points in both stronger and weaker hands (χ2(2) ≥ 8.40, p ≤ 0.015). Pairwise analysis revealed 
increased capacity to recruit excitatory neurons with increased TMS stimulation intensities (i.e. 
higher slope) post compared to pre intervention (Mdn = (Pre vs Post) = stronger: 1.33 vs 2.20, p = 
0.013; weaker: 0.67 vs 2.08, p = 0.028), which returned to baseline at follow-up (Figure 5.2). 




After 10-weeks of exercise training, availability to recruit corticospinal tract neurons with 
increased transcranial magnetic stimulation intensities was increased (i.e. higher slope) in both 
brain hemispheres corresponding to the stronger and weaker hands and returned to baseline at 3-
month follow-up (3-mo). Though, two participants (number 6 and 8) continued to increase 
corticospinal gain in the hemisphere corresponding to the weaker hand during follow up. The 
recruitment curve as collected using transcranial magnetic stimulation intensities of 105-155% of 
the active motor threshold (AMT) (increments of 10%), and the slope was determined from a linear 
regression between the normalized MEP amplitudes (% of the largest baseline motor evoked 
potential (MEP)) against the TMS intensities performed (105-155% of AMT).
Figure 5. 2 Effects of 10-week treadmill walking exercise training on corticospinal gain. 
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For MEP amplitudes, statistical significance between time points were noted at the 
intensities of 135% (χ2(2) = 7.00, p = 0.030) and 145% (χ
2
(2) = 9.33, p = 0.009) of AMT in the 
weaker hand, and at 145% of AMT in the stronger hand (χ2(2) = 6.00, p = 0.050). In all cases, 
pairwise analysis revealed increased corticospinal excitability (higher normalized MEP 
amplitudes) post compared to pre intervention with return to baseline at follow-up (% of largest 
baseline MEP; Mdn (Pre vs Post): weaker hand: 135% of AMT: 85.49 vs 111.39, p = 0.028; 145% 




(A) Higher normalized MEP amplitudes (% of largest baseline MEP) demonstrate higher 
corticospinal excitability after the exercise training (ET) with return to baseline at 3-month follow-
up (3-mo) in the hemisphere corresponding to the stronger hand at a transcranial magnetic 
stimulation (TMS) intensity of 145% of the active motor threshold (AMT) and (B) in the 
hemisphere corresponding to the weaker hand at the TMS intensities of 135% and 145% of the 
AMT. 




5.3.2 Exercise training reduced intracortical inhibition in the hemisphere corresponding to 
the stronger hand 
In the stronger hand, differences between time points time were noted for CSP investigated 
in all TMS intensities (105-155% of AMT; χ2(2) ≥ 6.00, p < 0.050). Pairwise analysis revealed 
reductions of CSP time post compared to pre intervention across all intensities used (p ≤ 0.048), 
which returned to baseline level at follow-up (Figure 5.4A). In the hemisphere corresponding to 
the weaker hand, there was a statistical significance difference for CSP time at the different time 
points at lower TMS intensities (105-125% of AMT (χ2(2) = 6.33, p = 0.042)), however statistical 
significance was not reached during pairwise analysis (p ≥ 0.063; Figure 5.4B).
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(A) In the hemisphere corresponding to the stronger hand, shorter CSP time (ms) at all transcranial 
magnetic stimulation intensities used (105-155% of active motor threshold AMT)) suggested less 
GABAergic-mediated intracortical inhibition post exercise training (ET), with return to baseline 
at 3-month follow-up (3-mo). (B) In the hemisphere corresponding to the weaker hand, although 
statistical significance was reached for the TMS intensities of 105, 115, and 125% of AMT 
between the different time points (Friedman’s test: Pre vs Post vs 3-mo; χ2(2) = 6.33, p = 0.042), 
there was no statistical significance during pairwise analysis. 




5.3.3 Changes in body composition, fitness, and exercise performance 
Lean body mass of the participants increased from pre to post intervention and from post 
intervention to follow-up, however, only the change from pre to follow-up was statistically 
significant (χ2(2) = 7.00, p = 0.030; Mdn, lean mass (Kg) (Pre vs Follow-up): 41.74 vs 48.57, p = 
0.028) (Figure 5.5A). Body fat also decreased during follow-up, and a statistical significance was 
noted from post to follow-up (χ2(2) = 8.33, p = 0.016; Mdn, body fat % (Post vs Follow-up): 40.00 
vs 37.35, p = 0.012; Figure 5.5B). 
Although 4 out of 8 participants improved their cardiorespiratory fitness (mL.min-1Kg-1lean 
mass), no overall statistical change was reached (p ≥ 0.368; Figure 5.5D). However, an increased 
capacity to perform exercise were noted as participants were able to perform a higher exercise 
workload (Kcal/session) in the last compared to the first exercise session (χ2(2) = 7.14, p = 0.028; 
Mdn, Kcal/session (Pre vs Post) = 121.39 vs 70.24, p = 0.023), and this capacity was maintained 
during follow-up (Figure 5.5C).
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(A) Amount of lean body mass (Kg) measured using Dual Energy X-ray Absorptiometry (DEXA) was higher at 3-month follow-up (3-
mo) compared to pre exercise training. (B) body fat percentage (%) measured using DEXA was lower at 3-month follow-up compared 
to post exercise training. (C) participants were able to perform a higher exercise workload (Kcal/session) at their last exercise session 
compared to the first. Total amount of workload performed was estimated using standardized equations98.(D) No change was noted for 
cardiorespiratory fitness measured as peak rate of oxygen uptake during a graded maximal exercise test (VO2peak = mL.min
-1Kg-1of lean 
mass (LM)). 
Figure 5. 5 Effects of 10-week treadmill walking exercise training on body composition and physical fitness 
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5.3.4 Overall corticospinal excitation increased post intervention in the stronger hand and 
was associated with reductions in fatigue 
In the stronger hand, overall corticospinal excitation (AUC, normalized MEP amplitudes) 
differed between time points (χ2(2) = 11.14, p = 0.004). Pairwise analysis revealed increased overall 
corticospinal excitation (higher AUC) post compared to pre intervention (Mdn, AUC105-155% of AMT 
(Pre vs Post) = 3237 vs 3947, p ≤ 0.016) with returned to baseline level at follow-up (Figure 5.6A). 
Relationship analysis demonstrated that greater increases in overall corticospinal excitation in the 
stronger hand were associated with greater reduction in fatigue severity levels measured with the 
FSS (rho = 0.762, p = 0.028; Figure 5.6B) and fatigue impact measured with the MFIS (rho = 




Figure 5. 6 Ten weeks of treadmill walking exercise training induced increased overall corticospinal excitation that was 
associated with reductions in subjective fatigue 
(A) In the hemisphere corresponding to the stronger hand, higher overall corticospinal excitation was noted post exercise training, with 
complete return to baseline during 3-month follow-up (3-mo). Overall excitation was calculated as the area under the curve (AUC) using 
the trapezoid rule ΔX x (Y1+Y2)/2, with X being the transcranial magnetic intensities used (105-155% of AMT; increments of 10%) and 
Y being the normalized MEP amplitudes (% of largest baseline MEP). (B) Increases in overall excitation (AUC) in the hemisphere 
corresponding to the stronger hand were associated to reductions in subjective levels of fatigue measured using the fatigue severity scale 
(FSS) and the modified impact scale (MFIS).  
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Nerve conduction speed (MEP latency) did not change in either side (χ2(2) ≤ 1.14, p ≥ 0.565; 
Mdn, milliseconds (Pre vs Post vs Follow-up): stronger hand: 24.17 vs 24.51 vs 22.12; weaker 
hand: 26.26 vs 25.94 vs 25.97). 
All the TMS values (median and range), differences between stronger and weaker hands 
across time points, and reasons for missing values across time points are reported on Table 5.2.
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Table 5.2 Transcranial Magnetic Stimulation Values Between Stronger and Weaker Sides  
Median (range) Pre Training Post Training 3-month Follow up 
TMS Variable Stronger Weaker Sig. Stronger Weaker Sig. Stronger Weaker Sig. 
RMT (MSO%) 40 (28-68)a 45 (30-73)a 0.618 37 (22-76) 48 (26-92) 0.205 43 (24-56)d 40 (29-81)f 0.138 























































































































































































































































































































































































































Note:  AMT, active motor threshold; CSP, cortical silent period; eREC, excitatory recruitment curve; iREC, inhibitory recruitment curve; MEP, motor 
evoked potential; MSO%, maximal stimulator output percentage; RMT, resting motor threshold; eREC Slope = MEP Amplitude (µV) by TMS intensity105-
155% AMT; iREC Slope = CSP time (ms) by TMS intensity105-155% AMT;  Area under the curve (AUC) was calculated for both excitatory and inhibitory RECs 
using the trapezoid rule ΔX x (Y1+Y2)/2, whereby X were the MSO% used (i.e. X axis values, 105-155% of AMT) and Y are the recorded CSP lengths (ms) 
or the MEP amplitudes (µV). 
 
* Difference between stronger and weaker hand is statistically significant at α < 0.05. 
a, missing data from participant 2 due to too low corticospinal excitability (i.e. no resting MEPs)). 
b, missing data from participant 2 and 7 due to too high AMT (AMT = 100% and 82%, respectively), thus the required increases in MSO% based on AMT 
to assess the REC could not be performed) 
c, missing data from participant 7 due to high AMT (AMT = 76%), thus the required intensities of 135-155% of AMT could not be performed, and the slope, 
R2 and AUC could not be calculated). 
d, Time point with n = 5 (participant 2 could not be reached during follow-up assessment, missing data from participant 7 and 6 due to too low corticospinal 
excitability (i.e. no resting MEPs) and overheating of equipment (i.e. stimulator). 
e, missing data from participant 2 (could not be reached during follow-up). 
f, missing data from participant 2 (could not be reached during follow-up) and 7 (too low corticospinal excitability, (i.e. no resting or contracting MEPs 
(RMT and AMT)). 




We undertook this study to determine whether a 10-week, 3x/week walking exercise 
training program would alter corticospinal excitability among people with walking disability due 
to progressive MS. We report four main findings. First, exercise training resulted in short-term 
enhancement of corticospinal excitability in both brain hemispheres, which was lost when re-
assessed during follow-up three months later. Secondly, participants’ intracortical inhibition was 
decreased after training, however, this effect was also short-term (lost at follow-up) and was 
restricted to the hemisphere corresponding to the stronger hand. Thirdly, the training augmented 
lean mass and reduced body fat, and although there was no change in cardiorespiratory fitness 
measured as peak of oxygen consumption, capacity to perform exercise (workload) was increased 
after training and sustained at follow-up54. Finally, enhancement in corticospinal excitability in the 
hemisphere corresponding to the stronger hand was correlated with reductions in both severity and 
impact of fatigue on everyday life (FSS and MFIS, respectively). 
5.4.1 Physical exercise training to enhance corticospinal excitation in progressive MS 
Motor thresholds and MEP amplitudes are considered indicators of corticospinal 
excitation; mediated by glutamate and its activity on NMDA and AMPA receptors20, 274. In fact, 
higher glutamatergic receptor activity is associated with greater capacity for synaptic plasticity290, 
291 and disruption of this excitatory circuitry is responsible for diminished neuroplasticity and 
lower capacity to learn new tasks and recover from neurological damage (e.g. aging, stroke, MS) 
14, 27, 262. Therefore, there are important initiatives underway to develop new treatments (e.g. 
exercise, pharmacological, non-invasive brain stimulation) aimed at increasing glutamatergic-
mediated brain excitation in the injured brain to enhance neuroplasticity and recover function27, 
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215, 265, 275, 292, 293. For instance, studies using TMS have confirmed that, in comparison to those who 
are less physically active, individuals with higher fitness have lower motor thresholds and higher 
MEP amplitudes35 (i.e. higher corticospinal excitability) and demonstrate superior increases in 
MEP amplitudes (i.e. greater neuroplastic response) following paired associative stimulation to 
induce neuroplasticity38, 39. 
We have previously shown that acute exercise increases corticospinal excitation (i.e. higher 
MEP amplitude) and reduces intracortical inhibition (i.e. shorter CSP) among people with walking 
disability due to progressive MS49. Importantly, this effect was noted only in the stronger hand49, 
likely due to a more intact (i.e. less affected) contralateral corticospinal representation48. Here, we 
showed bilateral reductions in AMT, increases in MEP amplitudes, and superior motor neuronal 
recruitment (higher recruitment curve slope) after 10 weeks of aerobic exercise training. This 
suggests that the stimulus from regular exercise training may have led to the chronic enhancements 
in excitatory synaptic transmission noted in these participants. Moreover, even though the 
hemisphere corresponding to the weaker hand, which was likely more affected by MS48, 174, was 
unresponsive after one exercise session49, in this longer term exercise training, it demonstrated 
capacity to improve in synaptic excitatory transmission. It is interesting to observe that Nicoletti, 
et al. (2019) recently reported enhanced corticospinal excitation in people with progressive MS 
after 4 weeks of D-aspartate treatment which aimed  to enhance NMDA receptor activity265. They 
also showed increases in MEP amplitudes following intermittent theta burst stimulation (i.e. 
enhanced neuroplasticity)265. It appears that exercise training has comparable benefits in terms of 
enhancing capacity for neuroplasticity in progressive MS. It is important to note that, the 
corticospinal excitability enhancements reported here and those by Nicoletti, et al. (2019) were 
short term and disappeared 3 months after cessation of the intervention. Therefore, we suggest that 
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treatments that enhance neuroplasticity, such as physical exercise training, should be prescribed 
continuously in progressive MS to protect the brain, improve brain function, and likely to 
potentiate the effects of treatments (e.g. drugs) and other neuroplasticity-inducing protocols (e.g. 
non-invasive brain stimulation). 
5.4.2 Physical exercise training to reduce intracortical inhibition in progressive MS 
When applying suprathreshold TMS stimulations to the primary motor cortex with 
participants performing a tonic muscle contraction of the contralateral target muscle, the length of 
the period of cessation of muscle activity (CSP) is an indicator of intracortical inhibition mediated 
by the activity of the inhibitory neurotransmitter GABA on its ionotropic and metabotropic 
receptors (GABAA and GABAB, respectively)
20, 29. Although the cortical and spinal contribution 
to the CSP length is still unclear20, 294, it is generally accepted that the cortex is the main modulator 
of CSP change29. Because excessive GABAergic-mediated intracortical inhibition is considered 
pathological25, 295, detrimental to neuroplasticity16, 31, 295, 296, and is associated with disease 
progression in MS88 and stroke40, decreasing its activity is an attractive treatment strategy to boost 
neuroplasticity16, 295. 
In healthy people and people with stroke, studies have confirmed that even a single bout 
of aerobic exercise is able to acutely reduce short intracortical inhibition40, 169, 219, 248, 258 assessed 
with TMS paired-pulse, a TMS biomarker of GABAA-receptor activity
20. We recently reported a 
similar effect after acute aerobic exercise in people with progressive MS49. Interestingly, here we 
showed that after 10 weeks of exercise training, CSP duration was reduced at all TMS intensities, 
indicating reductions in both GABAA and GABAB-mediated intracortical inhibition. This result 
aligns with findings in healthy individuals demonstrating that 4-12 weeks of strength exercise 
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training reduced both GABAA and GABAB-receptor activity, as decreasing in short-intracortical 
inhibition and duration of the CSP elicited at higher TMS intensities, respectively32. We have 
previously shown that among people with MS, superior cardiorespiratory fitness was related to 
shorter CSP41. In our present findings, although there were no significant improvements in 
cardiorespiratory fitness measured as the peak of oxygen consumption (VO2peak), there were other 
indicators of improved physical health98 such as higher capacity to perform exercise (i.e. 
Kcal/session), greater lean mass, and lower body fat percentage, and increases in other parameters 
of cardiorespiratory fitness such as the oxygen uptake efficiency slope (for details see 54). The fact 
that the beneficial reduction (acute and long-term) in intracortical inhibition was only observed in 
the brain hemisphere corresponding to the stronger hand may suggest a greater neuroplastic-
potential of inhibitory mechanisms in the hemisphere thought to be less affected by MS. 
Furthermore, our walking training provided a high degree of task-specific training107, 297, 298. 
Ziemann, U. et al. (2001) has shown that less GABAergic-mediated intracortical inhibition, 
assessed with TMS, was essential for motor learning processes from task-specific training to 
occur224. Decreasing GABAergic-mediated intracortical inhibition has also been proposed to be 
an important factor initiating increases in muscular strength32-34. Although we did not measure 
muscular strength (e.g. MVC pre-post training), we did note increases in lean mass at post and 
follow-up as well as improvements in walking function (e.g. walking speed; see54). Altogether, 
this indicates that long-term physical exercise that utilizes task-specific training in highly disabled 
people with progressive MS reduces intracortical inhibition and possibly improves and restores 
physical function through enhanced neuroplasticity. Though, because no correlation between 
changes in intracortical inhibition, body composition, and walking function was noted, it remains 
to be answered whether decreasing intracortical inhibition would lead to improvements in learning 
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and restoration of function in people with MS. Future research should examine whether such 
effects would take place in a larger sample with different walking abilities using a randomized 
controlled design. As well, because we measured overall gains in walking function54 and body 
composition, future research should examine whether the enhanced plasticity (reduced inhibition) 
measured in the hemisphere corresponding to the stronger side of the body indeed translates into 
global brain function improvement285 (e.g. bilateral and cognitive function) or whether it is 
restricted to the contralateral representation. This would be an important discovery for 
interventions aiming at improving function of the most affected side. 
It is interesting that, when compared to healthy controls, some studies have shown reduced 
intracortical inhibition (shorter CSP) in MS patients152, 299. Nantes, et al., (2016) reported that 
shorter CSP correlated with lower whole brain cortical volume (MRI, magnetic transfer ratio) in 
progressive MS, and that, interestingly, longer CSP was a predictor of upper extremity motor 
dysfunction122. Therefore, when compared to the healthy central nervous system (CNS), the CNS 
affected by MS may display decreased activity of inhibitory mechanisms that, curiously, may work 
as a compensatory mechanism during brain disease. The concept that there are compensatory 
mechanisms that increase brain excitation and decrease brain inhibition in order to preserve brain 
function in CNS disease has been recently proposed by other authors14, 41, 48, 130, 300, 301. However, 
these processes are certainly not uniform across CNS disorders. For instance, in Parkinson’s 
disease, Fisher, B. E. et al., (2008) showed that high-intensity treadmill exercise program improved 
walking performance and lengthened CSP time302, which is typically shortened in people with 
Parkinson’s disease303. Thomas, S. L. et al., (2005) also showed lengthening of CSP in people with 
incomplete spinal cord injury after a regimen of treadmill training304. Although the mechanisms 
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are not entirely clear, our work and the work of others suggests that rehabilitation and exercise 
primes the CNS as measured by shifting of CSP. 
5.4.3 Corticospinal excitability and fatigue in MS 
Fatigue is one of the most disabling symptoms in MS41, 120, 275. Although the etiology of 
MS-related fatigue is not completely understood, neuroimaging studies (e.g. MRI, fMRI) have 
proposed that its development and progression is due to structural and functional abnormalities in 
both cortical and subcortical areas275. Previous studies have shown that 10-12 weeks of physical 
exercise training can lessen subjective fatigue in people with MS119, including progressive MS54, 
231. Based on previous findings showing an association between shorter CSP and lowered levels 
of subjective fatigue in a cohort of people with MS41, we proposed that improving fitness through 
exercise training could mitigate fatigue by decreasing GABAergic-mediated intracortical 
inhibition (i.e. shortening CSP). In this current pilot study, we reported a strong association 
between increases in corticospinal excitation (recruitment curve; AUC) and reductions in 
subjective fatigue (FSS and MFIS). Nicoletti, et al (2019) also demonstrated reductions in 
subjective fatigue (FSS) and increases in corticospinal excitation (intracortical facilitation) after 
D-aspartate treatment in people with progressive MS265. Furthermore, Créange et al. (2013) have 
also shown increases in corticospinal excitation (e.g. RMT reduction) and reduction in levels of 
fatigue after erythropoietin treatment to improve walking in people with progressive MS305. Our 
results and the results of others support that there is a link between corticospinal 
excitation/inhibition and fatigue which should be examined in larger trials. In fact, non-invasive 
brain stimulation methods (repetitive TMS, transcranial direct current stimulation) which aim to 
increase cortical excitation and treat MS fatigue have been recently proposed275. It is important to 
note that the above mentioned experiments, and the present study, measured perceived (i.e. 
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subjective) fatigue and not fatigability (i.e. muscle/performance fatigability measured during 
contraction). Nonetheless, because perceived fatigue and fatigability closely associate306, our 
results showing reduced levels of perceived fatigue and improved fitness suggests that following 
training, subjects required less physical effort to perform activities of daily living, suggesting 
superior energy availability and reduced fatigability306. Therefore, we propose that exercise 
training might be able to mitigate symptoms of fatigue possibly by acting through increases in 
excitatory circuitry. 
5.4.4 Limitations 
There are some important limitations to consider when interpreting the results of the 
present study. First, this was a small pilot study, and no statistical sample size calculation was 
conducted for the outcomes presented in this manuscript, which limits the statistical power to 
obtain conclusive results. Second, no control group was included which limits the conclusion on 
the true effect of the intervention. Third, as only patients with progressive MS and severe MS-
related walking disabilities (EDSS 6.0-6.5) were included, the findings may not be applicable for 
relapsing remitting and/or less disabled MS patients. Despite these limitations, the novel insights 
from this study may serve as a rationale for larger studies and continued efforts in investigating 
the effects of exercise and physical rehabilitation on neuroplasticity and functional recovery in 
MS. 
As for considerations for future studies, although the aim to this study was to investigate 
changes in corticospinal excitability in a non-exercised hand muscle to demonstrate widespread 
effects of exercise training on global brain plasticity258, 285, investigating muscles that were more 
involved in the walking training (e.g. lower limb muscles) could provide more insight regarding  
the link between the trained muscle and cortical function (TMS)33. Moreover, having participants’ 
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neuroimaging data (e.g. magnetic resonance imaging) could help to better understand the role of 
lesion volume and location on exercise-induced corticospinal excitability changes. We determined 
averaged MEP amplitudes and CSP times from a small number of trials (three to six) as done 
previously by others38, 193, 287, and with participants performing tonic contraction, in order to reduce 
intra subject variability33. Future studies should examine the optimal number of stimulation 
trials307 in order to produce reliable MEP/CSP data. With respect to the TMS recruitment curve 
parameters, we  used linear regression (TMS intensities by MEP amplitudes), as done by others87, 
236, in an attempt to assess the corticospinal tract recruitment gain (slope) and accuracy (R2); 
biomarkers previously proposed by Potter-Baker, K. A. et al (2016) to reflect morpho-
physiological integrity of the corticospinal tract in stroke237. However, more studies are necessary 
in order to understand what the best model is (e.g. sigmoidal237 or linear87, 236) when calculating 
these parameters, while taking into consideration the different TMS methodologies (e.g. range of 
TMS intensities employed), the clinical population (e.g. stroke, MS), and lesion profile (e.g. lesion 
volume, location). 
5.5 Conclusion 
To our knowledge, this is the first study to investigate longer term effects of exercise on 
corticospinal function using TMS in patients with progressive MS. This exploratory pilot study 
provides evidence that a neuroplastic potential still exists in patients with progressive MS and 
severe MS-related walking disability. Specifically, we found that 10 weeks of vigorous treadmill 
training reduced intracortical inhibition and increased corticospinal excitability. These 
corticospinal adaptations were predominately found in the brain hemisphere corresponding to the 
stronger hand, suggesting a greater neuroplastic potential in the hemisphere that may be less 
affected by MS. Moreover, the exercise-induced enhancement in cortical excitation was associated 
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with reductions in fatigue, suggesting this as a potential mechanism involved in the effects of 
exercise on fatigue. The novel findings from this pilot study highlight the importance of long-term 
exercise efforts – even in patients with progressive MS – and can serve as a rationale for future 
studies and continued efforts in investigating the effects of exercise on the brain. 
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6.1 Thesis Overview 
 Two of the most important uses of any health biomarker are, 1) to track disease progression 
and, 2) to examine the mechanistic underpinnings of a therapy (‘how’ treatments work). The aim 
of my doctoral research was to use TMS to investigate CSE biomarkers of disease and symptom 
progression in MS and to examine whether exercise training would positively impact those 
biomarkers. My research asked the question, “Can superior fitness and exercise boost brain 
mechanisms to improve neuroplasticity and act as a disease modifying therapy to mitigate brain 
dysfunction and reduce symptoms in MS?” Such research would further inform therapists and 
clinicians of the importance of exercise prescription and rehabilitation to affect the central nervous 
system. My doctoral work addressing such questions was accomplished in four stages (i.e. studies). 
6.2 Summary of findings 
The main findings from the studies (Chapters 2, 3, 4, and 5) included in the thesis are 
summarized in the following sections. 
6.2.1 Findings from Chapter 2 
I undertook this study to examine the link between cardiorespiratory fitness, CSE, 
circulating tumor necrosis factor, and subjective symptoms of fatigue in MS.  
The key findings of this study were: 
1) Across all levels of disability, MS patients had very low levels of 




2) When controlling for MS demographics, low cardiorespiratory fitness predicted 
longer CSP time, a biomarker of increased GABAergic-mediated intracortical 
inhibition. 
3) Increased GABAergic-mediated intracortical inhibition (longer CSP) predicted 
worsened fatigue. 
In this study, I learned that: 
1) The levels of cardiorespiratory fitness were alarmingly low in this population 
of people with MS. This is concerning since, low fitness is known to contribute 
to comorbidities, increase risk of all-cause mortality, and may intensify 
symptoms and progression of MS. 
2) Poor fitness predicted greater GABAergic-mediated intracortical inhibition 
(longer CSP), a biomarker of impaired neuroplasticity. Poor fitness might be 
linked to an inability of the MS brain to undergo plastic changes, which could 
contribute to progression of MS and/or poor recovery from brain dysfunction 
and symptoms provoked by MS. 
3) Greater GABAergic-mediated intracortical inhibition predicted greater fatigue, 
which may indicate that this central nervous system mechanism is being 
responsible for some of the fatigue in MS. 
6.2.2 Findings from Chapter 3 
 Although unilateral deficits are commonly reported, studies investigating CSE 
typically report no differences in CSE between hemispheres in MS (i.e. no side-to-side 
differences). In this study, I challenged this concept by calculating a laterality index 
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between the hemispheres corresponding to the stronger and weaker sides. Also, I tested 
whether (a)symmetry would be useful as a biomarker of disease progression in MS. 
The key findings of this study were: 
1) Calculating a laterality index based on hand impairment (e.g. weaker 
and stronger sides) revealed two subgroups of people with MS: 1) 
people with MS with higher CSE (i.e. lower AMT) in the weaker side, 
who were less disabled and had less severe MS symptoms, and 2) people 
with MS with higher CSE in the stronger side, who were more disabled 
and had more severe MS symptoms. 
2) When controlling for MS demographics, the degree of CSE asymmetry 
towards higher CSE in the stronger side predicted worsened MS 
symptoms. 
In this study, I learned that: 
1) Higher CSE in the weaker side could be explained by the higher degree of 
neuroinflammation-mediated hyperexcitability, that may affect predominantly 
one hemisphere in early MS. This loss of this unilateral neuroinflammation-
mediated hyperexcitability may indicate a shift from inflammatory to 
neurodegenerative phases and signify MS progression.  
2) The AMT asymmetry ratio may serve as a biomarker in MS helping with 
surveillance of MS and predicting its progression as well as monitoring the 
effects of drugs and rehabilitative therapies. 
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3) Since one brain hemisphere can be predominantly affected during the course of 
MS, it may be important to consider such pathophysiology, and, rather than 
assessing sides arbitrarily (e.g. right, left, dominant, non-dominant), TMS 
experimenters should better discriminate between sides (e.g. affected, less 
affected) when performing TMS in people with MS. 
6.2.3 Findings from Chapter 4 
 In this study, I investigated whether neuroplasticity could occur in people with progressive 
MS in response to a single exercise session and whether the degree of exercise-induced 
neuroplasticity would be fitness dependent. 
 The key findings of this study were: 
1) Controlling for age, in the stronger side, reductions in intracortical inhibition 
assessed as CSP investigated at lower TMS intensities (105% of active motor 
threshold) and decreases in resting motor threshold (increased CSE) were 
associated to superior cardiorespiratory fitness (VO2max). In the weaker side, 
increases in MEP amplitude assessed at 145% of active motor threshold were 
associated to lower body fat percentage. 
2) As a group, exercise-induced CSE changes were noted in the hemisphere 
corresponding to the stronger hand only. Specifically, reduced intracortical 
inhibition investigated as CSP time stimulated at 115% of AMT and increased 
MEP amplitude tested using 125% of AMT were noted in the stronger hand 
post exercise. The hemisphere corresponding to the weaker hand was resistant 
to exercise-induced neuroplasticity and no CSE changes were noted. 
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In this study, I learned that: 
1) Exercise was able to positively induce CSE changes in this group of highly 
disabled people with progressive MS. This demonstrates that there is still 
capacity in the progressive MS brain to promote neuroplasticity, and moreover, 
can be induced by a single exercise session. 
2) The exercise-induced CSE benefits were noted in the brain hemisphere 
corresponding to stronger hand, only. No pre-post exercise CSE change was 
noted in the hemisphere corresponding to the weaker hand. This suggests that 
the hemisphere corresponding to the weaker hand, likely more affected by MS, 
was resistant to CSE changes induced by a single exercise session. 
3) Participants who were fitter (higher VO2max and lower body fat percentage) had 
greater CSE responsiveness to the exercise session. Exercise workload 
(Kcal/session) was not associated with CSE changes. This indicates that 
reducing sedentarism, prescribing exercise in the longer term, and decreasing 
body fat may positively affect the MS brain and potentiate the effects of 
neuroplasticity inducing-protocols in progressive MS. 
6.2.4 Findings from Chapter 5 
 I undertook this study to investigate whether a longer term exercise training aimed at 
restoring walking would induce CSE changes related to enhanced neuroplasticity in severely 
affected people with progressive MS who required walking aids (e.g. canes, walker).  
 The key findings of this study were: 
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1) After the exercise training, CSE was increased in both brain hemispheres as 
noted by decreases in AMT and increases in the ability of recruiting neurons 
with accordingly increases in TMS stimulation intensities (i.e. slope and area 
under the curve of the excitatory recruitment curve). 
2) Exercise training reduced intracortical inhibition (shortened CSP) only the 
hemisphere corresponding to the stronger hand. This CSP reduction was noted 
when tested at all TMS stimulation intensities (105-155% of AMT), likely 
signifying reductions in both GABAA- and GABAB-receptor activity. 
3) After training, increased overall CSE (excitatory recruitment curve area under 
the curve) in the stronger hand was associated with reductions in subjective 
fatigue (severity and impact of fatigue on daily life). 
4) All training-induced CSE enhancements were short-term, and disappeared three 
months after cessation of training (follow-up assessment). 
In this study, I learned that: 
1) Three months of this task-specific walking exercise training was able to 
enhance CSE in these deconditioned and severely affected people with 
progressive MS. Specifically, CSE increased bilaterally, while intracortical 
inhibition reduced only in the hemisphere corresponding to the stronger hand. 
This may indicate that, while exercise training was able to increase 
glutamatergic activity bilaterally, reduced GABAergic activity was restricted to 
the likely more intact hemisphere. Such CSE enhancements may signify 
enhanced neuroplastic capacity post-training. 
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2) The fact that all CSE enhancements were short-term may suggest on the 
importance of exercise prescription in the long-term, probably with no 
cessation, to maintain brain health and potentiation of neuroplastic mechanisms 
in people with progressive MS. 
3) Enhancement in CSE in the hemisphere corresponding to the stronger hand was 
correlated with reductions in both severity and impact of fatigue on everyday 
life. Exercise training might be able to mitigate symptoms of fatigue by acting 
through CSE enhancements. 
6.2 Overall Discussion  
The findings of my doctoral work provided evidence supporting the use of TMS to study 
the MS brain and provide biomarkers of disease progression in MS. Using TMS, I also 
demonstrated that improved levels of fitness and exercise training can positively affect the MS 
brain and reduce symptoms even in late stages of MS, by potentially enhancing neuroplasticity-
like mechanisms. In the following sections, I have linked and discussed the studies findings’ 
(Chapter 2, 3, 4, and 5), discussed its strengths and weaknesses, and provided insight for future 
research. 
6.2.1 Using TMS to Provide Biomarkers in MS 
In MS, the integrity of the central nervous system as well as disease activity is, to date, 
mainly probed with the use of imaging techniques such as Magnetic Resonance Imaging (MRI). 
MRI is the gold-standard technique in order to evaluate the presence of cortical and/or spinal 
lesions (i.e. disease-associated structural change) for the ultimate diagnosis MS. However, its use 
for monitoring dysfunction and disease activity has been shown to be less efficient. For instance 
MRI does not correlate with dysfunction and symptoms, and for this reason are considered weak 
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biomarkers in MS144, 145. This is not surprising since it is possible that symptoms arise and/or 
intensify due to dysfunction of brain networks that develop prior to structural damage detected by 
MRI. That is the reason why the use of electrophysiological tools that can measure brain 
connectivity and its molecular activity such as TMS20 is appealing to provide earlier and more 
sensitive brain biomarkers in MS51. By endeavouring to determine central nervous system 
excitability abnormalities that could help better monitor MS activity and predict its progression, 
several studies have suggested the potential use of TMS as a tool in MS management51, 53, 87, 147. 
However, despite its apparent usefulness, TMS findings in the MS literature is often conflicting, 
and, as with MRI, TMS has been considered a weak tool providing biomarkers in MS51. This 
discrepancy across studies’ results could be due to the different MS populations included and the 
heterogeneity of MS, small sample sizes included, and/or the different TMS methodologies 
employed across studies51. 
Standardization of TMS methods across laboratories could help to create a common 
understanding of CSE in MS, and ultimately a better understanding the rehabilitation-induced 
changes in the MS brain. In regard to that, the results of my studies (Chapter 3, 4, and 5) 
demonstrated that, because MS is a neurological disease and can affect brain hemispheres 
indiscriminately, rather than assessing brain hemispheres arbitrarily (e.g. left, right, dominant, non-
dominant), considering hand impairment might be essential to improve TMS results and provide 
better TMS biomarkers, and to understand rehabilitation-induced CSE changes in MS. Another 
factor that might contribute to the lack of concordance among TMS studies’ results, interpretations, 
and conclusions, is the numerous existing TMS protocols that are used. An example of that, are 
the many and popular TMS paired-pulses paradigms20, in which new protocols continue to be 
developed at the time of this writing. Briefly, during TMS paired-pulses, a conditioning stimulus 
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(first stimulation) is followed by a test stimulus (second stimulation) that is separated by a certain 
interval (interstimulus interval) in milliseconds. Depending on the interstimulus interval, 
intracortical mechanisms can be studied such as short- and long-intracortical inhibition and 
intracortical facilitation. In order to be comprehensive, however, a TMS paired-pulse experiment 
require testing in a wide range of stimulus intensities and interstimulus intervals due to the high 
inter- and intra-subject variability; in other words, subjects inhibit and facilitate at different stimuli 
and intervals308. This comes with the expense of a lengthy experiment that is not always practical 
in clinical settings. Moreover, because paired pulses rely on two stimulator units, incongruent 
voltage delivery during paired stimulation is highly possible and stimulation intensities for the 
conditioned and test stimulus may not remain standardized during the assessment221, 286. In fact, 
this occurred during my experiments and I was informed by the TMS manufacturer that there could 
be variation in pulse strength during paired-pulse protocols (~11 MSO% or ~350v difference 
between our TMS units output). Since most experiments often do not take those factors into 
consideration, the outputs could generate unreliable data without the experimenter even being 
aware of it. In my research, I carefully designed a single-pulse TMS experiment that was based on 
previously proposed concepts in an attempt to investigate multiple mechanisms of CSE. In the next 
session, I discuss in more detail each of the TMS variables included in my studies in the context 
of their proposed neurophysiology, clinical implications, and recommendations for future 
research. 
6.2.2 Single Pulse TMS to investigate Multiple Mechanisms of CSE 
6.2.2.1 Motor Thresholds – Is AMT a better biomarker than RMT? 
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A typical TMS assessment starts with the assessment of motor thresholds – the least TMS 
intensity to elicit a MEP in the corresponding muscle20. Motor thresholds are mainly used to adjust 
for individual factors (e.g. skull thickness, levels of arousal) to ensure normalization of the 
subsequent TMS experiments20. Because motor thresholds are reflective of global CSE, they can 
also be used as biomarkers. Resting motor threshold (RMT) is collected in the resting muscle (i.e. 
complete muscle relaxation), and because in this condition corticospinal motor neurons are below 
firing threshold, RMT MEPs likely result from the summation of many indirect waves (I-waves) 
from cortico-cortical connections20, 203. Because these cortico-cortical synapses are dependent on 
voltage-gated sodium channels, RMT is therefore believed to be mediated largely by glutamatergic 
synaptic activity203. Motor threshold can also be investigated in the contracted muscle, referred to 
as the active motor threshold (AMT)20. Physiologically, the difference between RMT and AMT is 
not entirely known20, 203. However, when compared to RMT, MEPs are more easily elicited during 
AMT assessment (requiring lower stimulation intensity), which implies that previously recruited 
indirect waves from the individual’s own voluntary motor drive (i.e. already-firing motor neurons), 
brings motor neurons closer to their firing threshold. AMT-evoked MEP likely results from direct 
waves (D-waves) and may evaluate more directly the axonal threshold (rather than temporo-spatial 
summation) and deeper corticospinal tract neurons20, 203. In my studies AMT was, in general, a 
stronger and more consistent biomarker than RMT. For instance, in my first study (Chapter 2), MS 
demographics (age, disease duration, disability, and MS type) were better predictors of AMT than 
RMT. In my second study (chapter 3), the index ratio using AMT (AMT (a)symmetry), but not 
RMT predicted multiple (physical and cognitive) objective and subjective MS symptoms. In my 
fourth study, AMT but not RMT was reduced after exercise training. The neurodegenerative 
processes in MS have been convincingly shown to be mediated by glutamatergic excitotoxicity. 
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Previous research has shown that spinal motor neurons are more vulnerable to neurodegeneration 
from glutamate-mediated excitotoxicity than cortical neurons309. It is possible that by investigating 
AMT, we better target these deeper corticospinal connections that are possibly more sensitive to 
glutamatergic activity, consequently better evaluating current and past MS-related processes. 
Another reasonable explanation for the AMT’s superiority as a biomarker is that MEPs, when 
controlling for muscle torque (i.e. during muscle contraction), are more reliable and may decrease 
inter- and intra-subject variability32, 33. Although it would seem that collecting both RMT and AMT 
would be standard practice, in MS, many studies have investigated RMT while relatively few have 
investigated AMT. My findings suggest that studies should consider collecting AMT preferably 
when studying CSE in MS. Future studies, in healthy and other clinical populations, should attempt 
to thoroughly investigate the physiological differences between RMT and AMT. 
6.2.2.2 Recruitment Curve to measure MEP amplitudes and CSPs to provide information 
on excitatory and inhibitory mechanisms 
In a healthy brain, incrementally increasing TMS stimulation intensity (e.g. above 
threshold; 120% of RMT) produces corresponding increases in peak-to-peak MEP amplitudes20.  
Assessment of MEP amplitudes at these suprathreshold increments provides an indication of 
corticospinal glutamatergic-mediated excitation as a consequence of faster temporospatial 
summation at corticospinal synapses and recruitment of high-threshold motor neurons.  The output 
curve that is produced in this experiment is called the recruitment curve (or MEP/stimulus response 
input-output curve); a very useful and important biomarker of CSE20, 237. In my early experiments, 
I observed that RMT was often impossible to elicit among people with MS having high levels of 
disability. Since RMT is the benchmark from which to create a recruitment curve, these patients 
would have absent values which would be subsequently lost in the analysis.  I modified the method 
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of measuring recruitment curve by taking AMT as the baseline and by performing fewer 
stimulations at each TMS intensity. In this way, I found that we were able to collect important data 
while decreasing experiment time, avoiding patient fatigue, and preventing equipment 
overheating. Furthermore, because I collected the recruitment curve during muscle contraction, 
the TMS variable cortical silent period (CSP), an interruption of background EMG activity post-
MEP and a biomarker of GABAergic-mediated intracortical inhibition, was concomitantly 
collected. Collecting CSPs at a wide range of stimulation intensities has been previously proposed 
as an alternative way to measure short- and long-lasting inhibition (GABAA- and GABAB-receptor 
activity, respectively)20, 29. It was interesting to note that, in my studies’ findings in progressive 
MS, reduced CSP was more prominent when assessed at lower TMS intensities after acute 
exercise, whereas after long term exercise, CSP was reduced at all TMS intensities. I also showed 
reduced CSP assessed at higher intensities in fitter MS individuals. These CSP findings coincide 
with data collected after exercise using paired pulse TMS techniques in healthy individuals 
showing reduced short intracortical inhibition (GABAA -receptor activity) after both acute and 
long-term exercise40, 258, and reduced long-intracortical inhibition (GABAB-receptor activity) after 
longer-term training32-34. The concordance between my findings using CSP derived from single 
pulse TMS, and the work of others using paired pulse TMS techniques, suggests there may be 
several methods to obtain the same biomarker. My experiences in observing data patterns and 
adapting the TMS technique for a unique group of individuals with substantial motor impairment 
supports the need for clear TMS protocols. Clearly, there is an art and a science of TMS; a field 
that is in its infancy. My future work will involve deciphering the neurophysiological mechanisms 
underlying these techniques in animal models. 
159 
 
6.2.3 Is There a Potential Link between Inflammation and CSE? 
The findings from chapter 3 showed that people with MS may display asymmetrical 
corticospinal excitability, in which, an asymmetry towards higher excitability in the hemisphere 
corresponding to the weaker hand predicts earlier and asymptomatic MS, whereas a shift towards 
an asymmetry towards less excitation in the weaker hand predicts late and more symptomatic MS. 
From this result, I proposed that this hyperexcitability in earlier stages could be reflective of 
increased MS activity and higher degree of neuroinflammation in the more affected hemisphere 
(i.e. corresponding to the weaker hand). In MS, hyperexcitability is known to cause 
neurodegeneration-mediated by excitotoxicity1-3; this could explain the gradual shift from higher 
to lower excitability in the more affected hemisphere as MS progresses. Nonetheless, to confirm 
such theory, longitudinal, and larger studies should be performed, ideally including additional 
techniques (e.g. brain imaging, inflammatory markers) for a better understanding of whether shift 
of CSE asymmetry relates to hyperexcitability and neurodegeneration-mediated by excitotoxicity.  
6.3 Summary and Conclusions 
In summary, the work within this thesis supports that TMS is a potential method to measure 
integrity of the corticospinal tract and possibly even the stage of inflammation or 
neurodegeneration in MS. Some of the variables derived from TMS more consistently relate to 
disease demographics and others are more responsive to exercise. The work outlined in this thesis 
is a starting point to develop and refine TMS techniques in neurological disorders. It helps set the 
stage for future research understanding the underlying mechanisms of TMS and creating a valid 
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